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Understanding brain health is crucial in diagnosing, preventing and treating neurocognitive 
conditions (e.g., dementia). However, the literature reveals discrepancies around the 
interpretation of brain health and differences between populations. This thesis investigates 
brain health measures from different disciplines, including: resting cerebral blood flow 
(CBF) and cerebrovascular reactivity (CVR) (using transcranial Doppler (TCD) ultrasound 
and magnetic resonance imaging (MRI)); cognition (including attention and memory); and 
quality of life (QoL) questionnaires. Differences between age (younger versus older) and 
cardiorespiratory fitness (fit versus unfit) groups were also investigated. Importantly, these 
multimodal brain health measures were completed in the same cohort. 
Declines were observed between younger and older groups in resting CBF measures 
(derived using TCD and MRI), and cognitive performance measures (attention-switching, 
learning and memory). In the older group, higher fitness offset declines in resting CBF and 
improved markers of cognition. In both groups, fitness significantly positively correlated 
with better QoL. However, no differences between age or fitness groups were observed in 
CVR measures. Further, CVR differed significantly depending on the imaging and analysis 
approach used. Future research is required to elucidate the cause of discrepancies and 
determine differences between groups (i.e., age/fitness/disease). Further, robust approaches 
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PASL    Pulsed arterial spin labelling 
PETCO2   End-tidal carbon dioxide 





PC angiography  Phase contrast angiography 
PCO2    Arterial content of carbon dioxide 
RAND-36  Research and Development 36-item short form survey 
RoI    Region of interest 
RT    Reaction time 
RTI    Reaction time task 
SPSS    Statistical package for the social sciences  
SWM    Spatial working memory 
TCD    Transcranial Doppler 
tDCS    Transcranial direct current stimulation  
QoL    Quality of life 
VE-CO2   Ventilatory sensitivity to carbon dioxide 
V̇O2 max   Maximum oxygen consumption 




1. INTRODUCTION  
 
Optimal functioning of the human brain is crucial in living a healthy lifestyle and avoiding 
neurological and psychiatric conditions that are associated with impaired brain health (e.g., 
dementia and depression). Complications arise when considering what the optimal 
approaches are for measuring brain health, as there is no singular universally agreed 
measure. Rather, there are countless outcome measures that have developed from a range 
of different scientific disciplines, each with very different and complex theoretical 
underpinnings. The overall aim of this PhD was to investigate a number of different 
approaches in obtaining brain health outcome measures; specifically, cerebral blood flow 
(CBF) (resting CBF and cerebrovascular reactivity (CVR) using transcranial Doppler 
(TCD) ultrasound and magnetic resonance imaging (MRI)), cognitive performance and 
quality of life. Further, associations with ageing and fitness were investigated. 
 
Chapter 2 introduces several approaches in measuring brain health that are present in the 
scientific literature, and includes their theoretical underpinnings, populations they have 
been investigated in, advantages and disadvantages of the chosen technique, and further 
questions that warrant investigation. This leads to a summary of research questions this 
thesis aimed to address.  
 
Chapter 3 investigated transcranial Doppler (TCD) ultrasound methodological approaches 
in assessing brain health by calculating the common outcome measure of CVR (i.e., the 
cerebrovascular response to breathing room air with increased carbon dioxide (CO2)). 
Specifically, the CO2 stimulus duration and method of data extraction (i.e., the defined 





approaches affected the TCD-derived CVR outcome measure. The stimulus duration and 
method of data extraction did indeed alter the outcome measure. Therefore, caution should 
be taken when comparing results between studies that use different stimulus durations of 
steady state time-points. This led to the question of whether different imaging modalities 
(e.g., TCD versus MRI) would also affect outcome measures involving CBF (either resting 
CBF or CVR).  
 
Therefore, Chapter 4 investigated different brain imaging modalities and analysis 
approaches in obtaining resting CBF outcome measures. Brain imaging modalities were 
TCD (middle cerebral artery blood velocity (MCAv), cerebrovascular conductance 
(CVCi), and cerebrovascular resistance (CVRi)), and MRI (cerebral perfusion and transit 
times obtained from the whole grey matter and specific regions of interest (RoIs)). Chapter 
5 investigated different brain imaging modalities and analysis approaches in obtaining 
CVR outcome measures. Brain imaging modalities were TCD (extracting 30-seconds of 
MCAv and end-tidal CO2 data from the stimulus duration) and MRI (calculating CVR 
from a linear regression across the whole stimulus duration, again obtained from the whole 
grey matter and RoIs). For both Chapter 4 and 5, differences between age and fitness 
groups were also investigated. Further, associations were calculated between outcome 
measures obtained using different approaches. 
 
Resting CBF measures showed similar differences between age and fitness groups, though 
none of the fitness effects were significant. These findings indicate that although resting 
CBF measures obtained using TCD and MRI are not technically measuring the same 
physiological phenomenon (i.e., TCD is targeting the centre of the MCA to obtain velocity 





between age and fitness groups. In contrast, no patterns were observed between age and 
fitness groups in CVR measures obtained using different modalities, illustrating that 
responses are different between the macro (i.e., MCA) and micro vasculature. Further 
TCD-derived and MRI-derived measures of CVR may be differentially affected by healthy 
ageing and aerobic fitness. 
 
Chapter 6 investigated whether differences in cognitive performance in several tasks 
(attention switching, memory, learning and mental arithmetic) and differences in quality of 
life (QoL) were observed between different age and fitness groups. The findings from 
these data showed that cognitive performance declines across the lifespan though can be 
offset by physical fitness. The fitness effect was specifically evident when looking at 
performance in the attention switching task and mental arithmetic, though fitness effects 
from the other cognitive tasks (memory and learning) were less clear. Quality of life 
measures significantly correlated with fitness in both the younger and older groups, 
indicating that being physically active improves mood and well-being and may protect 
against negative affect. Finally, Chapter 7 gives an overall conclusion of all the chapters 






2. BACKGROUND AND EXISTING LITERATURE  
    
2.1. Overview 
The aim of this chapter is to give an overview of the various brain health outcome 
measures that are used across different scientific disciplines and in clinical contexts, and 
consider how outcome measures are interpreted to reveal brain changes that occur during 
healthy ageing, in response to clinical conditions (e.g., dementia, stroke, depression), and 
in response to a targeted intervention (e.g., non-pharmacological interventions including 
cognitive training and physical exercise). This review will also consider how 
methodological approaches between research centres may change the outcome measures 
and interpretations. Further, recent studies will be discussed that combine different 
methodological approaches, and consider how they can be appropriately developed into 
multi-disciplinary brain health assessments that are individualised and person-centred.  
 
An exhaustive inclusion of all brain health outcome measures is beyond the scope of this 
review, here focus will be on: brain health outcome measures that assess structural and 
functional changes from different neuroimaging techniques (including Doppler ultrasound, 
magnetic resonance imaging (MRI) and near-infrared spectroscopy (NIRS)); brain health 
measures assessing performance in cognitive domains (including attention, memory, 
learning, emotional processing and mental arithmetic under time pressure); 
neuropsychological measures of psychological function used in a clinical context to 
determine severity of symptoms and therapeutic outcomes (via questionnaires), and quality 






2.2. Introduction and Background to Measuring Brain Health   
The incidence of cognitive decline and neurodegenerative diseases (e.g., stroke and 
dementia) is increasing. Numerous studies show that regular exercise has beneficial effects 
on brain health in healthy and clinical populations. However, the underlying mechanisms 
are poorly understood and the way in which ‘brain health’ is measured varies considerably 
between studies and disciplines. There is also a growing interest in optimising brain health 
in healthy individuals to improve cognitive function, emotional well-being and quality of 
life in an increasingly ageing population. Consequently, a robust measurement of brain 
health is necessary to: (a) assist with the diagnosis of conditions that are linked with 
impaired brain function; (b) determine whether a clinical or lifestyle intervention has been 
effective, and if so, by what mechanism(s), and (c) to understand and predict healthy 
ageing in relation to brain health for the general population. 
 
There is currently no universally agreed measure of brain health, and no single 
methodology that can adequately address any research question relevant to brain health. 
Therefore, the aims of this review are to: i) introduce the main methods that are currently 
used in the scientific and clinical literature; ii) consider the context in which they are used 
and the research questions that are being explored; iii) assess the strengths and weaknesses 
of each method considering the research question, and finally iv) consider how a 
combination of measures may be used to develop a multi-modal measurement of brain 
health. This will provide a much more informed and sophisticated overall picture of brain 
health. I will also address whether various methods are complementary or contradictory, 
particularly when assessing the same outcome measure (e.g., Doppler versus MRI 






Firstly, this review will introduce and discuss the theory and development of measures 
currently in use. These include imaging methods to measure cerebral blood flow (CBF) 
including: Doppler ultrasound (spanning transcranial Doppler (TCD), Duplex Doppler and 
transcranial colour Doppler (TCCD)), magnetic resonance imaging (MRI) (particularly 
arterial spin labelling (ASL) and blood-oxygen-level-dependent (BOLD) signal measures), 
and near-infrared spectroscopy (NIRS). They also include cognitive and 
neuropsychological measures such as: cognitive tasks (e.g., attention, memory, learning, 
emotional processing and mental arithmetic); clinical and neuropsychological batteries, 
and measures of well-being and quality of life. Next, these methods will be put into 
context by discussing the research questions in which they are used and consider the 
methodological strengths and limitations of each. Conflicts between and within different 
techniques including variations of use within the same technique will also be considered. 
Finally, the use of these measures specifically to assess the effects of physical exercise on 
the brain and natural variability of such measures across the lifespan due to healthy ageing 
will be reviewed. The overall purpose of this review is to shed light on the most 
appropriate measures of brain health to use that assess the effects of an exercise 
intervention in both clinical and healthy ageing populations. A summary of key studies 
using different brain health outcomes measures is presented at the end of this chapter 
(Table 2.1). 
 
2.3. Neuroimaging Brain Structure and Function 
The division between structural and functional imaging is difficult to define because they 
are often intertwined in the brain (Symms et al., 2004). Although definitions vary and are 
sometimes broad, structural imaging tends to be described as providing static anatomical 





information, often in response to a stimulus. The basis of functional neuroimaging 
measures involves the measurement CBF either at rest or during function (i.e., in response 
to a stimulus). This section will include a brief history of the measurement of CBF and the 
development of tools commonly used today, followed by focused sections on Doppler 
ultrasound technology, MRI and NIRS. 
 
2.3.1. Measuring Cerebral Blood Flow and Metabolism – A Brief History 
Over one hundred years ago, German physician and physiologist, Adolf Fick introduced 
the principle based on the conservation of mass; ‘that the quantity of a substance taken up 
by an organ per unit of time is equal to the blood flow through that organ multiplied by the 
difference between its arterial and venous concentrations’ (Fick, 1870). Since then the 
well-established ‘Fick principle’, originally proposed as a method of measuring cardiac 
output, has been translated to the assessment of CBF and has influenced the on-going 
development of this outcome measure.  
 
During the 1940s, cardiac catheterisation became available and the technique could be 
tested in humans. In 1945, Seymour Kety and Carl Schmidt applied the Fick principle to 
CBF measures in humans by using 15% nitric oxide (N2O) in air (Kety and Schmidt, 
1944). They then estimated blood flow across the whole brain from repeated sampling of 
arterial and jugular venous blood during inhalation of N2O (in air) until approaching tissue 
saturation (this would take approximately 10 minutes) (Figure 2.1). This became the first 






Figure 2.1. The Kety-Schmidt technique for measuring cerebral blood flow using nitric 
oxide (N2O) as a diffusible tracer. After approximately ten minutes of inhalation, brain 
tissue is reaching saturation and the arterial and venous concentrations of N2O are almost 
equal. The grey area is proportional to hemispheric blood flow (Kety, 1951). 
 
 
In 1951, the Fick principle was extended to account for the exchange of diffusible gases in 
the lungs and tissue and the convolution integral to CBF method was first applied in 
animals (Kety, 1951). This method, unlike earlier work, did not require brain tissue to 
meet saturation because the convolution integral yields tissue concentration at any time 
point. In these early animal studies, trifluoroiodomethane was inhaled or intravenously 
infused for one minute and post-mortem slices were used to determine cerebral uptake. 
This allowed for highly localised CBF measurements and clearly established differences in 






In 1961, human studies involving intra-carotid injections were introduced where the 
internal carotid artery (ICA) was injected with Xenon-133 (
133
Xe) a highly diffusible gas, 
and gamma radiation monitored by extracranial detectors (Ingvar and Lassen, 1961). 
Transit times were then implemented into a height divided by area analysis where the first 
quantitative regional assessment of CBF was possible in humans. Later developments 
involved less invasive inhalation methods rather than injections into the ICA (Mallett and 
Veall, 1965). Kety’s equation was first applied to human studies by using least squares 
curve fitting, which provided separate estimates of grey and white matter flow and 
133
Xe 
inhalation became the most widely used technique.  
 
Alongside these developments, brain imaging technologies such as Doppler ultrasound 
were evolving. In 1842 Austrian mathematician and physicist Christian Doppler described 
what is now known as the Doppler effect. This principle expresses how the observed 
frequency of a wave depends on the relative speed of the source and the observer. In the 
1950s, physicians used this principle to develop the first two-dimensional compound 
ultrasound scanner by incorporating an immersion tank using a cattle-watering container 
with an ultrasound transducer mounted on a wooden rail (described in Goldberg et al., 
1993; Figure 2.2). By the 1980s portable Doppler ultrasound technology was developed 







Figure 2.2. Colorado group’s earliest successful cattle-tank scanner. The transducer was 
mounted on a wooden rail that ran outside of the tank (Goldberg et al., 1993; reprinted 





The transducer uses the piezoelectric effect (pressure-electric) to create an ultrasound 
beam that is reflected to the transducer. Longitudinal waves bounce in and out of the tissue 
to produce a 2D grey scale ultrasound image. The beam continues through liquid densities 
and bounces back in response to air and bone, making it ideal for detecting soft tissue 
biological structures including the heart and arteries. When acquiring an image using 
ultrasound, identification of the acoustic window is required where there is a lot of liquid 
that allows the sound area to travel through so that the beam can reach biological 





CBF, and in 1982 Rune Aaslid developed and introduced the transcranial Doppler (TCD) 
method providing measurements of blood flow velocity in the middle cerebral artery 
(MCA), anterior cerebral artery (ACA) and posterior cerebral artery (PCA) (Aaslid et al., 
1982) located through the temporal bone above the zygomatic arch. 
 
The Circle of Willis provides the blood supply to the brain by connecting the internal 
carotid and vertebral artery (VA) circuits together (Figure 2.3). The ICA further divides 
into the MCA and ACA, and the MCA feeds the lateral sulcus. It is important that repeat 
measurements are taken from as close to the same location as possible to ensure that the 
same artery has been measured. Further, velocity measures may differ depending on where 
in the vessel they are taken. This is particularly evident in a clinical context, for example, 
in intracranial arterial disease where there is a focal increase in velocity at the site of 
luminal narrowing, and decreased velocity immediately downstream from the lesion 
(Sarkar et al., 2007). 
 
Figure 2.3. The main components of the Circle of Willis: the anterior cerebral artery, 
anterior communicating artery, the internal carotid arteries, posterior communicating 
artery, and the middle cerebral arteries (taken from American Accreditation HealthCare 





The application of Doppler ultrasound allows the methodological approach of calculating 
resting brain blood velocity (using TCD) as well as measures of vessel diameter and flow 
(using Duplex Doppler) and blood flow responsiveness (i.e., CBF response to a stimulus 
such as carbon dioxide or oxygen, or from a rapid change in blood pressure) outcome 
measures commonly acquired today, and these will be discussed in more detail in the next 
section.   
 
However, techniques using external detectors do not allow measurements of structure (i.e., 
hippocampal volume) or function (i.e., CBF) from deeper areas of the brain. During the 
1970s and 1980s, a form of MRI and computed tomography (CT) were developed, shortly 
followed by single-photon emission computed tomography (SPECT) and positron 
emission tomography (PET), allowing non-invasive neuroimaging that can now be used to 
reveal anatomical and CBF information from brain structures deep beneath the surface as 
well as the surface measures achieved with Doppler ultrasound. Each of these methods 
have strengths and limitations in what can be done with the methods, which will be 
discussed later in this chapter.  
 
2.3.2. Doppler Ultrasound 
The following section will describe Doppler ultrasound techniques in more detail including 
TCD, linear Duplex Doppler and TCCD. Current literature will be discussed including 
methodological development and considerations, and ageing and fitness effects on the 






2.3.2.1. Transcranial Doppler (TCD) 
Transcranial Doppler is a non-invasive technique used to measure CBF velocity within the 
cerebral vessels through ultrasound (described in more detail in Section 2.3.1). In the 
context of TCD, resting CBF velocity is used to index CBF. Responsiveness measures, 
where CBF changes in response to a stimulus, are often taken as well as resting CBF 
measures. General tests within this field include: cerebral autoregulation (CA) (Sorond et 
al., 2005, 2013; Meel-van den Abeelen et al., 2014), neurovascular coupling (NVC) 
(Sorond et al., 2011; Yam et al., 2005), and blood flow velocity response to increased 
carbon dioxide (CO2) inhalation (known as cerebrovascular reactivity/ responsiveness 
(CVR)) (Bailey et al., 2013; Barnes et al., 2013). These are discussed in more detail below 
after a brief overview of the main cerebral arteries that can be imaged using TCD. 
 
The MCA (Figure 2.3) has received the most attention in the literature because of its vital 
role in feeding the brain (total CBF perfusion distribution: MCA, 21%; distal MCA, 6%; 
ACA, 12%; distal ACA, 4%; ophthalmic artery, 2%; PCA, 8%; basilar artery (BA), 20%; 
and vertebral artery (VA), 28%; Zarrinkoob et al., 2015), its relative ease to locate using 
TCD, and that it has a high baseline velocity. For a more detailed review of this technique 
see a review by Willie and colleagues (Willie et al., 2011). The posterior cerebral artery 
(PCA) has also received attention and it had been assumed that the CVR outcome measure 
was similar within both posterior and anterior regions (Ainslie and Duffin, 2009), though 
other studies have challenged this assumption (Skow et al., 2013; Sorond et al., 2005). For 
example, Skow and colleagues reported that the absolute (though not relative) CVR 
measure was larger in the MCA compared to the PCA. Further, differences in both CA and 
CVR have been observed between the MCA and PCA territories (Sorond et al., 2005). 





exercise (Sato et al., 2011), heat (Bain et al., 2015) and hypoxia (Willie et al., 2012). 
Cerebral blood flow is measured with Doppler ultrasound in different ways depending on 
the technology used. Transcranial Doppler ultrasound measures CBF velocity in 
centimetres per second through the section of the artery being imaged. In contrast, Duplex 
Doppler measures of CBF involve a calculation of flow using measurements of CBF 
velocity and vessel diameter. Poiseuille’s Law describes the flow of fluids through an 
intravenous catheter. It states that the flow (Q) of fluid is related to a number of factors: 
the viscosity of the fluid (i.e., blood), the pressure gradient across the tubing (i.e., vessel), 
and the length and diameter (r) of the tubing. With regard to Duplex Doppler, the flow 
volume of an artery is determined using the formulae: flow volume = time-averaged 
velocity x area (Q = TAV x A) (Schöning et al., 1993).  
 
Transcranial Doppler has been used to measure brain health by assessing both absolute 
measures (i.e., cerebral blood flow velocity at rest) and functional measures in response to 
a stimulus (e.g., CVR). Measures of resting CBF velocity are often examined where 
participants are asked to lie down in a supine position, relax and breathe as naturally as 
possible whilst TCD measurements are taken (e.g., Ainslie et al., 2008; Brown et al., 2010; 
Bailey et al., 2013; Barnes et al., 2013). A key study by Ainslie and colleagues (2008) 
related to this thesis topic used this approach to quantify age-related and physical fitness 
effects on CBF (velocity). Their findings clearly demonstrated the age-related decline in 
MCA velocity independent of training status in healthy sedentary and endurance trained 
men between the ages of 18 to 79 years, and that MCA velocity was consistently elevated 






Figure 2.4. Graph showing the relationship between age, CBF velocity (obtained from the 
middle cerebral artery (MCAv)) and physical fitness. The red line represents the linear 
regression for the endurance-trained group. The blue line represents the linear regression 
for the sedentary group. MCAv was consistently elevated by 9.1 ± 3.3 cm · s
-1
 (CI = 2.7-
15.6, p = 0.006 (17%)) in endurance-trained men throughout ageing (Ainslie et al., 2008). 
 
 
Other studies have reported resting CBF values corrected for blood pressure and found 
similar age-related patterns (Brown et al., 2010; Barnes et al., 2013; Bailey et al., 2013) 
(Figure 2.5, A,C). Concurrent recordings of mean arterial blood pressure (MAP) enable 
researchers to calculate cerebrovascular conductance indices (CVCi) calculated as MCAv 
(cm·s
-1
) per MAP (mm Hg), and cerebrovascular resistance (CVRi), which is the inverse 
of CVCi (i.e., MAP/ MCAv). These measures have the additional benefit of accounting for 







Figure 2.5. Graphs showing the relationships between cardiorespiratory fitness and 
cerebrovascular haemodynamics in younger (A and B) and older (C and D) adults as a 
function of physical activity status. CVRCO2 indicates CVR to carbon dioxide (5% in air); 
MCAv, middle cerebral artery blood velocity; and V̇O2 max indicates maximal oxygen 
uptake (i.e., an individual’s peak aerobic capacity) (Bailey et al., 2013). 
 
 
Brown and colleagues reported similar patterns in older women (Brown et al., 2010); 
specifically, physically fit women had higher CVCi compared to their sedentary 
counterparts. Further, overall cognition was negatively correlated with age and positively 
correlated with fitness (as measured by V̇O2 max). In this study, fitness was calculated as 
a percentage of age-predicted V̇O2 max values (Tanaka et al., 1997) so that measures 
could be calculated across all participants without being confounded by effects of age. 
However, it could be argued that because the raw quantitative values derived from the 
fitness test are no longer being used, the fitness score is less representative due to the 
subjective nature that participants are put into one of three groups (determined by level of 
activity assessed via a questionnaire) to determine their age-predicted percentage, therefore 





Overall, these TCD-derived findings complement similar findings reported from MRI 
studies investigating baseline perfusion, where ageing is associated with a decrease in 
whole brain and region specific cerebral perfusion (Parkes et al., 2004; Chen et al., 2011; 
Clark et al., 2015); discussed in detail below. 
 
2.3.2.2. Cerebral blood flow regulation and Doppler Ultrasound 
High metabolic demands of the brain involving large amounts of oxygen over a relatively 
small mass are required to support the high rate of ATP production and glucose delivery, 
so that neuronal signal transmission is maintained (reviewed by Hoiland et al., 2016 & 
Bailey at al., 2009). This high rate of oxygen consumption is associated with a high 
‘vulnerability for failure’ and adequate delivery of oxygen to the brain via precise CBF 
regulation is vital to maintaining optimal function and avoid cellular damage (reviewed in 
Bailey et al., 2009).  
 
Cerebral autoregulation refers to the regulatory process of the brain vasculature that 
responds to maintain cerebral perfusion relatively constant during changes in blood 
pressure (BP) (Lassen 1959; Paulson et al., 1990; Van Beek et al., 2008; Lucas et al., 
2010; Willie et al., 2014) (Figure 2.6). Traditionally, a rise in MAP was considered to 
accelerate CBF, and a fall to slacken it (Bayliss et at., 1895). However, Lassen (1959) 
plotted average BP and total CBF from seven studies including 11 different patient groups 
(Figure 2.6), that revealed a plateau region where CBF appears to be stable across a wide 
range of blood pressures (~60-150 mm Hg).  Physiological studies support the idea of 
hysteresis in the dynamic pressure-flow relationship (reviewed by Ainslie and Brassard, 





The physiological relationship between reflex adjustments in cerebrovascular resistance 
and BP was termed static CA (Willie at al., 2014). Static CA (sCA) describes this CBF 
response over a longer period (i.e., minutes of BP change), whereas dynamic CA (dCA) 
traditionally refers to the alterations in CBF in response to rapid changes in BP (i.e., over 
seconds). Of note, a change in thinking regarding the distinction between sCA and dCA 
has emerged within the scientific literature where dCA may simply reflect a faster static 
function (Tan, 2012). This lack of clarity around the division between sCA and dCA 
parallels the MRI structural versus functional distinctions described above.  
 
Figure 2.6. Representation of the classical (left) and contemporary (right) relationships 
between mean arterial blood pressure (MAP) and cerebral blood flow (CBF), i.e., cerebral 
autoregulation (CA). Right panel indicates a small plateau region and CA hysteresis, and a 
far more pressure-passive CBF then is conventionally believed (taken from Willie, 2014). 
 
 
Given the transient nature of the process being assessed during CA (particularly dynamic), 
TCD is an ideal imaging approach to use due to its high temporal resolution. More 
recently, CA has also been assessed using MRI and compared with TCD, where 
similarities were observed between the techniques in acute ischaemic stroke (AIS) patients 





manoeuvre, where a sudden drop in CBF velocity is induced and dCA assessment is the 
rate of return to baseline.  
 
Dynamic CA has been shown to be impaired in several age-related clinical conditions, 
including ischemic stroke (Eames et al., 2002), carotid stenosis (White and Markus, 1997), 
and more recently, Alzheimer’s disease (Meel-van den Abeelen et al., 2014). Healthy 
ageing is generally associated with preserved CA in the MCA, in response to postural 
change using a sit-to-stand protocol, though there may be increased vulnerability of the 
posterior cerebral autoregulation to blood pressure (Sorond et al., 2005). 
 
Cerebral metabolic demands and increases in CBF are also linked with NVC. 
Neurovascular coupling is defined here as the functional and spatial relationship between 
neuronal activation and CBF, and ensures adequate oxygen and glucose to the activated 
neurons (Purkayastha and Sorond, 2012). Regional increases in CBF velocity are seen 
during cognitive and motor tasks due to increases in metabolic demand. NVC is a transfer 
function between neural and CBF responses. Therefore, TCD can be used to measure the 
output of NVC by recording CBF velocity during cognitive or motor tasks. Further, TCD 
is non-invasive and has high temporal resolution (see Phillips et al., 2016 for review of 
methods used to assess NVC and measurement guidelines). Impaired NVC has been 
associated with significant pathology (e.g., ischaemic stroke patients; Lin et al., 2011) 
though remains unaffected during normal ageing (Yam et al., 2005), in contrast to other 
Doppler-derived cerebrovascular measures (i.e., resting CBF and CVR). Further, physical 
activity and dietary modifications have been linked with altered NVC, and NVC has been 
associated with performance in cognitive tasks (Sorond et al., 2011; 2013 respectively). In 





using TCD during the N-Back task, in slower walkers compared to their fast walking 
counterparts, indicating improved NVC was associated with physical activity. In 2013, 
Sorond and colleagues showed that four weeks of controlled cocoa consumption had 
significant effects on NVC in participants with impaired coupling at baseline, and this was 
also positively associated with cognitive performance, again assessed with the N-Back 
task. 
 
2.3.2.3. Cerebrovascular reactivity 
The CVR to a stimulus such as changes in arterial content of CO2 or O2 can also be 
assessed by using TCD, and is emerging as a key marker of brain health that changes 
across the lifespan and in response to disease (investigated in Chapters 3 and 5, described 
in more detail in Sections 2.3.3.2, 3.2 and 5.2.1). Carbon dioxide is commonly used to 
induce this response, commonly referred to as CVR, cerebral vasoreactivity or CBF-CO2 
responsiveness. The term CVR will be used primarily throughout this thesis. 
Unfortunately, researchers have used different methodological approaches to assess this 
marker of vascular function. These difference approaches include the stimulus duration 
(e.g., 1, 2, 4 or 5 minutes) and gas concentration (e.g., 4, 5, 7% CO2) used; the brain 
imaging modalities used to collect data (i.e., MRI: BOLD and ASL, discussed in Section 
2.3.3.; and TCD: MCAv); and the analysis approaches used to calculate these measures. 
Such differences may in part explain some of the inconsistent findings in the literature to 
date, as discussed below. 
 
Based on TCD-derived measures, CVR is emerging as a potential indicator of brain 
vascular health in both general and clinical populations. For example, impaired CVR and 





Disease (Meel-van den Abeelen et al., 2014). In addition, CVR has been shown to predict 
the risk of stroke and transient ischaemic attack (TIA) in patients with carotid occlusion 
(Markus et al., 2001), and has also been linked with increased mortality (Portegies et al., 
2014). Further, CVR has been linked with healthy ageing and cognitive performance 
outcome measures (discussed below and in Section 2.5).  
 
Outcome measures of CVR have also been used to explore the effects of physical activity 
on brain health. Cross-sectional studies have shown that sustained aerobic fitness 
throughout the lifespan is associated with improved cerebral haemodynamics determined 
by CVR (Bailey et al., 2013) (Figure 2.5, right panel). In addition to this, Bailey and 
colleagues suggest age-related impairment in CVR may be an outcome of the poorer 
fitness effect they observed in those with lower CVR. Therefore, in this healthy 
population, ageing may be a risk factor for disease that responded well to aerobic fitness 
training. These findings are supported by other studies that have explored the effects of an 
exercise intervention on brain vascular health. Murrell and colleagues investigated the 
effects of a 12-week aerobic-based training programme on resting MCA velocity and 
CVR. They found a greater CVR in both younger and older sedentary individuals 
following the training (Murrell et al., 2013). Cross-sectional studies have also shown that 
higher CVR and cardiorespiratory fitness in older adults were significantly correlated 
(Barnes et al., 2013). Though, this association was not observed in the younger group.  
 
However, other studies report conflicting results, where higher aerobic fitness has been 
associated with reduced CVR, though these tend to be MRI-based studies (Thomas et al., 
2013; DuBose et al., 2016). Group comparison studies have investigated ageing and fitness 





group of older Masters athletes with a sedentary older and sedentary younger group, 
finding no differences between the older groups, in contrast to the younger group who had 
significantly lower CVR than the Masters athletes. They concluded that life-long aerobic 
training has minimal effects on the age-related differences in cerebral haemodynamics, 
though this is perhaps due to subtle fitness effects being less pronounced than the large age 
effects (i.e., the younger group had a mean age of 27 years and the older group 72 years); 
further, this study had a small sample size (10 sedentary elderly and 11 Masters athletes). 
The relatively subtle fitness effects may mean that there is more variability in the measure 
as a result of other factors (e.g., diet, lifestyle, genetics, etc.), such that significant 
differences between fitness groups are only seen with larger sample sizes or well defined 
and differentiated fitness groups. Indeed, this latter point was emphasised in the Bailey et 
al., (2013) study where clear effects were apparent between fitness groups (used TCD-
derived measures).  
 
An important point to consider is the relatively low sample sizes in the studies examining 
CVR fitness effects published to date. Consequently, conflicting findings thus far may 
reflect this noise. For example, a blunted CBF-CO2 response was reported in a group of 
Masters athletes (Thomas et al., 2013) relative to sedentary age-matched controls when 
measured using MRI techniques. Further, in another study of older adults, higher 
cardiorespiratory fitness was associated with lower CVR (DuBose et al., 2016). This leads 
us to consider methodological limitations in the utility of these techniques and whether 
CVR measures obtained with Doppler ultrasound are the same as those obtained with MRI 







2.3.2.4. Strengths and limitations 
The following section provides a summary of the strengths and limitations of using TCD 
compared with other techniques, and the various CVR-derived outcome measures used as 
tools to measure brain vascular health.  
 
Measures of CBF using TCD can show changes in real-time so that we can observe 
immediate cerebrovascular responsiveness to functional stimuli including standing, 
physical activity, cognitive tasks and stress. In contrast, the extent to which participants’ 
can be observed whilst moving is limited with other neuroimaging approaches, such as 
MRI, PET and magnetoencephalography (MEG). Some studies have investigated 
exercising whilst in a MR scanner, examples include using a hand-grip (Park et al., 2008) 
and recumbent cycling (Gusso et al., 2012; Figure 2.7).  
 
Figure 2.7. MRI cycle ergometer setting with: (a) cycle ergometer, (b) electronic box, and 
(c) optical fibre line (Gusso et al., 2012). 
 
However, these are less representative of real life due to restricted movement, making it 





regulation. Further, these adaptations often involve standing whereas most MRI, PET and 
MEG scanners require participants to be sitting or lying down. In contrast, TCD can be 
worn whilst participants are undergoing common and real life behaviours, including 
intense whole-body physical activity such as rowing (Faull et al., 2014), being ‘dropped’ 
into water (Button et al., 2015), or simple repeated postural shifts (Phillips et al., 2016). It 
is important to note that studies sometimes report dysfunction that is revealed during 
functional tests that require movement that can reflect the benefits of regular habitual 
activity (i.e., optimal function maintained in individuals with higher fitness). For example, 
in a study examining CBF velocity at rest and during different intensities, differences 
between fitness groups were only revealed during the exercise stress testing and not whilst 
recording resting values (Bruginaux et al., 2014). 
 
CBF velocity measures are also useful for examining changes that may occur in response 
to a clinical intervention, for example, taking measurements at baseline and following an 
8-week exercise intervention. Measurements using the TCD modality have the potential to 
be used more routinely in a clinical setting as they are more cost effective than other 
imaging methods such as MRI, PET and MEG (Alexandrov et al., 2012) and can be taken 
to the patient. All these factors put TCD at a distinct advantage related to the other imaging 
tools, but there are important limitations of this technique that need to be considered. 
 
Limitations of Doppler measurements of CBF velocity using TCD include velocity versus 
flow for indexing measures of CBF, the potential for vessel diameter change (especially 
with CO2 stimulus), and limited depth within the brain that can be reached using this 
technology. Issues with this CBF measurement come mainly from methodological 





whether the same results and conclusions would be drawn had a slightly different 
methodological approach been used. For example, the measurement of resting CBF 
velocity is generally consistent across studies where the mean blood flow velocity (mostly 
reported from the MCA) is the primary outcome measure, and is often reported along with 
MAP. In contrast, the way in which CVR is determined using TCD has many different 
approaches, including rebreathing versus steady state (e.g., Brothers et al., 2014; Skow et 
al., 2013), stimulus duration (i.e., 1, 2, 4 or 5 minutes) and concentration (i.e., 4, 5 or 7% 
CO2), and the time-point where steady state is defined (determining the point of data 
extraction).  
 
Steady-state methods involve participants breathing premixed gases similar to room air 
though with higher CO2 concentration. In contrast rebreathing methods involve 
participants rebreathing their own expired gas mixture continuously via a Y-valve 
connected to a rebreathing bag. Duffin and colleagues describe in more detail the 
chemoreceptor responses that occur throughout ventilation that affect these outputs 
(Ainslie and Duffin 2009; Duffin 2011), but extensive coverage of this area is beyond the 
scope of this review. Of relevance here is that although steady-state methods have the 
benefit of being more reflective of real life breathing conditions, the interaction between 
the vascular and ventilatory responses may cause the final measured values of CBF 
velocity (and therefore the CVR outcome measure) to vary depending on the time course 
from which they are taken (i.e., ventilation changes throughout the stimulus will likely 







There are also methodological variations within each of these techniques. For example, the 
open-circuit steady state inhalation of CO2 has been administered for a stimulus duration 
of 1.5 (Vernieri et al., 2009), 3 (Murrell et al., 2013; Bailey et al., 2013), 4 (Guiney et al., 
2015; Kastrup et al., 2001) or 5 minutes (Lavallee et al., 2009). Also, the determined time-
point of steady state (i.e., beginning or end of stimulus duration) and the duration of data 
extraction (ranging from 10-60 seconds) differs between studies (e.g., Vernieri et al., 2009; 
List et al., 2015). Further, how the TCD-derived CVR measure is presented (i.e., relative 
vs. absolute values) may also alter the interpretation. For example, Murrell and colleague’s 
study (2013) reported improved CVR in response to exercise training though this was only 
revealed by absolute, and not relative CVR (Murrell et al., 2013). Consequently, the 
question of whether the CVR outcome measure would have been the same and whether the 
same interpretations and conclusions would have been drawn between approaches arises. 
The first study of this thesis addresses this question; by comparing the different stimulus 
durations that are used as well as the time-point of steady state and duration of data 
extraction to determine whether the CVR outcome measure is altered depending on such 
methodological inconsistencies (see Chapter 3). 
 
2.4.3.2. Doppler Technologies and Neuroimaging 
As previously mentioned, one complication with CBF measurements using TCD is the 
interpretation of MCA vessel diameter change in response to changes in CO2 
concentrations (Ainslie and Hoiland, 2014), and whether changes in CBF velocity in 
response to hypercapnia (increased arterial CO2 content) and hypocapnia (lowered arterial 
CO2 content) are accurate representations of changes in cerebral blood flow per se 





concurrent measurement of vessel diameter in addition to blood flow velocity that can be 
combined to estimate absolute CBF in the insonated vessel (e.g., ICA, VA, CCA). 
 
Duplex Doppler techniques are not without limitations. Doppler sonography in general is a 
particularly specialised technique that takes relatively extensive training compared to other 
brain health measurement methods (e.g., cognitive function and questionnaire based 
measures) and despite this, data collection and consequential interpretation of the analysis 
are highly operator-dependent (Pinto et al., 2013). Technical recommendations have been 
developed to try and reduce inconsistent methodological approaches (e.g., Thomas et al., 
2015 for Duplex ultrasound; Willie et al., 2011 for TCD and Phillips et al., 2016 for NVC) 
and similar approaches to develop guidelines may be beneficial for other technologies that 
are influenced by experimenter abilities as well as data collection and analysis approaches 
(e.g., CVR). Another challenge with creating guidelines and ensuring they are up to date is 
that technologies are rapidly evolving. These developments improve data and imaging 
quality (for example) but also present challenges in ensuring consistent and reliable 
methodological approaches are maintained.  
 
Traditionally, the insonated vessels (e.g., ICA, VA, MCA) assessed using Doppler 
approaches were thought to be largely conduit in nature, with vasomotor regulation 
occurring further downstream in the pial vessels (Willie et al., 2014). However, recent 
findings have indicated that there are discrepancies between patterns of responsiveness in 
the middle cerebral artery (MCA) and internal carotid artery (ICA), and that ‘conduit’ 
vessels do have a role in flow regulation via changes in vasomotor tone (Willie et al., 2011 





investigate the cross-sectional area of the MCA during mild hypercapnia using a 6% CO2 
stimulus have found increases of approximately 8% (Coverdale et al., 2015). 
 
Recent developments in the transcranial approach have enabled the concurrent 
measurement of vessel diameter and blood velocity, via TCCD in healthy adults at altitude 
(Willie et al, 2013) and in clinical conditions including stroke and encephalic circulatory 
arrest (Bonvin et al., 2010; Tanzi et al., 2015).  TCCD measures blood flow velocity 
similarly to TCD, though also displays a 2-dimensional image of the vessel and can 
provide concurrent measures of vessel diameter. Studies investigating changes in CBF 
(including measures of velocity and flow) in humans at high altitude have reported 
variable time courses in blood flow increases both within individuals and between studies 
using other approaches (i.e., TCD) (Willie et al., 2013). This variation has been partly 
attributed to inter-individual variation in the ventilatory and cerebrovascular responses to 
hypoxia, and likely reflects proportional differences from central peripheral and 
chemoreceptor drives (Hirshman et al., 1975). This may be one reason why different brain 
imaging modalities and approaches result in different findings. 
 
Willie and colleagues (2013) study aimed to overcome this issue by using TCCD 
technology in co-ordination with linear Duplex Doppler ultrasound so that CBF could be 
measured in three distinct sites; the MCA using TCCD, the ICA and VA using linear 
Duplex. They found that following gradual ascent over 5-9 days to 5,050 m, CBF 
continued to increase over the first sixty hours at 5,050 m and then began to decrease. 
They observed sustained MCA dilation using the TCCD and no dilation in the VA using 





ascent and decent, accounting for approximately 40% of the statistical variation. These 
findings demonstrate that intracerebral vessel dilation facilitates increased oxygen delivery 
to the brain and should be considered in studies only using blood flow velocity. An 
additional consideration is that results from different Doppler ultrasound imaging 
approaches (TCD versus Duplex Doppler) show regional and anatomical differences (i.e., 
MCA versus VA) in vessel response (Willie et al., 2013). 
 
As discussed in Section 2.3.2.3, lower CVR has been associated with healthy ageing and 
with neurodegenerative disease, thus, in these instances lower CVR is considered to 
demonstrate an impaired CBF responsiveness. However, a lower CVR may not necessarily 
reflect maladaptation in all individuals, particularly when considering directional changes 
for responsiveness measures for disease states and individuals with high fitness (e.g., 
Thomas et al., 2013, discussed in Section 2.3.3). Further, whether CVR is altered similarly 
across the cerebrovasculature is unclear. Recently, Braz et al., (2017) compared Duplex 
and TCD outcome measures, finding that age and fitness effects for baseline CBF were 
different depending on the Doppler technique used (i.e., Duplex Doppler showed fitness 
but not age effects, whereas TCD showed age but not fitness effects). Perhaps lack of 
MCA diameter constancy accounts for differential findings in Braz and colleagues study 
(including the trend for a differential effect with CVR)) as well as operator consistency in 
recording measures.  
 
Taken together, this field of research is divided in terms of whether MCA diameter 
changes during alterations in arterial blood pressure, and whether this affects the CVR 
measure. The debate highlights recent technological advancements in Doppler ultrasound 





(Brothers and Zhang, 2016; Hoiland and Ainslie, 2016). These different techniques have 
revealed conflicting findings for key markers of brain vascular health, including resting 
‘flow’ and/or CVR (Bailey et al., 2013; Thomas et al., 2013); perhaps resulting from how 
such measures are derived (i.e., blood flow velocity, blood flow or changes in MRI-
derived BOLD signal intensity), methodological variations between and within studies, 
and/or pertinent study population characteristics. This highlights a need for more research 
into this area, particularly across different modalities where several measures of brain 
health are compared in the same cohort. Further, research is required to investigate 
whether similar ageing and fitness effects are observed across measures derived using 
different methodologies. 
 
2.3.3. Magnetic Resonance Imaging  
The following section will describe MRI techniques in more detail and will mainly focus 
on ASL, BOLD and PCA acquisition. Current literature will be discussed including 
methodological development and considerations, as well as ageing and fitness effects.  
 
Recent studies have incorporated MRI assessment of MCA diameter to investigate changes 
in response to manipulated CO2 concentrations (Verbree et al., 2014), though this area is in 
its early infancy, and rapidly developing due to technological advancement. In Verbree 
and colleagues study, MCA diameter was assessed using a 7-Tesla (7T) ultra-high-field 
MRI, which affords a higher signal-to-noise ratio and contrast–to-noise ratio, allowing 
high resolution acquisition and contrast-rich images compared to 3-Tesla (3T) MRI. 
Verbree and colleagues concluded that MCA diameter remains constant during ‘small’ 
changes in CO2 of -1 or +1 kPa (7.5 mm Hg or Torr), though changes in diameter of 7% 





advancement of 7T MRI technology from more commonly used 3T is exciting and will 
likely improve brain vascular health understanding and clinical applications (van der Kolk 
et al., 2013), studies so far have found similar patterns between age and fitness groups 
regardless of the MRI field strength (i.e., 7- versus 3-Tesla) (Bhogal et al., 2015; Driver et 
al., 2010; Hare et al., 2015). In contrast, comparative methodological research is needed 
that compares different modalities (i.e., MRI versus Doppler ultrasound) as well as 
different typical disciplinary approaches of analysis to determine brain health outcome 
measures. This will be explored in Chapters 4 and 5 of this thesis. 
 
2.3.3.1. Arterial Spin Labelling for Measures of Resting Cerebral Blood Flow  
Arterial spin labelling (ASL) is a commonly used MRI method to assess steady-state CBF 
and is also used to examine changes in CBF in response to cognitive challenges (Ye et al., 
1998), ageing (Bastos-Leite et al., 2008; Zimmerman et al., 2014) and clinical conditions 
including cerebrovascular disease (Detre et al., 1998), Alzheimer’s disease (Alsop et al., 
2000; Zhang et al., 2017) and traumatic brain injury (TBI) (Kim et al., 2010).  Advantages 
of ASL include that it is non-invasive (i.e., no introduction of tracer fusion or other 
instruments into the body) and provides quantifiable measures of CBF. Further, improved 
spatial resolution of MRI, compared with Duplex Doppler, allows the accurate 
representation of specific regions of interest, as well as grey and white matter.  
 
Measures of resting CBF in the context of ASL include cerebral perfusion and arterial 
transit times. Cerebral perfusion refers to the rate of delivery of arterial blood to the 
capillary bed in brain tissue in millimetres per 100 grams per minute. Transit time refers to 
the time for water to reach the tissue from a tagged location, usually in the neck, and is 





them to create an endogenous tracer by applying a 180-degree radiofrequency inversion 
pulse to the blood vessels in the neck. The tracer then flows from where it has been tagged 
in the neck region into an identified region of interest (RoI), with the time it takes known 
as the transit time. Importantly, oxygen is paramagnetic, and in the RoI, the inverted spins 
within the blood water reduce the magnetic properties of the tissue, thus changing the MR 
signal and image intensity. These changes in blood oxygenation concentration and 
magnetism are what allow the brain and cerebral blood flow to be imaged. The image 
obtained is known as the tag image. This procedure is then repeated without tagging the 
arterial blood and another image is created known as the control image. The images are 
subtracted to produce a perfusion image showing the amount of blood to reach each voxel 
within the slice from which the transit time can be calculated (Figure 2.8). The difference 
between the label and control images is in the order of 1% of the baseline images 
(Wintermark et al., 2005). Therefore, multiple image pairs are acquired to achieve an 
adequate signal-to-noise ratio.  
 
Figure 2.8. The calculation of cerebral perfusion and transit time using arterial spin 
labelling. Arterial blood is tagged (labelled; shown in yellow) by magnetic inversion and 
then travels to region of interest (slice; shown in purple) and the tag image is acquired 
(left). This is repeated without the tag to acquire a control image (right). The difference in 
magnetisation between control and tag image is proportional to cerebral blood flow 





Previous studies show cerebral perfusion declines during healthy ageing (Parkes 2004), 
and that it is attributable to more than just decreased tissue volume (Chen et al., 2011). 
Chen and colleagues found reductions in cerebral perfusion in distinct RoIs that were 
different to the regional effects observed when looking at grey matter atrophy. 
Specifically, they found age-related reductions in cerebral perfusion involving the 
superior-frontal, orbito-frontal, superior-parietal, middle-inferior temporal, insular, 
precuneus, supramarginal, lateral-occipital and cingulate regions. In another study by 
Clark et al., resting blood measures were measured using ASL in two older groups. They 
found reduced resting CBF and elevated cerebrovascular resistance (CVRi) in the younger-
old group (60-75 years) compared to the very-old group (80+ years). However, MAP 
measurements used to calculate CVRi were not taken during the scan and CVRi was 
calculated post data processing. They observed that verbal fluency performance was 
related to CVRi in the thalamus, with higher CVRi being associated with poorer 
performance (Clark et al., 2015), indicating that cognition may be in part mediated by 
measures of resting blood flow and blood pressure. 
 
Discrepancies are present in the literature between studies in the approach used to report 
ASL-derived resting perfusion measures, including whether absolute or relative values are 
reported, and whether resting perfusion in the whole brain should be analysed together, or 
separated into distinct RoIs. For example, Kim and colleagues suggested that although 
perfusion is a viable surrogate for an indirect index of structural or functional alterations of 
the brain, resting perfusion is less confounded by differences between individuals and over 
time, and therefore is less likely to be a noisy measure of pathology (Kim et al., 2010). 





limited spatial resolution, labour intensiveness, poor objectivity and low reproducibility, 
therefore warranting whole-brain mapping as a more appropriate approach for use in 
traumatic brain injury (TBI) populations. This work highlights that may be different 
approaches are preferential depending on the population; for example, absolute whole 
brain analysis of resting perfusion should be used in populations with focal damage such 
as TBI and stroke, while quantitative perfusion analysis is better in healthy and ageing 
populations, and RoI analysis a logical option for populations where specific parts of the 
brain and cognitively associated functions and/or behaviour are affected (e.g., dementia). 
 
Reproducibility studies have shown that cerebral perfusion measures remain stable in the 
short term, though large variation exists between participants. Parkes and colleagues 
(2004) examined this reproducibility question by acquiring repeated ASL measurements 
over the course of a day and a week in ten healthy participants, and five participants 
returned several months later (Parkes et al., 2004).  They found that the mean difference in 
standard deviation of perfusion between repeats was 7.1 % in the grey matter and 10.7 % 
in the white matter. Further, grey matter perfusion was significantly lower in males 
compared to females. Higher CBF velocity in females has also been reported in studies 
that have measured blood perfusion using Doppler technologies. CBF velocity measured 
using TCD has also been reported to be lower in the morning than later in the day (Conroy 
et al., 2005) and observed to follow a circadian rhythm where day-to-day variation is less 
than 10 cm·s
-1
 in 95% of individuals (Moppett and Mahajan, 2004). Therefore, studies 
utilising these techniques and taking multiple measurements across different days aim to 






In general, and demonstrated by the studies discussed in this section, resting cerebral 
perfusion declines across the lifespan and reduced cerebral perfusion is associated with 
impaired cognitive performance. Hypoperfusion has been shown to occur in 
neurodegenerative conditions including stroke, dementia and hypertension in some studies 
(Figure 2.9), however, contrary to this, increased hippocampal blood flow has been 
observed in sedentary adults at genetic risk for Alzheimer’s disease (Zlater et al., 2014).  
 
 
Figure 2.9. Processed ASL CBF images of a 32-year old (top row) and an 80-year old 
(bottom row). The reduction in CBF is readily observed in widespread brain areas of the 
older compared to the younger individual (Zhang et al., 2017). 
 
 
2.3.3.2. Blood-Oxygen-Level Dependent (BOLD) Signal to Measure Cerebrovascular 
Reactivity 
Magnetic resonance imaging (MRI) measures brain activity by detecting changes in blood 
oxygenation and flow that occur alongside neural activation. When a brain area is 
activated it consumes more oxygen so blood flow towards the active area will increase 
(i.e., neurovascular coupling). MRI does not directly measure neuronal activation but 
instead records the BOLD signal that is dependent on the difference in the magnetic 
properties of oxygenated or deoxygenated haemoglobin and the relative levels of these two 





During an MRI brain scan the person lies as still as possible whilst activation maps are 
produced. These maps can illustrate how different areas of the brain respond to stimuli 
including cognitive tasks or visual stimulation such as a checkerboard (Mullinger et al., 
2017), so that areas of the brain involved in certain cognitive processes can be studied 
(e.g., attention, memory, emotional processing, learning, visual processing, etc.). 
 
Magnetic resonance imaging can also be used to measure CVR, similar to TCD discussed 
in Section 2.3.2.3. However, the methodological approaches between these two imaging 
modalities are markedly different.  Measures of CVR from MRI use the blood-oxygen-
level dependent signal (BOLD) as a surrogate marker of CBF, in contrast to TCD or 
Duplex Doppler that use blood flow velocity/flow, respectively, through a specific artery 
such as the MCA or the ICA (though this can also be done with MRI using phase-contrast 
(PA) angiography, discussed in more detail below). The percentage change in BOLD 
signal intensity between a CO2 stimulus compared with normal room air is taken from 
either the whole grey matter of the brain (Frosch et al., 2017), or from specific RoIs and is 
then divided by the change in end-tidal CO2, similar to Doppler approaches to calculate the 
CVR outcome measure. However, this BOLD-derived CVR outcome measure is generally 
determined through linear regression in contrast to Doppler analysis approaches that 
extract 30 or 60 seconds of steady-state data whilst the participant is at rest and during the 
stimulus duration. An alternative MRI method to investigate CVR is arterial spin labelling 
(ASL). ASL is a direct measure of CBF in the capillaries, often termed perfusion. 
However, few studies have used ASL to assess CVR and instead use BOLD (Ekstrom et 
al., 2010; Bhogal et al., 2014, 2015, 2016; Duffin et al., 2017) due to the inherently low 






In healthy participants, the CVR in response to hypercapnia is assumed to be linear or 
sigmoidal. However, other response patterns occur, particularly in cerebrovascular disease 
(Duffin et al., 2017). Different response patterns will affect the CVR outcome measure, 
particularly as most MRI studies use linear fits to calculate the response and TCD 
approaches will extract approximately 30 or 60 seconds of data from a defined steady 
state, which can also differ between studies (e.g., after 90 s of stimulus vs. end of stimulus 
duration). When considering whether CO2 responses are predominantly linear or 
sigmoidal, the choice of fit does not seem to affect the CVR outcome measure when end-
tidal CO2 values are not going above a certain threshold (around 55 mm Hg). These 
observations of appropriate fitting models have been discussed and investigated in both 
TCD (Battisti-Charbonney et al., 2011) and MRI (Bhogal et al., 2014, 2015 and 2016) 










Figure 2.10. Linear and sigmoidal fits for CVR (left: BOLD, Bhogal 2014; right: MCAv, 
Battisti-Charbonney et al., 2011). Left graph shows BOLD 7T data. Dark blue shows grey 
matter, light blue shows white matter, grey shows whole brain and green line shows 
baseline PaCO2. Right graph shows MCAv (triangles) and MAP (diamonds) responses to 







Therefore, studies employing these methods, as is typical for MRI BOLD-derived CVR 
and rebreathing approaches using TCD, need to be cautious and consider that particularly 
high end-tidal carbon dioxide (PETCO2) values can potentially further confound the CVR 
outcome measure if linear fit models are being utilised for the calculation. 
 
More recently, Duffin and colleagues have modelled and investigated new MRI BOLD 
approaches that include sigmoidal reduction in resistance at the vascular beds in response 
to a progressive rise in CO2 in order to determine the CVR outcome measure (Duffin et al., 
2017). Developing more sophisticated models to determine CVR may lead to more 
accurate interpretations of the outcome measure and reduce inconsistent findings between 
studies, particularly those considering complex interactions with underlying disease 
pathology. 
 
Some studies have examined different analysis approaches for measures of blood flow 
within the same neuroimaging modality. For example, BOLD and ASL techniques have 
been reported to complement one another, with the strongest correlations between BOLD 
and CVR outcome measures in the grey matter, and with greater responses occurring in the 
occipital lobe than the frontal and parietal lobes (Zhou et al., 2015). Despite these 
associations, only decreases in resting CBF were associated with increased ageing, but 
there was no association with age during mild hypercapnia (5% CO2). Studies have also 
compared different methods for the inhalation of gases to induce the response. For 
example, Hare and colleagues compared carbogen gas (containing only 5% CO2 and 95% 
oxygen) with more typically used mixtures of 5% CO2 in air (21% oxygen balanced with 
Nitrogen). They compared CVR outcome measures acquired from BOLD and ASL 





one where a 5% CO2 in air stimulus was used and one where carbogen gas was used. 
Similarly to Zhou and colleagues study, Hare et al., found significant correlations between 
the CVR outcome measures derived using the BOLD modality with measures using the 
ASL modality when the 5% CO2 in air stimulus was used. However, this correlation 
between the different modalities was not present when the carbogen gas was used (Hare et 
al., 2013). They suggested that this was due to the high oxygen content making it 
impossible to identify the extent to which increased CBF is driving the BOLD signal, 
rather than an increase in venous oxygen saturation. Therefore, caution should also be 
taken when comparing studies that use different stimuli to induce the response.  
 
The signals of different neuroimaging techniques, as well as the techniques themselves 
have different physiological underpinnings that also warrant consideration when designing 
studies and comparing results between studies. In contrast to TCD approaches that only 
use MCAv as a metric of CBF (though some studies do use MAP also), the BOLD signal 
is driven by changes in CBF, blood volume and oxygen metabolism, and the balance of 
these three factors will largely influence the signal (Buxton, 2013). Therefore, the BOLD 
signal provides an arbitrary measure, and is not a direct measure of neuronal activation. 
ASL specifically measures CBF, however, it has worse spatial and temporal resolution 
than what BOLD currently provides. Therefore, a combination of BOLD and ASL data are 
sometimes acquired to provide additional quantitative information and a more complete 
assessment (i.e., using double acquisition background suppression (DABS). 
 
As previously discussed, higher CVR is traditionally associated with younger age and 
higher fitness. However, inconsistencies are also present within the MRI literature in terms 





to the TCD literature. In some instances, these discrepancies are due to whether the whole 
brain or a specific RoI was investigated. For example, Gauthier and colleagues 
investigated measures of vascular brain health, aerobic fitness and cognitive ageing in two 
groups of younger and older adults (Gauthier et al., 2015). They found that age was 
negatively associated with BOLD-derived CVR calculated from the frontal brain region. 
However, fitness (determined by V̇O2 max) was positively associated with BOLD-derived 
CVR, but only when taken from the periventricular watershed region, postcentral gyrus. In 
contrast, a negative association was found between fitness and BOLD-derived CVR when 
derived from the frontal regions. These findings indicate that there is not a simple one-way 
linear relationship between BOLD-derived CVR and fitness that is consistent across the 
whole brain, rather that responsiveness may differ between brain regions. Further, 
Gauthier and colleagues also found age-related changes in executive function and fitness, 
which may modify the region specific CVR observed.  In this study, CVR was assessed 
using a sequential gas delivery circuit (RespirActTM, Thornhill Research Inc., Toronto, 
Canada) and the hypercapnic manipulation consisted of two, 2-minute blocks of 
hypercapnia, with 2-minutes of air before and after each block.  It is important to note that 
participants were not fully familiarised to the gas challenge prior to the testing day, rather 
just once outside the MRI scanner before the scanning session on the same day. Other 
studies using similar techniques will typically fully familiarise participants to procedures 
involving breathing gases, before obtaining data used for CVR measures (Barnes et al., 
2013; Murrell et al., 2013; Lucas et al., 2012).  
 
An MRI study using ASL acquisition at rest and during mild hypercapnia of 
approximately 1 kPa (+5-7 mm Hg) has shown that reduced ASL-derived CVR is 





that vascular abnormalities may be associated with an increased risk and development of 
clinical conditions including insulin resistance, diabetes and dementia.  
 
Chapman and colleagues used MRI techniques to investigate and compared the effect of 
cognitive and physical exercise training interventions in 36 healthy sedentary adults (aged 
56-75 years). Outcome measures included resting perfusion using ASL, CVR using BOLD, 
and cognitive performance measures on higher executive function (Chapman et al., 2016). 
They found that the cognitive training group showed increased resting perfusion within the 
prefrontal and middle/ posterior cingulate cortex (PCC), but no change in CVR. 
Improvements in complex abstraction were associated with increased resting perfusion in 
the dorsal anterior cingulate cortex (dACC) for the cognitive training group. Participants 
doing the physical training who had higher resting perfusion in hippocampi regions 
showed better immediate memory. In this study, it was concluded that resting perfusion 
measures implicate increased neural health rather than improved vascular response 
determine by CVR.  
 
Neither BOLD or ASL measures of blood flow include measures of blood vessel cross-
section or diameter, or possible changes in response to a stimulus that may influence the 
outcome measure, a similar limitation of the TCD-derived CVR approach. Therefore, the 
next section will focus on different neuroimaging approaches using phase-contrast (PC) 






2.3.3.3. Phase Contrast Angiography for Measuring Cerebral Blood Flow 
As with linear Duplex and TCCD ultrasound approaches, MRI can be used for measures of 
blood flow that also consider changes in vessel diameter in addition to blood flow velocity, 
with PC angiography (Figure 2.11). 
 
  
Figure 2.11. Circle of Willis cerebral blood vessels imaged using phase-contrast (PC) 
angiography (left) and transcranial colour Doppler (TCCD) (right). PC angiography image 
shows the carotid artery (a), internal carotid arteries (b), middle cerebral arteries (c), 
basilar artery (BA) and connecting macro- and micro-vessels. The TCCD image shows the 
middle cerebral artery (e), anterior (f) and posterior (g) cerebral artery. 
A study compared CBF measures between MRI and Doppler ultrasound techniques by 
comparing blood flow velocity measures between TCCD and PC angiography (Balédent et 
al., 2006). Although measures of diameter were not included in this study (as they are 
more recent developments in these measurement approaches), this study is still a rarity in 
its approach to directly compare different imaging modalities. Blood flow velocities 
between modalities were compared at different levels of the arterial tree for the right and 
left ICA, VA, and the BA. They found significant correlations between modalities for the 
right ICA, VA and BA, with Spearman’s r correlation coefficients ranging from 0.23 - 





the TCD approach overestimated values is unclear, though poorer correlations between 
modalities were found for arteries of the circle of Willis in extra cranial arteries. As 
discussed in Section 2.2.2.2, MCA diameter changes have been reported in hypercapnia 
when values are at least +2 kPa (15 mm Hg). The advancement in technology and analysis 
now offers better opportunity to image and quantify such changes (see Verbree et al., 
2014; Figure 2.12). 
 
 
Figure 2.12. High-resolution 7-Tesla MRI scans planned perpendicular in the middle 
cerebral artery (MCA). Upper: the white square shows the location of the following 
zoomed images, zoomed image at hypocapnia (-1 kPa). Lower: zoomed imaged at baseline 
normocapnia (0 kPa), and hypercapnia (+1 and +2 kPa end-tidal CO2 respectively) 
(Verbree et al., 2014). 
 
More recently phase-contrast MRI from the Rotterdam population-based study in older 
adults (mean age 61 years) showed that lower resting cerebral perfusion was significantly 
associated with risk for dementia. Of 4759 participants who were scanned between 2005 
and 2012, 123 developed dementia. Further, increasing severity of white matter 
hyperintensities increased risk of dementia with hypo-perfusion (i.e., low cerebral 





In this study, cognition was assessed using the letter-digit substitution task, verbal fluency 
test, Stroop test and a 15-word learning test (immediate and delayed recall). 
 
Participant data from the Rotterdam study has also been collected and examined from 
measures of CVR using TCD (Portegies et al., 2014) to investigate risk of mortality, 
independent of stroke. In this analysis 1,695 participants aged 55+ years initially 
completed the CVR challenge. In a fully-adjusted model, the hazard ratio per standard 
deviation decrease in CVR was 1.10 for all-cause mortality, 1.09 for cardiovascular 
mortality, and 1.10 for non-cardiovascular mortality, meaning a 10% increased risk of 
mortality with every SD decrease in CVR. In this study, similar approaches of the gas 
challenge were employed as previously discussed (i.e., 5% CO2 in air inhalation for 2-
minutes) and lower responsiveness was concluded to reflect an impaired vascular system 




2.3.3.4. Other Imaging Approaches 
Other imaging approaches (e.g., examining brain structure volumes, diffusion tensor 
imaging and white matter hyper-intensities), have been used to assess brain health with 
regards to ageing and disease. Although thorough investigation of these measures is 
beyond the scope of this thesis, a brief overview is given in the following section that 
includes associations with cognition and aerobic fitness in human and animal studies.  
 
Structural magnetic resonance imaging (sMRI) produces images of the structure of the 
brain (e.g., hippocampus, entorhinal cortex), and closer analysis of the size of various 





have been associated with mild cognitive impairment (Nathan et al., 2017) and poorer 
memory performance (Erickson et al., 2011). Levels of physical exercise have been shown 
to increase hippocampal volume in healthy adult humans (Erickson et al., 2011; Killgore et 
al., 2013) and increase hippocampal neurogenesis in animal models (Nokia et al., 2016).  
Further, in a cross-sectional study investigating hippocampal change in cognitively healthy 
older adults, physical activity has been shown to reduce atrophy in those at genetic risk for 
Alzheimer’s disease (Smith et al., 2014).  
 
Several other MRI techniques are used to examine the brain, including analysing white 
matter hyperintensities (WMI) (Camicioli and Verghese, 2015), diffusion tensor imaging 
(DTI) (Madden et al., 2009) and magnetization transfer imaging. WMH are areas of high 
intensity on MRI scans that reflect lesions within the white matter produced by 
demyelination and axonal loss. They are seen in healthy ageing though are also associated 
with clinical conditions. DTI is a technique that allows the mapping and characterisation of 
the diffusion of water in tissue as a function of spatial location (Alexander et al., 2007). 
These measures are often explored alongside cognitive tasks that expose age-related 
cognitive decline, particularly in episodic memory, executive function and information 
processing speed.  
 
In a clinical and research context, structural and functional MRI are commonly used in 
tandem to assess changes in brain structure and function in the ageing brain and in clinical 
conditions such as dementia. Cerebral white matter ageing is associated with declines in 
episodic memory, executive function and information-processing speed, revealed by 
several MRI approaches including DTI and WMI (Gunning‐Dixon, Brickman, Cheng, and 





measures of resting CBF or CVR between different brain imaging modalities. Further, no 
known investigations have directly compared MRI with TCD measures in the same 
individuals, to determine whether outcome measures derived using different modalities 
will lead to similar/ different associations with ageing and fitness. Dementia is a 
neurodegenerative disease associated with cognitive decline, particularly memory, and 
white matter integrity is associated with cognitive decline. One challenge that has often 
been acknowledged is establishing what brain changes revealed by MRI are a result of 
natural ageing, and to what extent these are caused by modifiable lifestyle factors such as 
physical activity, nutrition and other lifestyle choices.  
 
Changes in cognitive performance in domains such as processing speed, reasoning, 
memory and executive functions across the lifespan as a result of healthy ageing have been 
investigated including the role of lifestyle factors such as exercise and diet (Deary et al., 
2009). A number of publications have acknowledged the beneficial effects of exercise on 
brain health by using MRI as an outcome measure (Burzynska et al., 2014; Camicioli and 
Verghese, 2015; Hayes et al., 2014; Hötting and Röder, 2013; Voss et al., 2011, Kramer et 
al., 1999; Colcombe et al., 2006). Hötting and Röder reviewed several studies using a 
range of designs (cross-sectional, intervention, animal and human studies) and suggested 
that physical activity may play a role in facilitating neuroplasticity and cognition (Hötting 
and Röder, 2013). The well recognised limitation with such cross-sectional and cohort 
studies is the difficulty in making cause and effect inferences about physically active 
people performing better in cognitive tasks and academically because there is always the 
possibility of reverse causation. This means that people with higher cognitive performance 
may be more likely to engage in physical activity, rather than regular physical activity 





to investigate changes over time and also explore a number of variables including: amount 
of physical activity, cardiovascular fitness as well as measures of cognition, emotion and 
well-being. Thus, they can provide us with a greater overall picture of brain health across 
the lifespan. 
 
In a prospective cohort study, Rovio and colleagues interviewed people 50 years of age 
about their lifestyle and physical activities (Rovio et al., 2010). Twenty-one years later, 
structural and functional MRI scans (i.e., T1-weighted images to investigate grey matter 
(GM)) density and FLAIR-images for white matter lesions (WML)) were taken from the 
same individuals and differences were found between individuals who exercised twice a 
week or more compared to those who exercised less. Specifically, in frontal brain regions 
associated with higher executive functioning more active individuals had larger grey 
matter volumes compared to their less active counterparts. In further support of these 
findings, another population study looking at Swedish twins found evidence that 
individuals who engage in light exercise such as gardening or walking, or regular exercise 
had a reduced risk for dementia compared to those who did very little exercise (Andel et 
al., 2008).  
 
Camicioli and colleagues measured activity in individuals using actigraphy and scanned 
them using MRI. They found that the harmful effects of white matter hyperintensities were 
less pronounced in people who engaged in more active lifestyles. This finding is consistent 
with previous studies showing that white matter hyperintensities are associated with 
impaired global motor function and indicates a protective effect of physical activity on 





amount of research illustrating the beneficial effects of physical activity on brain health by 
using MRI to investigate the brain.  
 
Studies using animal models also show conflicting conclusions with regard to the effects 
of exercise on resting measures of CBF and CVR, and introduce further imaging 
approaches to determine these measures. In a study investigating five weeks of voluntary 
running in transgenic mice, a 70% diminished response to a hypercapnic challenge was 
observed in the running compared to the non-running, whereas no difference in resting 
haemodynamics were observed between groups (Dorr et al., 2017). This study used two-
photon fluorescence microscopy to examine functional changes in cerebral vasculature by 
following the passage of a fluorescent dextran bolus through the microvasculature bed 
beneath the cortical surface. The inhalation of 10% CO2 was used to induce the cerebral 
vasodilation and increases in blood flow. It is often debated in the literature the relevance 
of animal studies to human functioning though researchers are beginning to integrate these 
methodologies to ‘bridge the gap’ between different approaches (Voss et al., 2013).  
 
2.3.3.5. Strengths, Limitations and Challenges of MRI 
The following section provides a summary of the strengths and limitations of using MRI as 
a tool to measure brain health. MRI data can reveal a large amount of information from a 
relatively small sample size, in contrast to an observational or cohort study that requires 
much larger sample sizes and across long periods such as the lifespan. As demonstrated by 
the studies described above, these quantitative outputs can be compared with other 
quantitative outputs such as behavioural performance measures revealed by cognitive 
tasks. We can combine these methodologies to investigate the interplay between brain 





For example, studies can investigate whether an increase in BOLD signal intensity (as a 
surrogate for neuronal activation) in the substantia nigra is correlated with better 
performance in a cognitive task involving valence manipulation (cognitive processing) 
(Guitart-Masip et al., 2012). This indicates that this area of the brain plays a role in reward 
and punishment processing and is responsible for behaviour that may lead to receiving a 
reward. The substantia nigra nests deep within the brain and is not accessible using other 
techniques used to measure brain health. Therefore, a major advantage in this methodology 
is that we can measure deep inside the brain, which contrasts many other neuroimaging 
methodologies that have relatively less spatial penetration depth and resolution (e.g., 
Doppler and NIRS, the latter discussed below). 
 
However, MRI also has several drawbacks. In terms of practicality, they are large 
machines that have limited portability (although mobile versions have been developed), so 
have less flexibility in terms of measuring real life movement behaviour that other 
methodologies do so more readily (e.g., transcranial Doppler (TCD) and NIRS, as 
discussed above (TCD) and below (NIRS)). Participants being scanned in an MRI machine 
are required to keep their head as still as they can so the quality of data is maintained, 
though physiological post-processing includes correcting the data to account for artefacts 
caused by movement and linear drift. Interpretations of the acquired data also rely on 
assumptions. As discussed previously, BOLD is not a direct measure of neuronal activity 
though is considered to reflect peri-synaptic activity in the local field potential, thus 
reflecting neural processing. However, models have been discussed where the underlying 






MRI is becoming a more popular tool to be used in a clinical setting, particularly in 
dementia as the quality of scans are becoming more technologically advanced. Further, 
mobile scanners housed in trucks have been developed that can allow wider use in the field 
or community (e.g., brain (and muscle) structural changes studied during a running 
endurance study across Europe (Schütz et al., 2012)). However, MRI technology is 
expensive and has high costs associated with its use (e.g., £500/ hour), so is unlikely to be 
a dominant measure in a current clinical (especially community) setting. Also, from a 
clinical perspective, it may be very difficult for some patient groups to lie still in an MRI 
scanner for extended periods. Populations who are likely to find this difficult include: 
children, particularly those with attention deficit hyperactivity disorder (ADHD), people 
with anxiety or claustrophobia, patients with movement disorders and patients with 
disorders affecting cognitive function such as mild cognitive impairment (MCI) and 
dementia. Further, extra caution is required in patients and individuals who have metal 
implants and in many cases, they cannot be scanned for safety reasons. 
 
Another consideration that also applies to other imaging modalities, is the consistency of 
methodological procedures and protocols across studies. For example, ‘resting state’ scans 
are often used to examine the brain at rest. However, MRI studies have shown large 
individual differences in inner phenomena revealed through descriptive experience 
sampling methods whilst scanning resting-state networks (Hurlburt et al., 2015), and it 
could be argued that the brain is never really at rest. Therefore it is important to ensure that 
approaches of defining, measuring and interpreting these ‘resting’ measures are consistent.  
In existing research studies, the resting state protocol requires the participant to lie still 
with their eyes either closed or open depending on the preferences of the research group, 





However, there are protocols with control versions of the task to account for this, such as 
congruent versus incongruent tasks to increase the cognitive load (e.g., Fernandez-Duque 
et al., 2008).  
 
Another important consideration, particularly when looking at measures of blood flow and 
volume, is reliability and re-testing when PETCO2 values are not taken (or considered) 
during scans, as this will affect the BOLD signal. This is important given that participants 
are often quite anxious about going into the scanner, particularly if it is their first time, so 
they are likely to hyperventilate. Hyperventilation in the context of the CVR functional test 
will lower CBF and therefore infer a lower cerebral perfusion in this ‘rested’ state. More 
research is needed to investigate how the BOLD signal is affected by breathing patterns 
and participants’ general state of mind (particularly levels of anxiety), which may not 
always be obvious or acknowledged by both participants and/or researchers/clinicians. 
 
Given the limited portability and practicality of MRI, as well as its high cost, it may be 
beneficial to use more transportable and cost effective techniques to measure CBF, 
particularly if we can be confident that they predict the same outcome measure. Though 
MRI techniques will be beneficial in some contexts, where more detail of specific regions 
of interests or deep structures need investigation, for example, in disease states. 
 
2.3.4. Functional Near-Infrared Spectroscopy 
Infrared radiation was first described in 1800 by Sir William Herschel when he was 
looking at sunlight using a red filter through a prism and deduced that the invisible 
portions of the electromagnetic spectrum were responsible for the localised rise in 





oxygenated and deoxygenated haemoglobin ((HbO2) and (HHb), respectively) from 
cortical tissue. Concentration changes are calculated using an attenuation change of the 
measurement of light and by solving a linear equation based on the modified Lambert-Beer 
law. NIRS can be used to monitor outcomes in clinical populations including 
cerebrovascular disease, epilepsy, migraine and traumatic brain injury (TBI) (Davies et al., 
2015).  
 
Near-infrared spectroscopy has been used to investigate the relationships between 
prefrontal oxygenation, cognitive performance and cardiorespiratory fitness in cross-
sectional studies (Albinet et al., 2014; Fabiani et al., 2014). NIRS has also been used to 
assess changes in HbO2 and HHb during and following acute bouts of exercise (Lucas et 
al., 2012; Giles et al., 2014). In these acute studies, bouts of physical activity involving 
cycling at various intensities increased oxygenated and deoxygenated haemoglobin in the 
prefrontal cortex. Further, in Lucas and colleagues’ study they found that regardless of 
age, cognitive performance in a modified Stroop task improved during exercise. Albinet 
and colleagues cross-sectional study revealed improved oxygenation response measures 
using NIRS in both the left and right dorsal lateral pre-frontal cortex (DLPFC) in older fit 
women compared to their unfit counterparts. These effects were mediated by executive 
performance, evaluated by using the auditory random number generator (RNG) task, 
designed to utilise inhibitory control (Albinet et al., 2006). Collectively, these studies 
demonstrate that both acute bouts of physical activity and general higher levels of fitness 
improve cerebral haemodynamics and cognition function.  Other studies have investigated 
associations between cerebral haemodynamics using NIRS and physical activity and found 
similar results (Cameron et al., 2015) where higher anterior frontal oxygenated 





and this was mediated by higher activity levels. Further, this study investigated young 
adults who were at the peak of development.  
 
More recently NIRS measured regional cerebral tissue oxygen saturation has been 
investigated in response to CVR gas challenges (Miller and Mitra, 2017), similar to MRI 
and TCD approaches described in Sections 2.3.2.3 and 2.3.3.2. NIRS approaches can also 
determine CVR by assessing regulatory responses to hypercapnia through administration 
of several hypercapnic challenges of 5 or 10 minute durations whilst continuously 
monitoring partial pressure of end tidal CO2.  The parameter for flow change using NIRS is 
regional cerebral tissue oxygen saturation. In the Miller and Mitra (2017) study, it was 
concluded that exercising more than ten hours a week may produce a higher resting CVR 
to CO2 inhalation  
 
Near-infrared spectroscopy is an attractive tool for assessing the brain due to its 
haemodynamic measurement basis. Other advantages of NIRS technology when compared 
with other neuroimaging modalities such as MRI, include its: portability, high temporal 
resolution, ability to record in natural settings, and cost. Long periods of recording time are 
achievable and it is less sensitive to head motion. Further, it is safe to use and can be used 
easily on infants, children and patients. However, NIRS has lower spatial resolution and 
can only record near the brain surface; although more recently research centres have 
developed the technology to allow recording deeper (though still relatively superficial 
compared to MRI) within the brain and shown these measures can be associated with MRI 
(Fabiani et al., 2014). NIRS may also be criticised for not having standard analysing 
packages, though this drawback also applies to other imaging modalities, as mentioned 





localisation. Despite these drawbacks, the advantages of NIRS are making this technology 
an increasingly useful tool to assess brain health in disease states and consider 
haemodynamic associations with cognitive function. 
 
2.3.5. Summary and Integration of Neuroimaging Measures 
To date, all three Doppler techniques and MRI have not been directly compared to 
examine whether they provide comparable outcome measures in populations that are 
thought to have different cerebrovascular regulation (e.g., younger versus older or levels of 
aerobic fitness). Further research is needed to explore how outcome measures may 
correlate with haemodynamic measures acquired from MRI techniques, and assess whether 
they are complementary or contradictory to Doppler-derived measures. In addition, 
research can be carried out to investigate how these measures may change in response to a 
clinical intervention such as one involving physical activity. Examples of populations 
where investigating further the effects of exercise on brain health may be those at risk for 
developing dementia (e.g., older adults, patients with hypertension, or individuals 
genetically profiled as APOE-E4 carriers, a gene associated with Alzheimer’s disease). 
Given that we know exercise has beneficial effects on these populations, we need to better 
understand the underlying mechanisms that drive these positive changes, and indeed, how 
to effectively measure changes in brain health, so that we can prescribe tailored individual 
approaches. 
 
2.4. Assessing Cognitive Performance, Neuropsychology and Quality of Life 
Behavioural measures and questionnaires are also used to measure brain health; measures 
spanning performance in cognitive tasks, responses to neuropsychological assessments and 





pertinent literature on this extensive area of research with the specific focus on measures 
that will be applied in this thesis. 
 
2.4.1. Cognitive performance tasks 
The following section will describe cognitive approaches that mainly focus on 
performance in tasks that target specific cognitive domains, including: attention, memory, 
learning, mental arithmetic and emotion recognition. Current literature will be discussed 
including methodological development and considerations, as well as ageing and fitness 
effects.  
 
Cognitive performance is often used to determine brain function and health. Behavioural 
measures including reaction times and percentage of correct responses to a behavioural 
task, usually administered on a computer, which provide quantitative outputs that can 
easily be compared. Researchers can observe differences between and within individuals 
either at the same time point or across several time points. For example, in large scale 
population studies such as Whitehall II, a decline in cognitive performance involving 
executive function across the lifespan in the general population has been reported 
(Shiroma and Lee, 2010). Differences in response to an experimental manipulation (e.g., 
pharmacological) on task performance has also been examined (Guitart-Masip et al., 
2012). Further, cognitive measures have also been used to show how cognitive 
performance is affected after stroke and how improvements can be seen across time 
through clinical intervention such as neuro-rehabilitation (Bickerton et al., 2014; 






There are several cognitive tasks used in clinical and research tools such as the Oxford 
Cognitive Test (Oxford University Innovation Ltd., Oxford, UK; http://www.ocs-test.org, 
previously the Birmingham University Cognitive Screen) (Demeyere et al., 2015; 
Bickerton et al., 2015), CogState (Cogstate Ltd., Melbourne, Australia; 
www.cogstate.com) and CANTAB (Cambridge Cognition Ltd., UK; 
http://www.cambridgecognition.com). These cognitive assessments focus on different 
cognitive modalities including: attention, memory, language, mathematical skills, spatial 
processing and verbal reasoning. Disentangling these different cognitive domains has been 
shown to be extremely useful in the assessment, diagnosis and treatment of disorders 
where cognitive health is affected. In establishing the domain that has been compromised, 
clinicians are now better placed to reach a more accurate diagnosis with such assessment 
tools. Examples of clinical conditions where regional and cognitive domain specific 
considerations are particularly informative include: Parkinson’s Disease, hemi-spatial 
neglect, different subtypes of dementia (semantic dementia, frontotemporal dementia, 
Lewy-Body dementia and Alzheimer’s disease) and other conditions where specific parts 
of the brain and different cognitive domains may be affected at different points in time 
depending on the nature and progression of the disease. However, although these tools 
have been used extensively for diagnosis and to monitor patient outcomes, less research 
has focused on examining the effects of an exercise intervention on these various cognitive 
modalities.  
 
Other types of cognitive measures have been designed to explore emotional processing, 
which can be useful in clinical disorders where mood is affected (e.g., depression 
(Browning et al., 2012)); and may be more in line with research exploring stimuli that has 





task, where participants are required to respond as quickly and as accurately as they can to 
faces expressing various emotions on the screen. Patients with mood disorders will 
typically respond differently compared to healthy individuals, taking longer to react to 
negatively expressed faces (Browning et al., 2012). Interestingly, these measures have 
been correlated with MRI outcome measures to identify specific brain regions involved 
with emotional processing such as the anterior cingulate and the amygdala (Etkin et al., 
2010).  Another example of cognitive tasks being used to explore attentional biases is a 
variation in the Stroop task, where the meaning of words is purposefully manipulated. 
Individuals with eating disorders will typically take longer to respond to words associated 
with foods (emotional words) (Epp et al.,  2012), in a similar way to how individuals with 
depression will take longer to respond to words or faces that have negative associations 
(Wilson and Wallis, 2013).  
 
An interesting question may be to explore the effects of a lifestyle intervention, such as 
physical activity, on negative cognitive biases and the interpretation of ambiguous 
scenarios. For example, whether we view the world in a more negative or positive light 
and whether we predict positive or negative outcomes from future experiences. Existing 
research has explored the effects of exercise on cognition in healthy and clinical 
populations. These are included in Hötting and Roder’s review on the beneficial effects of 
exercise on neuroplasticity and cognition (Hötting and Röder, 2013). Typically, the studies 
discussed have either explored the effects on cognition immediately after a single session 
of exercise or they have addressed chronic effects of an intervention that may last either 
several weeks or longer (e.g., 8 or 12 weeks). Other studies that have utilised cognitive 





section titled ‘Combining neuroimaging methodologies with cognitive performance’, as 
they tend to incorporate other measures such as neuronal activation or cerebral blood flow. 
 
As with the previously discussed tools to assess brain health, there are strengths and 
drawbacks of using cognitive tasks as a tool to measure brain health. Cognitive tasks often 
involve relatively meaningless stimuli to the individual, which may affect their motivation 
and overall performance; particularly if a monetary incentive has been given to encourage 
them to take part. It is therefore important to question whether the task is really measuring 
what it is intending to (i.e., measurement validity). Cognitive tasks tend to rely on 
assumptions that the cognitive domain being tested in the experimental condition reflects 
how it would function in a real-life setting and transferability across other cognitive 
domains. Indeed, an improvement in cognitive performance may be observed in a domain 
in response to an intervention, but this may not mean that improvements will be seen in 
other similar tasks (Owen et al., 2010).  
 
While cognitive measures provide fast detailed and quantitative information, they may also 
be affected by a large amount of inter-individual variability that is difficult to control for 
(Li et al., 2001). Therefore, it could be argued that they are more useful in determining 
differences in the same individual across time (i.e., within-individual), either through 
disease progression, clinical outcomes or lifestyle changes (not withstanding repeat testing 
learning effects). Further, when considering the effects of acute exercise on cognition (e.g., 
Lucas et al., 2012, discussed below), the time that the participant is tested after the exercise 
bout will also affect performance in the task due to the potential of chronic exercise effects 





whether cognitive performance provides meaningful information in the context of real life 
situations leads to the consideration of measures focusing on quality of life and well-being.  
 
2.4.2. Questionnaires for quality of life and well-being 
Another crucial approach in determining brain health is via measures that aim to assess 
well-being and quality of life. These are generally questionnaire based and include those 
that are designed to recognise clinical symptoms related to mood disorders such as anxiety 
and depression. Examples of questionnaires that have been rigorously studied in terms of 
their validity and reliability include the Beck Depression Inventory (BDI) (Beck, 1988), 
Hamilton Rating Scale for Depression (HRSD) (Hamilton, 1960) and the Hospital Anxiety 
and Depression Scale (HADS) (Zigmond and Snaith, 1983).  
 
Questionnaires have also been developed to assess the subjective health and well-being in 
the general population (for example, the World Health Organisation Quality of Life 
questionnaire; abbreviated version (WHOQOL-BRIEF); Skevington et al., 2004), though 
further explorations of these in the scientific literature are much more difficult to interpret. 
This is due to the complexities of human nature on a whole and the definition of ‘normal’ 
everyday life stresses and experiences, as well as additional influences of culture, religion 
and moral reasoning. Questionnaires that measure well-being and quality of life may also 
be used to assess the outcome of an intervention either at the clinical, community or 
population level. One issue with these measures is that they tend to be very subjective and 
rely on the individual’s interpretation of themselves (Gough et al., 2012). Experience 
sampling methods (ESM) may provide an attractive solution to this where people are 





(Moberly and Watkins, 2008; Myin-Germeys et al., 2009). However, it could be argued 
that this is still quite intrusive and interrupts the natural flow of a person’s day.  
 
Responses in neuropsychological questionnaires may sometimes rely on someone else’s 
interpretation of an individual’s experience. This is particularly relevant in conditions like 
dementia, where a family member or member of care staff who works closely with the 
individual will answer questions on their behalf (Whitaker et al., 2013). This is due to the 
communication difficulties that arise because of the condition and a perceived lack of 
mental capacity as defined by the Mental Capacity Act in 2005 (Greaney et al., 2005). 
After appropriate assessment by a qualified clinician or researcher, it may be decided that 
the person’s next of kin make important decisions on their behalf, as well as communicate 
information for them (Whitaker et al., 2014).  
 
Despite the limitations of subjective questionnaires, they are invaluable as they are directly 
tapping into the real life and experience of the individual (Moberly and Watkins, 2008). 
Other measures are more likely to make inferences or assumptions around cause and 
effect. For example, observing a specific neural or physiological response often leads to 
assumptions that this represents a particular level of brain health and this is further 
complicated by individual variability. The ability to directly tap into an individual’s 
experience is particularly important in populations where we may be more interested in 
quality of life, well-being and general levels of contentment, rather than cognitive or 
physiological performance. The priority for these patients is to reduce their distress and 
support them in being happier and healthier. In contrast, physiological and cognitive 
performance may be prioritised more highly in competitive elite athletes or Nobel Prize 





conditions including depression and anxiety; providing examples of the uncoupling 
between brain health, physical or academic (i.e., cognitive) performance and well-being. 
Though in these cases, poor psychological outcomes may be more related to injury or 
social pressure (Kontos et al., 2012 and Hammond et al., 2013 respectively). Populations 
where quality of life may be considered particularly important include people who are 
suffering significant psychological distress because of a clinical condition (e.g., dementia, 
anxiety and depression) as well as in the general population. After all, a society that is in 
good health, functions well both physically and psychologically, and consists of people 
who are generally content in their existence and their interactions with others, is one that is 
likely to function much more successfully.  
 
2.5. Combining Neuroimaging Methodologies with Cognitive Performance 
Some studies have already been discussed that use multimodal approaches including 
neuroimaging and cognition. The aim of this section is to focus on more studies like these, 
summarise the main conclusions and consider future directions.  
 
More recently, studies have incorporated a combination of methodological approaches 
either to compare directly to one another and establish associations (Boots et al., 2015) or 
to give a broader understanding of the effects of an intervention. Vaughan and colleagues 
undertook a randomised controlled trial of community-dwelling healthy women aged 65-
75 years and randomly assigned 25 to an intervention group and 24 to a no exercise control 
group (see Vaughan et al., 2012 for methods). Neurocognitive functioning was measured 
via tasks related to processes of working memory, inhibition shifting, verbal fluency and 
reaction times (all components of higher executive functioning). Physical functioning was 





2000), the 1-leg test of balance (Fregly et al., 1973), waist and hip measures, resting heart 
rate and blood pressure. They also assessed brain derived neurotropic factor (BDNF), a 
considered biomarker of brain plasticity (Martinowich et al., 2007). They found that the 
16-week exercise intervention led to improved cognitive functioning and improved 
physical functioning  (Vaughan et al., 2014). Although this study clearly illustrates the 
benefits of an exercise intervention in older adults and incorporates several measures, more 
research is needed to understand the underlying mechanisms that drive these 
improvements in cognitive and physical function.  
 
Boots and colleagues selected 315 participants from the Wisconsin Registry for 
Alzheimer’s Prevention (WRAP); the WRAP is a longitudinal cohort of approximately 
1,500 cognitively healthy adults aged 40 to 65 years (Boots et al., 2015).  They found 
significant associations between cardiorespiratory fitness and a range of brain health 
measures, including: MRI measures of brain structure (grey matter volumes) and measures 
of cognition and mood. Studies like these provide evidence that supports a range of 
promising measures to assess brain health, particularly due to the large sample sizes they 
employ. However, they do not reveal the underlying mechanisms by which improvements 
in outcome measures are mediated or include functional measures of brain activity. More 
specific studies are required to assess these mechanisms in more detail, though 
unfortunately these types of studies often have smaller sample sizes for practical reasons. 
 
A promising area of research has combined cognitive outcome measures with functional 
physiological measures of CBF velocity measured by TCD. Studies have demonstrated 
that the regulation of CBF velocity is not only related to cognitive function and physical 





2015). In this study by Guiney and colleagues, performance in cognitive control was 
examined by using tasks focusing on inhibition and switching. In addition, they examined 
CVR to a CO2 stimulus (open circuit, steady-state method: 4 min of 5% CO2 in air) in 55 
healthy young adults. They found that the measures of cognitive performance and 
cerebrovascular health were related to habitual physical activity levels. Those who were 
more physically active had better CBF regulation (as indexed by CVR) and better 
cognitive inhibitory control. They also found that frequency of activity indicated improved 
cognitive control mediated by this measure of CBF regulation. Their findings 
complemented those from a study examining the effects of exercise on cognition in older 
women (Brown et al., 2012; discussed in 2.3.2.1, Vaughan et al., 2014) and cerebral 
haemodynamics assessed with NIRS (Cameron et al.2015). Future studies like this are 
required that adapt a multimodal approach to explore the relationship between blood flow 
and cognition and other measures associated with brain health. 
 
The effects of healthy ageing and acute exercise on cognitive function and cerebral 
perfusion have also been investigated in a combined TCD and NIRS study (Lucas et al., 
2012).  In this study, cognitive function improved whilst exercising in both age groups 
(young 24 ± 5 y; older 62 ± 3 y), though imaging measures of cerebral perfusion were 
differentially affected between imaging modalities. Specifically, increases in MCAv 
observed by the TCD modality in response to exercise were similar during cognitive tasks 
for both age groups, whereas prefrontal cortical haemodynamic NIRS measures showed 
smaller increases in the older group between exercise intensities. Interestingly, the 
exercise-induced improvement in cognition was similar between the age groups. As such, 
while exercise reveals improvements in cognition in both younger and older participants, 





about how perfusion may differ across the vascular tree (i.e., conduit versus capillary flow) 
and could indicate potential regional differences (prefrontal versus global flow) as well as 
how measurements during acute exercise differ to resting perfusion changes during 
cognitive tasks. Against this background, whether these measures are derived using blood 
flow velocity and/or vessel diameter in an isolated region such as the MCA, or across the 
whole GM or relatively larger RoIs (in contrast to the centre of the MCA cross-section) 
using the BOLD signal, will likely affect reported outcome measures of resting CBF and 
CVR. 
 
Measures of CVR and associations with cognitive function have also been investigated in 
clinical populations (Hajjar et al., 2014). In hypertensive patients, lower CVR was 
associated with a worse executive function test. In this study by Hajjar and colleagues, 
executive function was assessed using the Trail-Making test and measures of memory and 
attention. CBF was assessed using TCD measures of MCAv with a hypercapnic challenge 
of five minutes 5% CO2 inhalation. In contrast to other studies using gas challenge 
protocols whilst participants are in a supine position, in this study they were sat upright. 
According to other research findings, postural differences do not affect this measure 
(Tymko et al., 2016), though this is another example of methodological inconsistencies. 
Further, this study also did not observe regional differences in CBF between anterior and 
posterior regions found previously in the literature (as discussed in Section 2.3.2.1).  
 
Other studies have combined MRI measures of BOLD-derived CVR with executive 
function using the Stroop task (Gauthier et al., 2015; discussed in 2.3.3.2) and complex 
abstraction (Chapman et al., 2016; discussed in 2.3.3.2) to investigate ageing and fitness 





arch elasticity, though there was no significant association between performance on the 
Stroop task and BOLD-derived CVR. However, CVR in the frontal regions involved in 
executive function were determined to be negatively associated with fitness, indicating that 
fitness may mediate cognitive performance via decreased CVR in the prefrontal cortex 
(Figure 2.13). Finally, fNIRS and cognition have also been investigated in fitness and 
ageing studies, reporting links between fitness, DLPFC oxygen supply and cognitive 




Figure 2.13. Conceptual framework for links between vascular health, cardiorespiratory 
fitness, and executive functions. The black arrows represent the links supported by data in 
Gauthier and colleagues’ study, including V̇O2 max and preserved executive function, 
V̇O2 max and CVR, and aortic pulse wave velocity and executive function and general 
cardiovascular health (e.g., blood pressure). The grey arrow shows links supported by the 
literature. The broken arrows show missing causal links likely to underlie the association 
between cerebrovascular health, cardiorespiratory fitness and cognitive function (Gauthier 








Finally, it is also important to consider mechanistic and translational aspects of this area of 
research. Although beyond the scope of this thesis, other areas of research have focused on 
exercise-induced physiological stress on cells, tissues and organs within the body, that lead 
to molecular adaptations (see Burley et al., 2016 for review). These translate to 
haemodynamic and structural brain modifications, such as improved CBF and CVR 
(discussed previously), angiogenesis, neuroplasticity (Voss et al., 2013) and cognitive 
functioning (Kramer et al., 1999), as well as changes in clinical presentation, quality of life 
and well-being. Possible underlying mechanisms that mediate these adaptations in the 
brain have been reviewed (Lucas et al., 2015; Lautenschlager et al., 2012; Voss et al., 
2013) and are briefly summarised in Figure 2.14. It is crucial that we improve 
understanding of these mechanisms and their relative contribution to help optimise 







Figure 2.14. Potential mechanistic pathways through which the components of optimised 
intervention strategies may lead to beneficial brain adaptations of structure and function, 
and ultimately, improve brain and cognitive health. Strategies can occur concurrently to 
create multi-modal and individualised interventions. They include: physical activity; 
cognitive activity; nutritional supplementation; hydrostatic stress; thermal stress, and 
hypoxia. Such strategies induce physiological stress on cells, tissues and organs that 
facilitate stimulus-strain responses within the brain and systemic organs, tissues and cells 
and involve a number of mediators that can be adaptive or maladaptive depending on their 
concentrations. Thus, emphasising the potential hormesis effect for dose-response 
requirements to avoid toxicity (which may lead to dysfunction) and optimise physical and 
cognitive health. Mediators include:  NO (nitric oxide); eNOS (endothelial nitric oxide 
synthase 3); BDNF (brain-derived neurotrophic factor); free radicals; ROS (reactive 








2.6. Summary  
Although the measures discussed vary quite substantially in terms of the process through 
which they measure brain health and exactly what they are measuring, the vast majority 
have demonstrated a positive role for regular exercise and greater fitness in improving the 
efficiency of the brain in some way (although some have led to reconsideration of what is 
considered impaired (i.e., studies using MRI-derived CVR measures showing the opposite 
fitness association to studies using TCD-derived CVR measures)). Whether that be 
through an increase in cerebrovascular responsiveness as seen with TCD, an improved 
cognitive performance determined by faster reaction times and increased number of correct 
responses in behavioural tasks, an improved subjective interpretations of emotional well-
being revealed through questionnaires, an increased neuronal activation and improved 
integrity revealed by MRI, or increased oxygenation levels in brain tissue measured with 
the NIRS.   
 
However, when used in isolation they all possess weaknesses that force us to question how 
confident we can be in the way that we interpret the results. For example, it may be 
possible that a patient with mild cognitive impairment may present a significantly 
improved score on a cognitive task that measures their attention and ability to ignore 
irrelevant stimuli, have an excellent cerebrovascular response measured with TCD, show 
increased neural activation in frontotemporal regions associated with higher executive 
functioning, yet, through clinical and psychological questionnaires measuring well-being 
and symptoms of depression, present as significantly depressed and suicidal. This is an 
incredibly over-simplified scenario though illustrates the dangers of relying on any 
measure in isolation, no matter how ‘good’ a measure it may be. If clinicians were to end 





outcomes, then they would have failed to help this patient. Therefore, one measure cannot 
quantify all the effects associated with brain health. Further, it is important that we adopt a 
broader multi-disciplinary approach that utilises a range of measures on a person-centred 
basis. 
 
Research studies are already beginning to utilise a more multimodal approach, where 
findings revealed from a combination of measures may either complement one another and 
strengthen the observed findings or contradict one another and evoke further exploration. 
Neurovascular coupling is an example of a more holistic brain-body approach where we 
can combine neuronal response measures in the brain with physiological measures in the 
cerebral vasculature (e.g., Phillips et al., 2016). We can further expand on this holistic 
approach by incorporating the various other methods introduced in this review. However, 
this needs to be done in a manner that is not going to lead to an excessive overload of 
measurements as this is neither therapeutic nor practical.  This review demonstrates that 
more research is needed to better understand how we can most effectively utilise measures 
of brain health with the ultimate goal of confidently providing reliable, clinically relevant 
outcomes to any therapeutic intervention. 
 
No known studies to date have directly compared TCD approaches to MRI approaches for 
outcome measures of resting CBF or CVR, yet both these measures are commonly used (in 
isolation) to predict health and brain targeted intervention. Considering the various issues 
discussed in this chapter within the different neuroimaging modalities, in addition to the 
different underlying mechanisms that determine the CVR measures (i.e., BOLD intensity 
signal or MCA velocity), and the discrepancies between ageing and fitness affects reported 





addressed.  Further, although some studies have investigated cognitive performance 
associations with cerebrovascular health measures, this area of research is in its early 
infancy and no study thus far has explored whether these measures translate to, or are 
associated with, improved quality of life and well-being. 
 
Therefore, this thesis will address the following research questions: 
1. Do different methodological approaches (CO2 stimulus duration and method of 
data extraction) affect the TCD-derived CVR outcome measure? (Chapter 3) 
2. Will differences in resting CBF measures be observed between different age and 
fitness groups? (Chapter 4) 
3. Do different neuroimaging modalities (TCD versus MRI) and analysis approaches 
alter the resting CBF outcome measure? (Chapter 4) 
4. Will differences in CVR measures be observed between different age and fitness 
groups? (Chapter 5) 
5. Do different neuroimaging modalities (TCD versus MRI) and analysis approaches 
alter the CVR outcome measure? (Chapter 5) 
6. Will differences in cognitive performance, quality of life and well-being be 





Table 2.1. Summary of key studies assessing measures of cerebral blood flow and multimodal approaches (i.e., with cognition). 
Study Index of brain 
health 
Modality Participants Fitness and age categorisation/ Intervention 
groups 
Results 





TCD 153 healthy 
sedentary and 154 
endurance-trained 
men aged 78-79 
years  
Lifelong physical activity or inactivity to 
determine group. Confirmed by 
cycle/treadmill V̇O2 max test (endurance 















independent of training status. MCAv elevated in 
endurance-trained (9.1±3.3 cm·s
−1
). Approximately 17% 








TCD 81 healthy males. 4 
groups: younger/ 
older and trained/ 
sedentary 
Younger, ≤30 years, and older≥60 years. 
Lifetime PA level: trained, ≥150 minutes 
aerobic exercise (confirmed with V̇O2 max 
test), and sedentary, no activity 
PA attenuated age-related decline in resting MCAv (older 
group: trained, 46 cm·s
-1 
versus sedentary, 37 cm·s
-1
) and 









). Linear relationship 







TCD 29 healthy volunteers 
aged 55-77 years 





, and older: mean age 





MCAv and CVCi were lower in older adults compared to 

























adults (23-88 years) 
Young (age<40 years), middle-aged (40 
≤age<60 years), and older (age≥60 years) 
groups 
Observed age-related reductions in perfusion involving: 
superior-frontal, middle-inferior temporal, insular, 










based training on 
resting MCAv. 
Ten younger (23±5 years) and 10 older 
(63±5 years) 
Effects of training on MCAv at rest 












TCD 81 healthy males. 4 groups: 
younger/ older and trained/ 
sedentary 
Younger, ≤30 years, and older, ≥60 
years. Lifetime PA level: trained, ≥150 
minutes aerobic exercise (confirmed 
with V̇O2 max test), and sedentary, no 
activity 
PA attenuated age-related decline in CVR (older group: 
trained, 0.54 %·mm Hg
-1 
versus sedentary, 0.42 %·mm Hg
-1
). 




CVR TCD 29 healthy volunteers aged 
55-77 years 
Younger: mean age 26 years; mean 




, and older: 






MCAv-CVR and CVCi -CVR were lower in older adults 

























10 Masters athletes (MA) (8 
male, 2 female), 10 sedentary 
elders 9 (SE) and sedentary 
younger control (YC) 
participants 
MA consistent age-group place winners 
for 23 years with weekly mileage of 32 
miles of equivalent cycling or 
swimming 
MA had higher resting CBF in posterior cingulate, and lower 
CVR compared to SE. Dose-response relationship shown by 





32 healthy older adults (50-
71 years) 
V̇O2 max values were correlated with 
CVR values for RoIs using lobular 
approach 
In entire cohort, V̇O2 max inversely correlated with frontal 
(r=-0.43, p<0.05), occipital (r=-0.46, p<0.05), parietal (r=-
0.46, p<0.01) and temporal (r=-0.44, p<0.05) lobe CVR 
using lobular, not voxel-wise approach. Correlations 








TCD 12-week aerobic-based 
training on MCAv response 
to exercise and CVR to 5% 
CO2  
Ten younger (23±5 years) and 10 older 
(63±5 years) 
Absolute MCAv response to exercise was greater in the 
younger (9 and 9 cm·s
−1
) than older (5 and 4 cm·s
−1
) 
(p<0.05) and was similar following 
training. After 12-week training, CVR was elevated  











 Multi-modal approaches (Cerebrovascular health and cognitive function outcome measures)  
Chapman 
(2016) 
Resting CBF and 
CVR; cognition 




aged 56-75 years 
Intervention study: cognitive 
(CT) versus physical (PT). 
3hrs/ week for 12 weeks. 
Measures taken pre, mid and 
post 
CT showed improved executive function, increased 
resting CBF in PCC, and no change in CVR compared 
to PT group. Complex abstraction associated with 
resting CBF in dACC. Higher resting CBF in 





and MAP; cognition 
ASL CVRi; verbal 
fluency 
58 older adults Divided into ‘young-old’: 65-
80 years and ‘very-old’: 85+ 
years 
Very-old participants had elevated CVRi and reduced 
CBF compared to young-old in regions implicated in 
AD. Significant age-related interactions between 
elevated CVRi in the thalamus to reduced performance 











Acute exercise effects: 
cycling 30% and 70% of HR 
max 
Stroop performance was slower for older than younger 
group. Cognition improved (similarly for younger and 
older groups) whilst exercising. Higher MCAv 
correlated with faster response times at rest, became 
uncoupled during exercise. Prefrontal NIRS showed 
smaller increases between intensities in older group 
Brown 
(2010) 
Resting CBF (MCAv, 






verbal fluency)  
42 healthy women 
aged 50-90 years 
Younger: 50-64 years and 
older: 65-90 years. Active: 
V̇O2 max>90% age predicted 
score; sedentary: V̇O2 
max<90% age predicted score 
V̇O2 max was a predictor of resting CVCi (positive 
correlation) and MAP (negative correlation). MAP and 
CVCi were predictors of cognition. Cognition 














Older and younger groups 
defined. No fitness groups. 
Correlations across sample 
whilst controlling for age and 
gender 
Older group showed a decline in executive function 
(slower performance in Stroop), higher aortic pulse 
wave velocity and lower V̇O2 max than younger. V̇O2 
max negatively correlated with BOLD CVR in frontal 
regions though negatively correlated with CVR in 











counting task (CNT) 
and random number 
generation (RNG) 
task 
34 older women 
aged 60-77 years. 
High-fit versus low-fit 
defined by median split of 
scores (n=17 per group) 
High-fit showed significantly better performance on 
RNG compared to low-fit. High-fit showed significant 
increases in HbO2 responses during RNG task. 
Increases in HbO2 found to mediate relationship 
between V̇O2 max and executive performance 
Guiney 
(2015) 







55 healthy young 
adults 
NZPARQ self-report 
questionnaire and V̇O2 max. 
Correlations across sample 
Exercise frequency predicted CBF regulation and 
inhibitory control. Mediation analysis indicated more 
frequent exercise may result in improved inhibitory 








4,759 mean age 61 
years  
2005-2012, population study, 
123 developed dementia 
Hypoperfusion associated with accelerated cognitive 
decline and risk for dementia 
      
Abbreviations: ASL, arterial spin labelling; BOLD, blood-oxygen-level dependent signal; CBF, cerebral blood flow; CVCi, cerebrovascular 
conductance; CVRi, cerebrovascular resistance; CVR, Cerebral blood flow responsiveness to carbon dioxide (CVR); MRI, magnetic resonance 
imaging; fNIRS, functional near-infrared spectroscopy; HbO2, deoxygenated haemoglobin; MCAv, middle cerebral artery blood velocity; 
NZPARQ, New Zealand Physical Activity Readiness Questionnaire; PA, physical activity; PC angiography, phase contrast angiography; RoI, 





3. CEREBROVASCULAR REACTIVITY TO CARBON DIOXIDE 
USING TRANSCRANIAL DOPPLER ULTRASOUND 
 
 
3.1. Abstract  
Background: Cerebrovascular reactivity to carbon dioxide (CVR) is calculated from 
alterations in arterial carbon dioxide content (PCO2) and is a common functional test to assess 
brain vascular health. However, studies measuring CVR have used different CO2-stimulus 
durations to induce the response, and different durations of data extraction, from different 
time points of the stimulus duration, for its analysis that may alter the CVR outcome measure 
and explain conflicting findings reported to date. Therefore, the purpose of this study was to 
examine whether these methodological differences alter the CVR outcome measure.  
Methods: Eighteen healthy volunteers (24 ± 5 years) completed a familiarisation trial and an 
experimental trial, which required them to inhale four stimulus durations (1, 2, 4 and 5-min) 
of 5% CO2 (in air) via the open-circuit Douglas bag method, in a randomised order. A 5-min 
resting baseline preceded each CO2-stimulus duration. CVR data were derived from 
transcranial Doppler (TCD) measures of middle cerebral artery blood velocity (MCAv), with 
concurrent ventilatory sensitivity to the CO2-stimulus (VE-CO2) determined via measures of 
respiratory rate and volume. Repeated measures ANOVAs compared CVR and VE-CO2 
measures between stimulus durations, steady-state time-points (1-min into stimulus versus 
end of stimulus) and extract durations (30 versus 60 s).  
Results: An effect of stimulus duration was observed (p = 0.002, ² = 0.140), with 1-min (p = 
0.01) and 2-min (p < 0.001) being different from the 4-min, and 2-min being different to the 





durations (p < 0.001, ² = 0.485). CVR measures calculated from different steady-state time-
points within each stimulus duration were different (p < 0.001, ² = 0.454); specifically, for 
the 4-min (p = 0.001) and 5-min (p < 0.001), but not the 2-min stimulus duration (p = 0.23). 
These findings demonstrate that methodological differences alter the CVR measure. 
Therefore, caution is needed when comparing studies that use different approaches. 
 
 
3.2. Introduction  
Regulation of cerebral blood flow (CBF) in response to a physiological stressor is a common 
functional test used to assess brain vascular health. Effective regulation of blood flow to and 
within the brain is vital for optimal brain function momentarily and across the lifespan. CBF 
declines by approximately 50% across healthy adulthood (Brown et al., 2010; Barnes et al, 
2013; Bailey et al., 2013), which unfortunately coincides with a decline in the most potent 
regulatory mechanism of CBF - its responsiveness to changes in arterial carbon dioxide 
pressure (PCO2; termed cerebrovascular reactivity to carbon dioxide (CVR)). Elevation in 
CO2 in the bloodstream is known as hypercapnia. This response demonstrates how well pH 
balance is maintained and is a crucial homeostatic function to ensure biological processes 
operate in optimal environments and protect against disease. Reduced CBF and CVR are 
exacerbated in clinical diseases such as hypertension (Immink et al., 2004), stroke (Markus, 
2001) and dementia (den Abeelen et al., 2014). Furthermore, CVR is associated with all-cause 
cardiovascular mortality (Portegies et al., 2014). 
 
It is well recognized that regular exercise has a positive effect on brain function (Voss et al., 





associated with higher aerobic fitness (Bailey et al., 2013; Barnes et al., 2013) and improves 
following 12 weeks of exercise training (Murrell et al., 2013). However, conflicting 
observations have been reported in a group of Masters athletes with life-long history of 
aerobic exercise training (Thomas et al., 2013). These athletes demonstrated a blunted CVR, 
contrary to the expected higher response associated with aerobic fitness that is more 
commonly reported. 
 
A possible explanation for inconsistent findings is that methodological inconsistencies are 
present throughout the scientific literature in this area. For example, the open-circuit 
inhalation of CO2 has been administered for a stimulus duration of 1.5 (Vernieri et al., 2009), 
3 (Murrell et al., 2013), 4 (Guiney et al., 2015; Kastrup et al., 2001) or 5 minutes (Lavallee et 
al., 2009), as well as with different CO2-stimulus concentrations (5% or 7%; see Fierstra et 
al., 2013 for a full review). Further, CVR can be derived from varying proportions of the 
overall stimulus duration (e.g., 15, 30 or 60 seconds of data extracted from any stimulus 
duration). In addition, there is variation in how long participants have been breathing CO2 
before data is extracted for calculation (i.e., how the time-point of the steady-state period is 
defined) as well as an unclear methodological approach to determine how to identify the 
steady-state period.  
 
For example, List and colleagues used measures of change in middle cerebral artery blood 
velocity (MCAv) in response to CO2 to investigate the effects of transcranial direct current 
stimulation on cerebral autoregulation in ageing and cerebrovascular diseases (List et al., 
2015). The methodology describes how researchers ‘recorded over the MCA during a 60-s 





velocity became stable’. Similarly, Vernieri and colleagues used a ’90-s CO2 inhalation period 
– always including for each subject the 30-s plateau period’ (Vernieri et al., 2009). However, 
in both these studies, determining how MCAv has become stable or reached a plateau period 
is unclear. Typically, on visual inspection of MCAv, the point at which steady state has been 
reached is open to interpretation as the trace fluctuates in nature. Further, the MCAv profile 
will vary between individuals such that some may take longer than 2 minutes (e.g., more than 
five minutes has been reported) to reach steady state (Regan et al., 2013). Thus, 2 minutes 
may not be long enough for some people to reach this state. Furthermore, given the known 
interaction between ventilatory and cerebrovascular responses that occur during hypercapnia 
at rest (Ogoh et al., 2008), the change in CBF between 1 or 2 minutes of stimulus to that of 4 
or 5 minutes will likely be different given the circulatory delay associated with the delivery of 
the inspired CO2 to the central chemoreceptors. These methodological inconsistencies may 
account for the different ageing and fitness results seen between the studies described 
previously (Thomas et al., 2013; Bailey et al. 2013; Barnes et al., 2013).  
      
3.2.1. Study Aims and Hypotheses 
To maximise the utility of CVR as a measure of brain vascular health it is important to 
identify whether methodological nuances affect the CVR outcome measure. Therefore, the 
overall aim of this study was to compare different methods of calculating the CVR outcome 
measure within the same individuals using the open-circuit technique where individuals 
inhaled a fixed fractional concentration of 5% CO2 from a pre-mixed Douglas bag. 
Approaches similar to these are the most commonly used techniques because they use low 
specification and relatively inexpensive equipment, and are used in clinical settings to 





VE-CO2 and individual variability were also examined to determine whether these factors 
may have influenced the CVR measure (described in more detail in Sections 2.3.2 and 2.3.4). 
The study had two main aims examining variations in data collection and analysis. 
Specifically, aim (1): Mean CVR outcome measures and VE-CO2 values were compared by 
calculating the final 30 seconds of four different stimulus durations of breathing 5% CO2 (1, 
2, 4 and 5 minutes); Aim (2): Mean CVR calculations derived from different methods of data 
extraction (including the time-point of the steady-state period used to determine data 
extraction and the duration of data extraction) within the same stimulus duration were 
compared. It was hypothesised that: 1) the stimulus duration of 1, 2, 4 or 5 minutes would not 
give the same calculated CVR outcome; 2) the time-point of data extraction would alter the 
CVR outcome (i.e., the CVR calculated by extracting data from 90 s into stimulus duration 
would be different from those calculated from data extracted at the end of the stimulus 
duration for durations longer than 2 minutes), and 3) CVR outcome measures calculated from 
30 s of extracted data will be the same as CVR outcome measures calculated from 60 seconds 
of extracted data.  
 
 
3.3. Materials and Methods  
Ethical approval was obtained for all experimental protocols and procedures by the University 
of Birmingham Ethics Committee and conformed to the Declaration of Helsinki (project code: 
ERN_14-0555). All testing took place in the School of Sport, Exercise and Rehabilitation 
Sciences at the University of Birmingham. Prior to participation, a detailed verbal and written 
explanation of the study was provided, and written informed consent to participate was 





3.3.1. Study Design and Protocol 
Eighteen healthy volunteers (9 male and 9 female; mean age 24 ±5 years) participated in the 
study and were included in the analysis. Participants were required to make two visits. During 
the first visit participants provided informed consent and completed a general health 
questionnaire to check for contraindications (Appendix A3.3). Participants were not taking 
any medication and had no history of cardiovascular, cerebrovascular or respiratory disease. 
Following successful screening participants then completed a familiarisation session of the 
open-circuit gas challenge protocol. They were asked to lie in supine position, relax and 
breathe as naturally as possible. First, participants lay supine for ~20 minutes while they were 
instrumented with equipment (detailed below, Appendix A3.4). Once instrumented, baseline 
data were collected for 5 minutes. They then breathed 1 minute of a 5% CO2 (in air) stimulus, 
followed by 5 minutes of room air, followed by 5 minutes of the 5% CO2 stimulus. After 
satisfactory completion of familiarisation trials (i.e., no adverse reactions to breathing the CO2 
stimulus were experienced by the participant and adequate Doppler signals were identified by 
the PhD candidate), participants were invited back for the second visit that was a full 
experimental testing session. For this second visit, four different stimulus durations of the 
same 5% CO2 stimulus were administered (1, 2, 4 and 5 minutes) and each included a 5-
minute baseline recovery period (Figure 3.1). These stimulus durations were performed in a 
randomised order between participants to avoid order effects. For both the familiarisation and 
experimental visits, participants were asked to avoid vigorous exercise and alcohol 24 hours 








Figure 3.1. Example of gas challenge protocol for the second visit. Shaded boxes show the 
stimulus durations (1, 2, 4 and 5 minutes of 5% CO2; random order of administration between 
participants). White boxes show baseline periods where participants were breathing room air. 
 
3.3.2. Measures and Equipment 
Beat-by-beat middle cerebral blood flow velocity (MCAv) and blood pressure (BP) along 





) and end-tidal CO2 partial pressure were continuously measured during 
the gas challenge protocol. MCAv was assessed using transcranial Doppler (TCD) (Multi Dop 
X, DWL, Compumedics Ltd Germany) with a 2-MHz probe placed over each temporal 
window to measure bilateral MCAv. Probes were prepared with ultrasound gel and held in 
place with a headset. Search and identification procedures were performed in accordance with 
established guidelines (Willie et al., 2011).  
 
BP was measured using a finger cuff placed on the middle finger of the left hand (Portapres, 
Finapres, Medical System BV, Netherlands). Respiratory rate and volume were measured 
using a heated pneumotachograph (3813 Series, Hans Rudolph Inc, Kansas, USA) attached to 
a facemask, while fractional changes in inspired and expired O2 and CO2 were measured via a 
sample line attached to the facemask and a fast responding gas analyser (ML206, 
ADInstruments Ltd, New Zealand). Measures were recorded at 1k Hz via an analogue-to-











































































analysis using commercially available software (LabChart v7.3.5, ADInstruments). 
Calibration of equipment was performed before each testing session.  
 
3.3.3. Data Analysis  
The analysis was split into two parts. For Aim 1, data from the last 30 seconds of each of the 
four CO2 stimulus durations (1, 2, 4 and 5 minutes) and 60 seconds of baseline data before 
each stimulus duration were extracted (Figure 3.2).  For Aim 2, data were extracted from two 
different steady-state time-points (i.e., after 60 seconds of stimulus duration and at the end of 
stimulus duration; Figure 3.3), for two different durations (60 and 30 seconds) from three 
stimulus durations (2, 4 and 5 minutes). The 1-minute stimulus duration is not included in this 
analysis as there is not enough time for MCAv to reach steady state (i.e., plateau). Finally, 3-
minute stimulus duration CVR measures were calculated from the final 30 seconds of data 3 
minutes into the stimulus duration for both the 4- and 5-minute stimulus durations.  
 
 
Figure 3.2. A representative CO2 trace of gas delivery to a participant taken from LabChart. 
Shows where for Aim 1 30 seconds of data were extracted from the end of four different CO2-






Figure 3.3. Percentage CO2 trace from LabChart showing where data were extracted from two 
different steady-state time-points. Time-point 1: after 60 seconds of stimulus duration and 
Time-point 2: end of stimulus duration, for two different durations (60 and 30 seconds).  
 
 
Mean right and left MCAv and CVR measures were compared for hemispatial effects. Mean 
baseline MCAv was calculated preceding each gas stimulus and analysed separately to see if 
they were different. Mean absolute and relative changes (percentage increase from baseline to 
hypercapnia) in MCAv and CVR measures were calculated. Ventilatory sensitivity was also 
calculated and compared across stimulus durations. The following equations were used to 
calculate absolute and relative CVR (Equation 3.1 and 3.2), and VE-CO2 (Equation 3.3) 








hypercapnic (5% CO2) MCAv – resting MCAv 
hypercapnic (5% CO2) PETCO2 – resting PETCO2 
Equation 3.1 
Relative CVR: 
100 ((hypercapnic (5% CO2) MCAv – resting MCAv) / resting MCAv) 
hypercapnic (5% CO2) PETCO2 – resting PETCO2 
Equation 3.2 
VE-CO2: 
hypercapnic (5% CO2) VE – resting VE 
hypercapnic (5% CO2) PETCO2 – resting PETCO2 
Equation 3.3 
 
After preliminary analysis and for completeness, a further analysis was performed on the 4- 
and 5-minute stimulus durations to determine whether CVR calculated 3-minutes into the 
stimulus duration differed to CVR values calculated from the 2-minute stimulus duration. 
 
3.3.4. Statistical Analysis 
Statistical analysis was performed in SPSS software (IBM SPSS version 22.0, Chicago, IL). 
Measures were compared using repeated analysis of variance (ANOVAs) with the main 
factors being stimulus duration (1, 2, 4 and 5 minutes), steady-state time-point (1 and 2), and 
duration of data extraction (60 and 30 seconds). Data are presented as means and standard 







3.4.1. Baseline Measures 
A 2x4 within-participants ANOVA with two factors: hemisphere side (2 levels: left and right) 
and baseline number (4 levels: baseline preceding 1, 2, 4 and 5 minute stimulus durations), 
revealed there was no significant effect for mean MCAv between baseline measures (F(3,48) 
= 1.73, p = 0.17, ² = 0.098), nor was there any effect between hemispheres (F(1,16) = 0.41, 
p = 0.53, ² =0.025).  
 
3.4.2. Aim 1: Does the CO2 Stimulus Duration Alter the Cerebral Blood Flow 
Responsiveness to Carbon Dioxide (CVR) Measure?  
3.4.2.1. Cerebral Blood Flow Responsiveness to Carbon Dioxide (CVR) 
Relative and absolute CVR measures were analysed using a 2x4 within participants ANOVAs 
with two factors: side (2 levels: right and left), and duration of stimulus (4 levels: 1, 2, 4 and 5 
minutes of CO2 stimulus where data were extracted from the last 30 seconds of stimulus 
duration; see Figure 3.2). For both relative and absolute CVR measures, there was a 
significant main effect of stimulus duration (relative: F(3,48) = 3.49, p = 0.037, ² = 0.161; 
absolute: F(3,48) = 3.10, p = 0.048, ² = 0.162), whereas neither stimulus duration displayed 
a significant effect for hemisphere (relative: F(1,16) = 1.99, p = 0.18, ² = 0.111; absolute: 
F(1,16) = 1.86, p = 0.19, ² = 0.104). Therefore, the remaining analysis was performed on 
average CVR measures of bilateral MCAv (averaged right and left side). Relative and 
absolute CVR measures and VE-CO2 values are presented in Table 3.1 with significant p 






Table 3.1. Summary table showing mean and standard deviation (SD) for average (right and 
left MCAv) relative and absolute CVR measures and VE-CO₂ values for each stimulus 
duration. Repeated-measures ANOVAs revealed significant differences between stimulus 
durations.  
  
CO₂ stimulus duration 
  
 
    1 minute 2 minute 4 minute 5 minute n p ²  
Relative CVR mean 2.93 3.20 2.50 2.63 18 0.036 0.153 
(% change in MCAv /                
mm Hg change in PETCO2) SD 1.05 1.25 0.93 1.00 
  
 
Absolute CVR mean 1.93 2.13 1.70 1.75 18 0.036 0.153 
(cm·s-1·mm Hg-1) SD 0.70 0.94 0.70 0.67    
VE-CO₂ mean 0.32 0.70 0.90 0.95 18 0.000 0.485 
(L·min-1·mm Hg-1) SD 0.22 0.25 0.36 0.43 
  
 
Abbreviations: CO2, carbon dioxide; CVR, cerebrovascular reactivity; MCAv, middle cerebral 
artery blood velocity; PETCO2, end-tidal carbon dioxide; VE-CO2, ventilatory sensitivity to CO2. 
 
 
Figure 3.4. Mean (± SD) relative CVR calculated for each stimulus duration. Significant post-
hoc effects and trends towards significance of stimulus duration are shown in bold font. 
Abbreviations: CO2, carbon dioxide; CVR, cerebrovascular reactivity; MCAv, middle cerebral 
artery blood velocity; PETCO2, end-tidal carbon dioxide. Adjustment for multiple comparisons 





3.4.2.2. Ventilatory Sensitivity to Carbon Dioxide (VE-CO2)  
Ventilatory sensitivity to CO2 (VE-CO2; average from the 30-second time window selected, 
see Section 3.3.3 for calculation) increased ~3-fold from the 1 minute to the 4- and 5-minute 
stimulus durations (p < 0.001,² = 0.485) (Table 3.1; Figure 3.5).  
 
Figure 3.5. Mean (± SD) VE-CO2 values calculated for each stimulus duration. Significant post-
hoc effects and trends towards significance of stimulus duration are shown in bold font. 
Abbreviations: CO2, carbon dioxide; VE-CO2, ventilatory sensitivity to CO2. Adjustment for 
multiple comparisons was done via Bonferroni. 
 
3.4.2.3.Within-Individual Variability 
We observed visual differences in the beat-to-beat MCAv-response profile between durations. 
For example, a steady-state profile typified the 4 and 5 minute tests, whereas the 1 minute test 





within individuals across the four stimulus durations; CoV ranging from 7 – 46% between 
individuals (Figure 3.6). 
 
Figure 3.6. Within-individual variability in relative CVR measure (from mean right MCAv) 
between CO2-stimulus durations. Covariance within participants ranged from 7-46%. 
 
3.4.3. Aim 2: Does the Time-Point of Steady State or the Duration of Data Extraction 
Alter the CVR Outcome Measure?  
The purpose of this next analysis was to investigate whether the time-point of steady state 
used for data extraction (time-point 1 or 2; Figure 3.3) and the duration of data extracted (30 
or 60 s) altered the CVR outcome measure. Time-point of steady state and duration of data 
extraction were examined for the 2-, 4- and 5-minute CO2-stimulus durations for both CVR 
and VE-CO2 measures. One important note is that for the 2-minute stimulus duration, because 
of the shorter length, data is extracted from almost identical time-points regardless of the 





stimulus for time-point 1, and data is extracted 1 minute preceding the end of the stimulus 
backwards to 1 minute into the stimulus for time-point 2 and would be almost identical since 
the stimulus duration was exactly 2-minutes). Mean MCAv traces and mean PETCO2 traces for 
all four stimulus durations (1, 2, 4 and 5 minutes) for one participant are shown in Figure 
3.10. 
 
3.4.3.1. Cerebral Blood Flow Responsiveness to Carbon Dioxide (CVR) 
Average (right and left MCAv) CVR measures were analysed using a 2x3x2 within 
participants ANOVA with three factors: steady-state time-point (2 levels: time-point 1 and 2), 
stimulus duration (3 levels: 2, 4 and 5 minutes of CO2 stimulus), and data extraction duration 
(2 levels: 30 and 60 seconds). There was a significant effect of stimulus duration (similar to 
Aim 1): F(2,68) = 4.78, p = 0.02, ² = 0.123, and steady-state time-point: F(1,34) = 28.24, p < 
0.001, ² = 0.454. The effect of data extraction duration was not significant: F(1,34) = 1.12, p 
= 0.300, ² = 0.032. Therefore, a 2x3 ANOVA was performed with two factors: steady-state 
time-point and stimulus duration, for average CVR measures calculated from 30 and 60 
seconds of extracted data.  
 
Repeated measures ANOVA revealed a significant main effect of time-point: F(1,17) = 
14.373, p = 0.001, ² = 0.458, and a trend towards stimulus duration: F(2,34) = 28.24, p = 
0.064, ² = 0.149. Further, a significant time-point by stimulus duration interaction was 
observed (p = 0.008, ² = 0.232).  Paired t-tests were used to examine effects of time-point for 
each of the different stimulus durations separately (Figure 3.7). As expected, given the similar 





(p = 0.343). However, there was a significant effect of time-point for the 4-minute (p = 0.012) 
and 5-minute (p = 0.002) stimulus durations. In summary, this analysis shows that the time-
point of steady state used to determine data extraction does alter the CVR measure (Figure 3.7 
and Table 3.2).  
 
3.4.3.2. Ventilatory Sensitivity to Carbon Dioxide (VE-CO2) 
VE-CO2 values were analysed using a 2x3x2 within participants ANOVA with three factors: 
steady-state time-point (2 levels: time-point 1 and 2), stimulus duration (3 levels: 2, 4 and 5 
minutes of CO2 stimulus), and data extraction duration (2 levels: 30 and 60 seconds). There 
was a significant effect of time-point: F(1,17) = 54.76, p < 0.001, ² = 0.763, while effects of 
extract duration and stimulus duration were not significant (F(1,17) = 2.52, p = 0.131, ² = 
0.129 and F(2,16) = 0.746, p = 0.490, ² = 0.085 respectively).  However, there were 
significant interactions between time-point and stimulus duration: F(2,34) = 15.90, p < 0.001, 
² = 0.483 and time-point and data extraction duration: F(2,34) = 14.61, p = 0.001, ² = 
0.462. Therefore, four separate ANOVAs were performed for each method of data extraction; 
30 and 60 seconds of data extracted from time-point 1 and time-point 2 (Table 3.3; Figure 
3.8).  
 
When data were extracted from time-point 2, VE-CO2 sensitivity increased from the 2 minute 
to the 4 and 5 minute test durations (similar to in Aim 1). In contrast, when data were 
extracted from time-point 1 there is less variability within the VE-CO2 sensitivity measure 
between the stimulus durations (i.e., data is extracted from roughly the same time-point 





Table 3.2. Mean and standard deviation (SD) for relative CVR measures calculated using data 





CO2 stimulus duration  
 
 
(% change in MCAv / mm 
Hg change in PETCO2) 
Time-point of data 
extraction    2 minute 4 minute 5 minute F p ² 
Time-point 1 mean 3.26 2.81 3.02    
 
SD 1.27 0.70 0.80 1.58 0.221 0.085 
Time-point 2 mean 3.22 2.50 2.62    
 
SD 1.24 0.92 0.97 4.61 0.024* 0.213 
 
Abbreviations: CVR, cerebrovascular reactivity (CVR); MCAv, middle cerebral artery blood 
velocity. 
 
Table 3.3. Mean and standard deviations (SD) for VE-CO2 values calculated using different 
methods of data extraction (steady state time-point and data extraction duration) from 3 
stimulus durations (2, 4 and 5 minutes). Separate within subject ANOVAs were performed for 
each steady state time-point (with stimulus duration and duration of data extraction as factors) 










Method of data 
extraction   2 minute 4 minute 5 minute F p ² 
Time-point 1 mean 0.64 0.60 0.54    
 
SD 0.21 0.23 0.23 1.25 0.299 0.069 




SD 0.20 0.31 0.40 5.46 0.009** 0.243 
 






Figure 3.7. Mean ± SD relative CVR measures (averaged right and left MCAv). Graphs shows measures calculated from two steady-state time-points from three stimulus 
durations (2, 4 and 5 minutes). Paired t-tests revealed significant effect of time-point for the 4-minute and 5-minute stimulus durations. Abbreviations: CO2, carbon 
dioxide; CVR, cerebrovascular reactivity; MCAv, middle cerebral artery blood velocity; PETCO2, end-tidal carbon dioxide. 
 
Figure 3.8. Mean ± SD VE-CO2 values. Graphs shows measures calculated from: two steady state time-points from three stimulus durations (2, 4 and 5 minutes).  
Paired t-tests revealed significant effect of time-point for the 2- minute, 4-minute and 5-minute stimulus durations. Abbreviations: CO2, carbon dioxide; VE-CO2, 





3.4.3.3. Three Minute Stimulus Duration CVR Measures 
In addition, CVR measures were calculated from the final 30 seconds of data 3 minutes into 
the stimulus duration for both the 4 and 5 minute stimulus durations. Paired t-tests revealed no 
differences between relative CVR measures calculated from the mean right MCAv (t = 0.474; 
p = 0.643), a trend for a difference between relative CVR measures calculated from the left 
MCAv (t = 1.965; p = 0.070) and no differences for measures calculated from average (right 
and left) MCAv (t = 1.686; p = 0.504) when comparing between the 4 minute and 5 minute 
stimulus durations. Further, a repeated-measures ANOVA comparing average CVR measures 
obtained from 3 minutes into the 4- and 5-minute stimulus duration with the CVR measures 
obtained from the 2-minute stimulus duration, were also not significantly different (p = 0.184, 
² = 0.121) (Figure 3.9). 
 
 
Figure 3.9. Mean relative average (right and left MCAv) CVR calculated from data extracted 




















































Figure 3.10. Mean MCAv (lighter lines; lower four traces) and mean PETCO2 (darker lines; upper four traces) for all four stimulus durations 












































The purpose of this study was to compare CVR measures and VE-CO2 values calculated 
from: 1) different CO2 stimulus durations, and 2) different durations of data extraction and 
different time-points of steady state to determine data extraction. The main findings were: 
1) CVR outcome measures calculated after 60 seconds of stimulus (time-point 1) were 
higher than measures obtained at the end of the stimulus duration (time-point 2); 2) there 
was less variability in the CVR outcome measure when it was derived from 60 seconds 
after stimulus onset (time-point 1), indicating a more reliable point to determine CVR; 3) 
within-participant variation increased when the stimulus duration was longer than 2 
minutes, likely due to increased effects of the ventilatory response. Collectively, these 
findings demonstrate that methodological differences of stimulus duration and time-point 
used to determine the steady-state, do indeed alter the CVR outcome measure and VE-CO2 
values. 
 
CVR is a commonly used method of assessing brain health and has been applied in both 
healthy and clinical populations. Therefore, it is important that the methodologies used are 
consistent across research and clinical centres. Based on the findings of the present study, 
CVR outcome measures calculated 60 seconds after stimulus onset (time-point 1) with 
stimulus duration of between 2 and 3 minutes will be less affected by individual variability 
and therefore more reliable for both within (i.e., repeated measures) and between (cross-
sectional) study comparison. 
 
In aim 1, we found a significant effect of the CO2 stimulus duration on the CVR outcome 
measure, as well as marked variability within the same individuals across the different 






minute and the 2-minute stimulus duration, and was lowest when taken from the 4- and 5-
minute stimulus durations. This observation was also clear in the second part of the 
analysis for aim 2, where CVR measures were higher for the 2-minute stimulus duration 
and lower for the 4- and 5-minute stimulus durations. These differences are likely driven 
by the change in VE-CO2 that increased approximately 3-fold as the stimulus duration 
increased.  Indeed, the difference in VE-CO2 values between 1 and 2 minutes were 
significant, becoming progressively less different as the stimulus duration increased to 4 
and 5 minutes. These values support those previously shown in the literature (Lucas et al., 
2011; Murrell et al., 2013; Brothers et al., 2014) and were again similar in the second part 
of the analysis. 
 
In aim 2, we found significant effects of steady-state time-point on CVR measures, though 
only when calculated from the 4- and 5-minute stimulus durations. The lack in variability 
from the 2-minute duration was expected since the data are extracted from the same point 
for both steady-state time-point approaches (i.e., for time-point 1, data are extracted 1 
minute into gas delivery and for time-point 2, data are extracted during the final minute of 
gas delivery which is also 1 minute into gas delivery given that the stimulus duration is 2 
minutes). In contrast, there was no effect of data extraction duration for each stimulus 
duration on the CVR measure (30 vs. 60 seconds; p = 0.300).  
 
When considering the 2-minute stimulus duration to calculate CVR, MCAv was just 
reaching steady-state, or was still increasing to reach steady-state in some people (Regan et 
al., 2013), and calculated CVR measures were higher. Consequently, measures calculated 
by extracting data from this period may be less susceptible to increased ventilation effects, 






seconds of data are extracted. However, this may lead to an overestimation of the CVR 
measure. To address this, CVR measures from the final 30 seconds of data 3 minutes into 
the stimulus duration for both the 4-and 5-minute stimulus durations were compared with 
the CVR measure calculated using the 2-minute stimulus duration. This comparison 
revealed no significant difference between these CVR measures. Given this, perhaps a 2- 
or 3-minute stimulus duration is the most suitable to use to obtain an accurate CVR 
measure, since they are least affected by intra-individual variation in vascular and 
respiratory responses, including the time to reach steady state. Further, a shorter duration 
will also not unnecessarily overstress participants.  
 
The duration of data extraction (60 or 30 seconds) does not seem to affect CVR measures 
based on this dataset. However, a consistent approach should be used that avoids any 
interference resulting from the on-kinetics of the stimulus and the gradual increase to 
steady state that occurs within the first 2 minutes. Extracting a relative small proportion of 
the dataset is the commonly used approach in research centres using Doppler ultrasound to 
calculate the CVR measure. In contrast, research centres using magnetic resonance 
imaging (MRI) to measure CVR will extract data from the entire time course as well as the 
preceding baseline to calculate the CVR measure using a linear regression. Further, in 
protocols using a number of different levels of hypercapnia, data will be extracted from the 
entire protocol (Driver et al., 2016), rather than a relatively small segment. These 
approaches that utilise more of the dataset may avoid the possible sensitivity issues 
observed here. This leads to question whether CVR outcome measures (in addition to 
resting CBF measures) are different between different imaging modalities (i.e., TCD and 







3.5.1. Limitations and Methodology Considerations 
Limitations within this study include that it is difficult to test natural variation that may 
appear in the same individual across time. This is because it is impossible to test exact 
reliability between stimulus durations, as we cannot give a subject the different stimulus 
durations at the same time (i.e., the 2-minute stimulus duration cannot be given at the same 
time as the 4- or 5-minute stimulus duration). This study came as close as possible in 
achieving this by comparing four different stimulus durations within an hour whilst 
allowing adequate recoveries between them. The stimulus durations were also 
administered in a randomised order to account for potential order effects. Further research 
is needed to compare these measures between days. Individual variation in CO2 responses 
may be explained by genetic factors as well as sex, fitness level and other circumstances 
(Secher, 2015), indicating that the CVR measure is far more complicated than often 
presumed. Nevertheless, the CVR outcome measure is often collected from a single 
clinical visit, where the individual has not had time for their physiological measures to 
reach a resting baseline, and then used to predict current health status and disease risk. 
 
Another limitation with this study is that we are unable to consider possible effects of 
vessel diameter change in response to CO2 and how these may contribute to changes in 
blood flow velocity, which is currently debated in the literature (e.g., Brothers and Zhang, 
2016; Hoiland and Ainslie, 2016). However, our findings can direct us towards an 
approach that avoids as much variability as possible and lead us to consider other factors. 
For example, future research may aim to establish where the peak CVR is likely to occur 
and the extent to which individual responses range from the lowest to highest CVR 
measure. Our findings demonstrated that some individual’s CVR measures vary 






relatively stable across the different durations tested here (as shown in Figure 3.6). We 
could also consider implementing the ventilation response into the calculation in some 
way. For example, determining the point where CVR is at its peak and the ventilation 
response is at its lowest. Perhaps this approach would give a more accurate representation 
of CVR measures that is less influenced by within subject variability and the ventilatory 
response. 
 
A familiarization trial was performed with each participant to ensure they were 
comfortable with the 5% CO2 gases and experienced no adverse effects. This trial also 
ensured that the PhD candidate could obtain sufficient MCA signals that could be 
replicated for the second visit. Mean MCAv values were also compared between the four 
baselines. On visual inspection there is notable variability between the baseline velocities 
with some participants showing more variability than others (i.e., CoV ranging from 1 – 
8%). This may be a natural variability that occurs across time in response to many 
environmental influences and warrants further investigation, particularly if day-to-day 
variation within the same individual may also influence the CVR measure. In contrast, 
there is less variability between the baseline mean PETCO2 values (i.e., CoV ranging from 0 
– 5%; mean CoV = 2.4%) (Appendices Table A3.2). 
 
3.5.2. Perspectives and Significance 
To maximise the utility of CVR as a measure of brain vascular health it is important to 
identify where methodological nuances affect CVR outcome measures and consider where 
these inconsistencies between studies alter the measure, and thus, their collective 
interpretation of how CVR depicts brain vascular health in various populations. It may then 






imperative to investigate given that study findings are often compared and some studies 
have been used to predict risk of cardiovascular mortality (Markus and Cullinane, 2001; 
Portegies et al., 2014).   
 
In addition to the open-circuit technique, re-breathing and stepped end-tidal clamping are 
other approaches that are used to measure CVR with transcranial Doppler (TCD), though 
investigating these are beyond the scope of this study, but are likely to introduce more 
variability for between study comparisons of the CVR outcome measure. Further, magnetic 
resonance imaging (MRI) also provides a measure of CVR. Though in contrast to TCD, 
responsiveness measures are derived from changes in the blood-oxygen-level dependent 
(BOLD) signal (Bhogal et al., 2016; Thomas et al., 2013; Zhou et al., 2015). As well as 
variations within one methodological approach, the choice of measurement technique 
differs across studies (TCD or MRI).  
 
Recommended areas that focus on methodological inconsistencies to be explored include: 
1) investigating how the respiratory and vascular responses interact; 2) individual 
variability in average, maximum and minimum CVR measures, maximum change in CVR 
measure and time in which CVR response takes to peak, and 3) the response to CO2 
stimulus being applied or discontinued (i.e., the on and off-kinetics), as time to reach 
steady-state or return to baseline may also be an important indicator of cerebrovascular 
health. Further, these areas of investigation are likely to be influenced by ageing and 
fitness.  
 
Given conflicting findings on CVR, where fitness has been associated with both higher 






Thomas et al., 2013), and the findings shown by this study demonstrating possible causes 
of this variability, future research is required to elucidate other causes of variability on the 
CVR measure.  
 
In conclusion, the present study showed that the stimulus duration does alter the CVR 
measure, and so does the method of data extraction (i.e., choice of steady-state time-point); 
though these effects are different between stimulus durations. Given these findings, whilst 
also considering that slow responders may take longer to reach steady-state (this study 
recruited only young and healthy participants), we recommend using a 3-minute stimulus 
duration where data is extracted from the end of the stimulus duration (taking a 30-second 
average). Our findings strongly indicate that a more consistent approach in collecting data 
and calculating the CVR measure is required. This should be employed across studies 
exploring brain health, particularly where results between studies are compared. In order to 
achieve this, a better understanding of what is indeed the best method of calculating this 
response is also required. Gold-standard approaches are needed so that findings between 







4. RESTING CEREBRAL BLOOD FLOW AND PERFUSION USING 




Background: Resting cerebral blood flow (CBF) and perfusion measures are used to 
quantify brain health and to better understand neurological conditions (e.g., dementia and 
stroke). Yet, different imaging modalities are used to obtain these measures, and different 
measurements can be described as representing resting CBF. This study examined whether 
different approaches alter the resting CBF outcome measure between age and fitness 
groups. In the same cohort, we examined: (1) imaging modality (transcranial Doppler 
(TCD) approach measuring middle cerebral artery blood velocity (MCAv) and 
cerebrovascular conductance (CVCi) vs. magnetic resonance imaging (MRI) approach 
using arterial spin labelling (ASL)), and 2) typical analysis approach (resting MCAv and 
CVCi (TCD) vs. quantitative estimate of cerebral perfusion and blood flow transit times 
(MRI ASL)) for determining resting CBF. 
Methods: Thirty-five healthy volunteers participated (20 young: 24 ± 7 years; 15 old; 66 ± 
7 years). Participants completed two experimental sessions (TCD/MRI) on separate days 
(randomised and counter-balanced). Resting CBF outcome measures were calculated for 
TCD and MRI data using typical analysis approaches (e.g., Brown et al., 2010; Parkes 
2004, respectively). Between group ANOVAs examined effects of ageing and aerobic 
fitness within each imaging modality. CBF measures were correlated (Pearsons) against 







Results: Differences were observed between younger and older participants for resting 
CBF measures derived using both TCD (MCAv: 69 vs 55 cm·s
-1





; p < 0.01) and MRI (transit times: 0.67 vs 0.73 s; p < 0.01). On 





; p = 0.13). Older fit participants had higher TCD CVCi compared to their 




; p = 0.02), and fitness was positively 
associated with both MCAv (r = 0.52) and CVCi (r = 0.73) measures (p < 0.05). 
Unexpectedly, the younger fit group had slower MCAv (TCD) and transit times (MRI 
ASL) compared to their unfit counterparts (61 vs 75 cm·s
-1
, p = 0.02 and 0.70 vs 0.65 s, p 
< 0.01, respectively), and fitness was negatively correlated with TCD MCAv (r = -0.49, p 
< 0.05) and positively correlated with MRI transit times (r = 0.61, p < 0.05). No significant 
difference was observed between fitness groups for the other resting CBF measures. 
Across the whole cohort, MRI transit times correlated with TCD MCAv and CVCi (r = -
0.60 and r = -0.46 respectively; both p < 0.01). 
Conclusions: Findings indicate that TCD and MRI modalities can provide complementary 
resting CBF measures (e.g., TCD velocity and MRI transit times), with similar differences 
across the whole cohort and between subgroups (age/fitness) observed across modalities. 
However, having accounted for differences in transit times between cohorts, tissue 
perfusion measures obtained with MRI ASL (the most common measure used for MRI), 
did not show significant age or fitness effects between groups. Thus, to enable comparison 
of studies across modalities that assess resting CBF the metrics of CBF measured must be 









Resting cerebral blood flow (CBF) is a common measure used to determine brain health 
and has been shown to predict clinical outcomes (as reviewed in Chapter 2).  Studies 
measuring resting CBF have used different methodological approaches to determine this 
outcome measure, including the choice of imaging modality to collect the data as well as 
the analysis approach or metric used to determine the resting CBF. Neuroimaging 
modalities include transcranial Doppler (TCD) ultrasound and magnetic resonance imaging 
(MRI). Arterial spin labelling (ASL) MRI measures are commonly used to assess cerebral 
perfusion into all grey matter tissue (global flow) or grey matter tissue in specific regions 
of interest (RoIs), and can also be used to estimate blood transit times through the cerebral 
vasculature. TCD-based measures include middle cerebral artery blood flow velocity 
(MCAv) and/or cerebrovascular conductance (CVCi) (calculated by dividing MCAv by 
mean arterial blood pressure (MAP)), and cerebrovascular resistance (CVRi) (the inverse 
of CVCi, calculated by dividing MAP by MCAv)); and are often used to assess resting 
CBF. Given the physiological and theoretical differences between MRI and TCD 
approaches (i.e., phenomena being measured and approach to measurement, discussed in 
detail in Chapter 2, Section 2.3), it is important to consider whether the results obtained 
reveal similar differences between groups irrespective of modality acquisition and analysis 
approach or metric used. The purpose of this study was to examine whether these 
methodological differences alter the outcome measure of resting CBF between groups with 
expected differences (i.e., younger/older and fit/ unfit).  
 
4.2.1. Measuring Resting Cerebral Blood Flow (CBF) 
Resting CBF has been shown to decline in healthy ageing and these effects are offset by 






Bastos-Leite et al., 2008; Zimmerman et al., 2014). This finding is consistent across studies 
using different neuroimaging modalities, including Doppler ultrasound (Ainslie et al., 
2008; Bailey et al., 2013; Barnes et al., 2013) and MRI (Bastos-Leite et al., 2008; 
Zimmerman et al., 2014) (previous findings described in more detail in Chapter 2, Section 
2.3.2). Further, measures of resting CBF are impaired in cerebrovascular disease (Detre et 
al., 1998) and neurocognitive conditions, including: stroke (Markus et al., 2001) dementia 
(TCD studies: Meel-van den Abeelen et al., 2014; Wolters et al., 2017; MRI studies: Alsop 
et al., 1996, 2000; Zhang et al., 2017) and traumatic brain injury (Kim et al., 2010). From a 
mechanistic perspective, cerebral hypoperfusion may lead to cognitive decline during 
sedentary ageing and the development of neurocognitive conditions via reduced substrate 
delivery (i.e., oxygen and glucose) to the brain (see Chapter 6 for investigation into 
cognitive performance measures and effects of age and fitness). 
 
The MCA is the largest branch of the internal carotid artery (ICA) and supplies the frontal, 
temporal and parietal lobes of the brain (described in more detail in Chapter 2, Section 
2.3). This makes it an ideal blood vessel to investigate blood flow to the brain. Blood 
pressure is also important to consider when investigating resting CBF due to links between 
elevated blood pressure, hypertension and cognitive impairment (Elias et al., 2012). 
Concurrent recordings of mean arterial blood pressure (MAP) taken from the arm or index 
finger enable researchers to calculate cerebrovascular conductance indices (CVCi), 
calculated as MCAv/MAP. This metric is an alternative measure of resting CBF and has 
the additional benefit of accounting for changes in CBF driven by blood pressure (Harper 
et al., 1966). Studies have shown that TCD measures of MCAv-derived and CVCi-derived 






and Brown et al., 2010). Further, these measures have been associated with measures of 
cognitive performance (see Chapter 6). 
 
Another imaging method often used to provide a measure of resting CBF is MRI. One of 
the most common MRI sequences used is ASL, which provides quantitative measures of 
resting cerebral perfusion and blood flow transit times. Cerebral perfusion refers to the rate 
at which blood is delivered to the capillary bed and is commonly expressed in millilitres of 




; Liu and Brown 2007). Transit 
times refer to the time taken for blood to travel to various regions of the brain from the 
neck where the blood has been ‘tagged’ (see Chapter 2, Section 2.3.3.1 for more detail).  
 
Similarly to resting CBF measures reported in the TCD literature, ASL-derived cerebral 
perfusion and transit time measures have been shown to differ between older and younger 
populations for all grey matter (Bastos-Leite et al., 2008) and frontal and parietal RoIs 
(Zimmerman et al., 2014) (discussed in Chapter 2, Section 2.3.3.1). Further, cerebral 
perfusion, as measured with ASL MRI, has shown to be impaired in several clinical 
conditions including dementia (Alsop et al., 2000; Zhang et al., 2017) and traumatic brain 
injury (TBI) (Kim et al., 2010) (discussed in more detail in Chapter 2, Section 2.3.3.1).   
 
One important consideration with ASL measures is that cortical atrophy due to healthy 
ageing will affect measures of cerebral perfusion and transit times due to an overall 
reduction in tissue. If transit times are not accounted for then incorrect estimates of 
perfusion will be obtained as the images are not acquired at the correct time relative to the 
‘tag’ inversion pulse. Therefore, it is important to consider transit times when calculating 






to healthy ageing) are accounted for. Another consideration when investigating resting 
CBF measures and perfusion using TCD and MRI modalities is that they are targeting 
different aspects of the vascular tree. TCD is targeting a specific point (e.g., the centre of 
the MCA), whereas ASL is measuring perfusion in the tissue consisting many micro-
vessels.   
 
In summary, previous studies have use different neuroimaging modalities that target 
different aspects of the vascular tree, combined with different analysis approaches and 
metrics to report outcome measures of resting brain blood flow. Therefore, it is important 
to consider whether these differences alter interpretation of the outcome measure and 
differences between groups. This can be achieved by comparing these measures in the 
same individuals and selecting groups to compare that have expected differences (e.g., age 
and fitness). Further, no previous studies have directly compared TCD and MRI (ASL) 
measures of resting CBF in the same cohort. 
 
 
4.2.2. Study Aims and Hypotheses 
The overall aims of this chapter were to: (1) investigate differences between age (younger 
versus older) and fitness (fit versus unfit) groups on resting CBF outcome measures, and 
(2) determine whether differences in neuroimaging modality (i.e., TCD versus MRI) and 
associated analysis approaches and metrics would influence the resting CBF outcome 
measure and its interpretation across all participants. In addition, associations between 
different measures of resting CBF were examined (i.e., resting MCAv, CVCi and CVRi 







There were two main research questions addressed in this chapter: 
 
1. Ageing and fitness effects on resting CBF outcome measures: Do TCD and MRI 
approaches show the same differences between populations where differences in 
resting CBF outcome measures are expected? (i.e., younger/older and fit/unfit). 
2.  Imaging modality and metric used to obtain the resting CBF outcome measure: Do 
resting CBF outcome measures obtained from data collected using different brain 
imaging modalities (TCD versus MRI) directly correlate with one another?  
 
It was hypothesised that: (1) TCD and MRI assessment of resting CBF will provide a 
similar pattern between younger versus older and fit versus unfit participants, where 
younger participants will have higher resting CBF measures than older participants, and fit 
participants will have higher resting CBF than unfit participants, and (2) resting CBF 
measures obtained using the TCD modality will correlate with resting CBF measures 
obtained using the MRI modality across the whole group. Thus, indicating that although 
different imaging and analysis approaches are being used to obtain the resting CBF 






4.3. Materials and Methods 
Ethical approval was obtained for all experimental protocols and procedures by the 
University of Birmingham Ethics Committee and conformed to the Declaration of Helsinki 
(project code: ERN_14-1423). Participants completed five visits on separate days to either 
the School of Sport, Exercise and Rehabilitation Sciences (four visits) or the Birmingham 
University Imaging Centre (one visit) at the University of Birmingham. Prior to 
participation, a detailed verbal and written explanation of the study was provided, and 
written informed consent was obtained (see Appendix A4.1 and A4.2).  
 
4.3.1. Participants 
Thirty-five healthy volunteers in two age groups participated: 20 younger participants, 
mean age 24 ± 7 years and 15 older participants, mean age 66 ± 7 years. These groups 
were further divided into fit and unfit groups, as determined by performance on a 
maximum oxygen consumption (V̇O2 max) fitness test (see below for details). The 
partitioning of fitness for each age group was as follows. For younger participants, a V̇O2 




placed them in the fit or unfit group, 




placed them in the fit or unfit group, respectively. Partitioning values were decided by the 
PhD candidate after referring to several sources with varying normative data, though 
ranges described in the general population show that male 20 to 30 year olds with a V̇O2 












and above would be described as 




















4.3.2. Experimental Visits 
4.3.2.1. Overview 
The first visit for the participants included general health screening, MRI safety screening 
(see Appendix A4.3), fitness questionnaires (see Appendix A4.4), quality of life 
assessments and an electrocardiogram (if over 50 years of age). The second visit included 
the aerobic fitness test on a treadmill or stationary bike. The third visit included a cognitive 
performance assessment (data presented in Chapter 6). The fourth visit was a 
familiaristaion of the CBF measures using TCD and included a gas challenge protocol. The 
final two visits involved collecting CBF measures, one using TCD and the other using 
MRI. The order of these final two visits was randomised and counterbalanced between 
participants. Across the entire study, participants completed measures of resting cerebral 
blood flow (CBF) (investigated in this Chapter), cerebrovascular reactivity (CVR) (data 
presented in Chapter 5), and measures of cognitive performance and quality of life (data 
presented in Chapter 6).  For all visits, participants were asked to avoid vigorous exercise 
and alcohol 24 hours prior to study participation, caffeine for 12 hours and heavy meals for 
4 hours prior. 
 
4.3.2.2. Electrocardiogram (ECG) and general health screening 
All participants underwent a pre-exercise evaluation prior to the exercise testing and 
completed a general health questionnaire and the New Zealand Physical Activity and 
Readiness Questionnaire Short Form (NZPARQ-SF). Participants over 50 years of age also 
completed a resting 12-lead electrocardiogram (ECG) assessment and a resting blood 
pressure measurement, which was reviewed by a cardiologist. Participants who revealed a 






questionnaire (e.g., family history of heart attack), had high resting blood pressure (systolic 
>160, diastolic >90), or showed ECG abnormalities (e.g., S-T suppression, multiple 
ectopic beats in a row (i.e., >3)) were excluded from the aerobic fitness testing and the rest 
of the study (and referred on to their GP). All participants included in the study were not 
taking any medication and had no history of cardiovascular, cerebrovascular or respiratory 
disease. 
 
4.3.2.3. Aerobic fitness assessment 
Measures of aerobic fitness included maximal oxygen consumption (V̇O2 max) and 
measures scored from the NZPARQ. After screening and inclusion into the study, all 
participants completed a maximal aerobic fitness test to determine V̇O2 max. Participants 
were able to choose to either cycle on an electromagnetically braked cycle ergometer or 
run on a treadmill. For the cycling protocol, participants were asked to cycle at a rate of 70 
rpm (rotations per minute) or above. The initial workload began at 35 Watts and then 
depending on the participant’s sex, body mass and habitual physical activity levels, 
workload increased by between 20 and 35 Watt increments every three minutes. This 
continued until the participant reached volitional exhaustion, or heart rate reached 100% of 
the participant’s estimated maximum heart rate (i.e., 220 b·min
-1
 (beats per minute) minus 
the participant’s age), or the participant was unable to maintain over 50 rpm on the bike (in 
line with ACSM Guidelines for Exercise Testing and Prescription, 2013). For the running 
protocol, participants’ heart rate and pace were monitored during the warm-up to 
determine pacing during the test. The initial pace began at a speed where heart rate was 
approximately 65% of their predicted maximum, and then depending on the participant’s 
sex, body mass and habitual physical activity levels, speed increased by 0.5 to 1.0 
km·hour
-1






This continued until the participant reached volitional exhaustion or heart rate reached 
100% of the participant’s estimated maximum heart rate. Respiratory gases and gas 
volume were collected for measurement of the rate of V̇O2. V̇O2 max was then calculated 
from a 30-second average around the peak V̇O2 (i.e., highest value) and divided by body 
weight (kilograms). 
 
In addition to the V̇O2 max test, participants’ physical activity levels were assessed using 
the NZPARQ (McLean and Tobias, 2004). Three measures of activity were scored from 
the NZPARQ: 1) last 7-days frequency of activity (0-7 days), self-rated activity category 
(1-5; 1 being the least active to 5 being the most active), and activity category (1-3; 
assessed by adding together participant responses to frequency of mild, moderate and 
intense activity; category 1 being the least active and category 3 being the most active). 
This questionnaire was completed by all participants during the initial screening visit. 
 
4.3.2.4. Resting cerebral blood flow and perfusion outcome measures 
Participants completed a familiarisation of the CO2 gas challenge (including measures of 
resting CBF and CVR measured with TCD; see Chapter 5 for CVR measures), and were 
required to tolerate the gases before continuing the rest of the study. Following 
familiarisation of the breathing protocol, participants completed two experimental sessions 
(TCD/MRI) on separate days (randomised and counter-balanced). During resting CBF 
measures for the TCD experimental session, participants wore a nose-peg and breathed 
through a mouthpiece that was connected to a Douglas bag circuit that allowed switching 
from room air to premixed concentrations of CO2 in air, though were only breathing room 






mouthpiece resting on their chest, which was placed in the mouth after the resting 
measures presented in this Chapter were done (for CVR measures, see Chapter 5).  
 
All resting measures were recorded from the period during which participants were 
breathing room air prior to any gas challenge and following at least 20 minutes of supine 
rest (see schematic Figure 4.1). For the TCD session, the supine rest period included 
locating the right and left MCA and complementary physiological measures (described 
below). For the MRI visit the supine period consisted of setting up breathing equipment 
and standard set-up scans required for planning the experimental scans. Resting CBF 
measures were recorded prior to the gas challenge using a flow-sensitive alternating 
inversion recovery (FAIR) pulsed ASL (PASL) sequence (see Section 4.3.3, Figure 4.2).  
 
 
Figure 4.1. Gas challenge protocol schematic for the TCD visit. Resting CBF measures 
were taken during the initial four-minute baseline. Data for CVR measures (see Chapter 5) 
were taken separately during the 4-minute 5% CO2 and 4-minute 7% CO2 stimulus 








Figure 4.2. MRI protocol schematic. The eight-minute PASL FAIR resting scans combined 
with the M0 scan (1 minute) were used to determine measures of resting CBF. The DABS 
sequence allowed simultaneous acquisition of ASL and BOLD scans, during which the 
same gas challenge protocol illustrated in Figure 4.1was administered to allow measures of 
CVR to be acquired (see Chapter 5). A T1-weighted anatomical scan (MPRAGE) was also 
acquired to allow individual subject identification of grey and white matter. The whole 
MRI protocol, including set-up time, lasted approximately 90 minutes.   
 
 
4.3.3. Data Acquisition 
Thirty-five datasets were obtained using the TCD modality and thirty-three datasets were 
obtained from the MRI modality. One participant chose not to complete the MRI visit and 
one MRI dataset was lost due to technical issues.  
 
TCD session: Bilateral blood flow velocity in the right and left middle cerebral artery 
(MCAv) was measured using TCD (Doppler Box, DWL, Compumedics Ltd, Germany), 
with a 2-MHz probe placed over each temporal window on the right and left side of the 
head. Probes were prepared with ultrasound gel and held in place with a headset. Search and 






2011). Beat-by-beat blood pressure (BP) was measured using photoplethysmography via a 
finger cuff placed on the middle finger of the left hand (Portapres, Finapres, Medical System 
BV, The Netherlands). A 3-lead electrocardiogram (ECG) was used to continuously 
measure heart rhythm and electrical activity.  
 
MRI session: All MRI data were acquired on a 3-T Philips Achieva MRI scanner (Philips 
Medical Systems, Best, The Netherlands) (see Figure 4.2 for protocol). A whole-body 
transmit coil and 32 channel head receiver coil were used for all data acquisition. Prior to 
scanning sessions, a customised MR sequence code was uploaded to the MRI scanner to 
allow the MRI sequence acquisitions acquired in this study (i.e., the scanner was ‘patched’). 
The MRI scanning protocol included two ASL sequences to answer different questions, one 
for resting CBF and one for CVR. This chapter focuses on the MRI acquisitions required to 
produce resting CBF measures from the MRI data. The acquisition protocol used to obtain 
CVR measures from MRI data is described in Chapter 5. 
 
To allow quantification of resting perfusion using MRI, images were acquired using a FAIR 
PASL sequence with two-dimensional echo-planar imaging (2D-EPI) readout. The imaging 
parameters were: echo time (TE): 9 ms; repetition time (TR): 8 s; inversion times (TIs): 0.4, 
0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8 s voxel size: 3.25 mm in plane; slice thickness: 5 mm; slices: 
12; field of view (FOV): 212 x 212 mm; label duration: 1 s; no background suppression or 
vascular crushing; sensitivity encoding in parallel imaging (SENSE factor): 2.5. Four 
volumes of data were acquired for TIs of 0.4  1.4 s whilst 10 volumes of data acquired for 
TIs of 1.6  1.8 s. A base equilibrium M0 scan was acquired with the same parameters but 
without the inversion pulses required for ASL sequence. Slices were positioned to cover as 






A whole head T1-weighted anatomical image (magnetisation prepared rapid gradient echo; 
MPRAGE) with 1 mm
3
 resolution was also acquired to allow definition and segmentation of 
the grey and white matter so that resting CBF and CVR measures in these tissues could be 
assessed separately.  
 
4.3.4. Data Analysis 
TCD data: Mean resting MCAv (cm·s
-1
) data were extracted from a 60-s duration during 
the initial baseline. CVCi was calculated by dividing the mean MCAv by the mean MAP 
during the same 60-s duration. CVRi, the inverse of CVCi, was calculated by dividing the 
mean MAP by the mean MCAv data extracted from the same 60-s duration. 
 
MRI data: Data were checked for movement between TIs. The data were then segmented 
into different TIs and averaged over repeats for each TI. The FMRIB Software Library 
(FSL) Brain Extraction Tool (BET) (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki) was used to 
create a whole brain image without the skull and scalp and grey matter mask from the 
anatomical image (Smith et al., 2002). This allowed for grey matter to be defined as well as 
the whole brain to be used for normalisation of individual participants to standard space 
(see later). A region of interest (RoI) in a single slice was checked to ensure the signal 
followed the expected pattern (gradual increase in signal strength and then beginning to 
decrease; inverted-u shape, reflecting increase and loss of signal with increasing inversion 
time). Resting CBF data were corregistered to the participant’s whole brain image from the 
MPRAGE data. The extracted brain image from the MPRAGE data was then normalised to 
Montreal Neurological Institute (MNI) standard brain (MNI152_T1_2mm_brain) using the 






2009). Corregistered resting CBF data were then moved from native space into MNI space 
with FLIRT using the transform derived for the anatomical data. 
 




) and transit time (seconds) measures were 
calculated using the FSL Bayesian Inference for Arterial Spin Labeling MRI (BASIL) 
toolset (Chappell et al., 2009) to assess the delivery rate for blood to reach all grey matter 
brain tissue followed by several brain tissue RoIs. RoI masks were defined from the 
conjunction of the Harvard atlas (in FSL) and the normalised individual subject’s grey 
matter mask. RoIs used were: cingulate gyrus, frontal lobe, motor lobe, occipital lobe and 
parietal lobe. To determine resting cerebral perfusion and transit time the inversion of a 
kinetic model of label inflow (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BASIL) was found using 
FSL BASIL toolbox, along with a separate calculation of the equilibrium magnetisation of 
arterial blood using the M0 scan (Chappell et al., 2009). ASL data acquired at multiple 
times post-inversion of the arterial blood were fitted to the kinetic curve model so that 
perfusion estimation errors associated with variable transit times (i.e., bolus arrival times) 
across subject groups could be avoided, since the arrival time becomes a parameter of the 
model where the value is determined from the data. The model fitting was performed with a 
least squares technique, providing parameter estimates of cerebral perfusion and transit 
time over the imaged region. This was carried out using the functions ‘oxford_asl’ and 
‘asl_calib’ in from the BASIL toolbox (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/ BASIL). The 
parameters input to the models based on measured literature values and the ASL data 
acquisition were: bolus duration: 1.0 s; bolus arrival time (BAT): 0.8 s; tissue relaxation 
time (T1): 1.3 s (FSL default setting; Chappell et al., 2009); blood relaxation time (T1b): 
1.65 s (Lu et al., 2004); timing between slices:19 ms; label efficiency (alpha): 0.98 (Wong 






3.3 s (at 3T); T2CSF (reference tissue): 0.3 s; T2blood: 0.15 s; and echo time (TE): 9 ms 
(unreferenced relaxation times are set to standard FSL values). 
 
Finally, mean cerebral perfusion and transit time group maps were created for all 
participants and the younger and older groups separately by averaging the participant’s 
individual mean perfusion and transit time maps (see Appendix A4.5 and A4.6). In 
addition, the mean cerebral perfusion and transit times of the groups were determined for 
the whole of the imaged grey matter and the different RoIs. 
 
4.3.5. Statistical Analysis 
This analysis includes typical approaches to calculate resting measures of CBF obtained 
from MRI (cerebral perfusion and transit times) (Chen et al., 2011; Parkes 2004) and TCD 
(MCAv and CVCi) (Brown et al., 2010), and measures of resting MAP and HR. Means 
were calculated for younger and older groups and fit and unfit sub-groups (younger fit and 
younger unfit; older fit and older unfit). Between group ANOVAs were used to examine 
effects of ageing and aerobic fitness. Outcome measures were also correlated against age 
for all participants together, and against fitness separately for the younger and older groups 
(see Table 4.2 and Table 4.3). Resting CBF measures using different imaging modalities 





Thirty-five participants completed the resting TCD measures. Thirty-three participants 






Table 4.1 including: age, fitness (V̇O2 max), heart rate (HR) and MAP (Figure 4.3). There 
were more male than female participants.  
 
Table 4.1. Characteristics of participants who completed the resting CBF measures using 
































          


























































12:8 10:5  7:1 5:7  8:1 2:4  
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 









for the younger and older groups respectively. Significant 
age/fitness effects (different from younger group/ different from fit group): * p ≤ 0.05; ** 
p ≤ 0.01. 
t 
Shows a trend towards significance: 0.05 < p ≤ 0.1. Abbreviations: V̇O2 max, 





4.4.1. Age, Fitness and Resting Cerebral Blood Flow (CBF) Outcome Measures 
Between-group outcome measures are shown in Table 4.2, Figure 4.3 and Figure 4.4. 
Correlations between age and fitness are shown in Table 4.3, Figure 4.5 and Figure 4.6. 
 
MAP and HR data: No significant differences were observed between younger and older 
groups for MAP (p = 0.445) or HR (p = 0.124) (Table 4.2, Figure 4.3). In line with existing 
literature, MAP and HR were on average lower in the fit groups compared to their unfit 
counterparts for both the older (HR: 55 vs. 61 b·min
-1
, MAP: 79 vs. 89 mm Hg; Figure 
4.3), and younger group (HR: 55 vs. 70 b·min
-1






though differences only reached statistical significance for HR in the younger group (p = 
0.018). 
 
TCD data: Significant group differences were observed between younger and older 
participants for measures of MCAv (p = 0.008) and CVCi (p = 0.005), where averaged 
MCAv and CVCi values were ~30% higher in the younger group than the older group 
(Figure 4.4). As expected, MCAv and CVCi were higher (31% and 60%, respectively) in 
the older fit group compared to the unfit group, though was only significant for the CVCi 
measure (p = 0.016; MCAv: p = 0.099). In contrast, the younger fit group had on average 
lower MCAv and CVCi (23% and 7%, respectively) compared to their unfit counterparts, 
though was only significantly so for the MCAv measure (MCAv: p = 0.024 and CVCi: p = 
0.170; Figure 4.4).  
 
Correlational analysis showed that as age increased MCAv significantly decreased (at a 
rate of 3.9 cm·s
-1 
every 10 years), and CVCi significantly decreased (at a rate of 0.06 cm·s
-
1 
· mm Hg every 10 years) (Figure 4.5, C and D). Correlations between resting CBF TCD 
measures and fitness (V̇O2 max) are shown in Figure 4.6 and Table 4.3 separating younger 
and older groups. In the younger group, fitness negatively correlated with MCAv (r = -
0.484; p < 0.05), where increased fitness was associated with slower resting CBF. In 
contrast, the older group showed that fitness positively correlated with MCAv (r = 0.520; p 
< 0.05) and CVCi (r = 0.732; p < 0.01), where increased fitness was associated with faster 
resting CBF.  
 
MRI data: Significant group differences were observed between younger and older 






7% faster in the younger group (p = 0.001). Grey matter cerebral perfusion was 13% 
higher in the younger group than the older group, though this difference did not reach 
statistical significance (p = 0.129). No differences were observed between the older fit and 
unfit groups for measures of transit times or grey matter cerebral perfusion (Figure 4.4). 
Unexpectedly, the younger fit group had significantly slower (8%) grey matter transit time 
compared to their unfit counterparts (p < 0.001; Figure 4.4).  
 
Correlational analysis showed that grey matter transit times significantly increased with 
age (r = 0.606; Figure 4.5B, Table 4.3). In addition, analysis of different RoIs 
demonstrated that this reduction in transit time was widespread, occurring in the frontal 
lobe, motor lobe, parietal lobe and occipital lobe (see Table 4.4). Age also correlated 
(negatively) with grey matter cerebral perfusion, though this did not reach statistical 
significance (Figure 4.5A, Table 4.3). Correlations between resting CBF measures and 
fitness are shown in Figure 4.6, separating younger and older groups.  In the younger 
group, fitness significantly correlated with MRI grey matter transit time (r = 0.785; p < 
0.01), where increased fitness was associated with slower resting CBF. In the older group, 
no fitness effects were observed for resting MRI measures. Perfusion measures showed no 







Table 4.2. Means ± standard deviations for resting CBF measures obtained from MRI data (grey matter cerebral perfusion and transit times) 
and TCD data (MCAv and CVCi). Measures are shown for all participants followed by groups separated into: younger and older; younger fit 
and unfit; and older fit and unfit.  
 
 All participants By age groups  By age and fitness groups 
  





Younger fit  
n= 9 
Younger unfit  
n = 10 
Older fit  
n = 9 
Older unfit  
n = 7 
MRI: GM cerebral perfusion (mL·100g-1·min-1) 65.9 ± 15.0 69.3 ± 12.9 61.2 ± 16.8 72.2 ± 8.55 67.2 ± 15.3 61.6 ± 16.3 60.8 ± 19.1 
MRI: GM transit time (s) 0.70 ± 0.46 0.67 ± 0.34 0.73 ± 0.44** 0.70 ± 0.02 0.65 ± 0.27** 0.72 ± 0.04 0.73 ± 0.05 
TCD: MCA velocity (cm·s
-1







) 0.80 ± 0.23 0.89 ± 0.19 0.67 ± 0.23** 0.81 ± 0.17 0.94 ± 0.20 0.77 ± 0.18 0.48 ± 0.19* 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (50-80 years). Significant age/fitness effects (different from 




Table 4.3. Correlation (Pearson’s r) of resting CBF measures with age, and fitness (separately for the younger and older group). 
 
 All participants  Younger Older 
 Age Fitness: V̇O2 max Fitness: V̇O2 max 
Measure r  r r 
MRI: GM cerebral perfusion (mL·100g-1·min-1) -0.231   0.099  0.086 
MRI: GM transit time (s)  0.606**  0.785** -0.126 
TCD: MCA velocity (cm·s
-1





) -0.586** -0.250  0.732** 
Values represent Pearson’s r correlations. Significant (2-tailed) age/fitness effects: * p ≤ 0.05; ** p ≤ 0.01. t 
Shows a trend towards significance: 0.05 < p ≤ 0.1. 
 
Abbreviations: CBF, cerebral blood flow; MRI, magnetic resonance imaging; TCD, transcranial Doppler; GM, grey matter; MCAv, middle 







Table 4.4. Correlations of measures of resting CBF with age and other measures of resting CBF, calculated using TCD (MCAv and CVCi) and MRI ASL 
(grey matter cerebral perfusion and transit times; including RoIs of the cingulate gyrus and frontal, motor, occipital and parietal lobes) brain imaging. 
Values represent Pearson’s r correlations. Significance (2-tailed): * p ≤ 0.05; ** p ≤ 0.01. 
t 
Shows a trend towards significance: 0.05 < p ≤ 0.1. Correlations in the 
orange block show resting CBF measures from TCD versus MRI data modality. Red numbers show correlations between typical approaches from each modality. 
Green numbers show correlations between measures that are derived from taking the measurement from anatomically close areas though from different modalities 
(TCD: MCA and MRI: motor lobe and frontal lobe). Abbreviations: ASL, arterial spin labelling; CP, cerebral perfusion; CVCi, cerebrovascular conductance; MRI, 
magnetic resonance imaging; GM, grey matter; MAP, mean arterial blood pressure; MCAv; middle cerebral artery blood velocity; RoI, region of interest; TCD, 
transcranial Doppler; TT, transit time; V̇O2 max, maximum oxygen consumption. 















































































































age _                
V̇O2  max -0.42*                
MCAv (cm·s-1) -0.54** _               
CVCi (cm·s-1 ·mm Hg-1) -0.59**  0.71** _              
CVRi (mm Hg-1 · cm·s-1)  0.57** -0.74** -0.91** _             
GM CP (mL·100g-1·min-1) -0.23  0.12  0.21 -0.34 _            
GM TT (s)  0.61** -0.60** -0.46**  0.43* -0.18 _           
Cingulate gyrus CP (mL·100g-1·min-1)  0.12 -0.06  0.01 -0.06  0.84**   0.13 _          
Frontal CP (mL·100g-1·min-1) -0.33  0.18  0.32 -0.43*  0.85** -0.31  0.52** _         
Motor CP (mL·100g-1·min-1) -0.19  0.12  0.25 -0.37*  0.94** -0.12  0.76**  0.86** _        
Occipital CP (mL·100g-1·min-1) -0.41*  0.30  0.33 -0.42*  0.86** -0.47**  0.63**  0.75**  0.74** _       
Parietal lobe CP (mL·100g-1·min-1) -0.33  0.19  0.25 -0.36*  0.96** -0.30  0.80**  0.79**  0.87**  0.89** _      
Cingulate gyrus TT (s)  0.32 -0.35* -0.34  0.25 -0.15  0.86** -0.06 -0.27 -0.16 -0.41* -0.23 _     
Frontal TT (s)  0.64** -0.65** -0.45**  0.42* -0.03  0.92**  0.14 -0.15  0.03 -0.37* -0.16 0.70** _    
Motor TT (s)  0.62** -0.52** -0.42*  0.38* -0.01  0.84**  0.26 -0.19  0.03 -0.33 -0.14 0.71** 0.81** _   
Occipital TT (s)  0.34* -0.29* -0.17  0.12  0.33  0.51**  0.41*  0.07  0.32  0.27  0.26 0.33 0.50** 0.47** _  
Parietal TT (s)  0.63** -0.51** -0.32  0.31







Figure 4.3. Graphs show resting mean arterial blood pressure (MAP) and heart rate (HR). Top row compare means for the younger and older groups, middle row compare 
means for older fit and unfit sub-groups. Bottom row compare means for younger fit and unfit sub-groups. Error bars show standard deviation.  Significance: * p ≤ 0.05; ** p ≤ 
0.01. 
t 







Figure 4.4. Graphs show resting CBF measures obtained from MRI data (grey matter cerebral perfusion and transit times) and TCD data (MCAv and CVCi). Top row of 
graphs compare means for the younger and older groups respectively, middle row compare means for older fit and unfit sub-groups. Bottom row compare means for 
younger fit and unfit sub-groups. Abbreviations: ASL, arterial spin labelling; CVCi, cerebrovascular conductance (MCAv/ MAP); CVRi, cerebrovascular resistance (MAP/ 
MCAv); MRI, magnetic resonance imaging; MAP, mean arterial blood pressure; MCAv; middle cerebral artery blood velocity; TCD, transcranial Doppler; TT, transit 
time; V̇O2 max, maximum rate of oxygen consumption. Error bars show standard deviation.  Significance: * p ≤ 0.05; ** p ≤ 0.01.   
t 
Shows a trend towards significance: 









Figure 4.5. Correlations between age (years) and resting CBF measures. A. Grey matter 
(GM) cerebral perfusion (MRI), B. GM transit time (MRI), C. MCAv (TCD), and D. 
CVCi (TCD). Black lines denote lines of best fit with Pearson’s r and associated p values 
reported. Abbreviations: CVCi, cerebrovascular conductance; GM, grey matter; MRI, 
magnetic resonance imaging; MAP, mean arterial blood pressure; MCAv; middle cerebral 









Figure 4.6. Correlations for younger and older groups between fitness (V̇O2 max) and 
resting CBF measures. A. GM cerebral perfusion (MRI), B. GM transit time (MRI), C. 
MCAv (TCD), and D. CVCi (TCD). Lines of best fit are shown with Pearson’s r values 
presented. Abbreviations: CVCi, cerebrovascular conductance; GM, grey matter; MRI, 
magnetic resonance imaging; MAP, mean arterial blood pressure; MCAv; middle cerebral 
artery blood velocity; TCD, transcranial Doppler. Black lines denote lines of best fit with 
Pearson’s r and associated p values reported. 
 
 
4.4.2. MRI Resting CBF Measures for Specific RoIs 
The effects of ageing on MRI resting CBF measures are shown in Figure 4.7A, including 






specified RoIs. The effects of fitness are shown in Figure 4.7B and Figure 4.7C for whole 
grey matter and RoIs, for older and younger groups respectively. Whilst a significant 
difference in transit times was observed between the younger and older groups over all 
grey matter, no differences were observed for cerebral perfusion. However, this may be 
due to differences being region specific. Therefore, region specific effects were 
investigated in the specific RoIs. 
 
Cerebral perfusion in RoIs: Significant group differences were observed between younger 
and older participants for measures of cerebral perfusion in the occipital lobe (p = 0.01) 
and the parietal lobe (p = 0.05). Specifically, perfusion in the occipital lobe was 37% 
higher and in the parietal lobe was 24% higher in the younger group compared to the older 
group. Perfusion was also higher in the younger group in the cingulate gyrus (1%), frontal 
lobe (21%) and motor lobe (10%), though these did not reach significance (Figure 4.7A 
left panel). Similar to the whole grey matter cerebral perfusion observations, cerebral 
perfusion in the RoIs were similar between fitness groups for both younger and older 
participants (Figure 4.7B and Figure 4.7C left panels). 
 
Transit times for RoIs: Significant group differences were observed between younger and 
older participants for measures of transit times in the frontal lobe (p = 0.01), motor lobe (p 
< 0.01), and the parietal lobe (p < 0.01). Specifically, blood flow was 7%, 9% and 10% 
faster in the frontal, motor and parietal lobes, respectively, in the younger compared to the 
older group (Figure 4.7A right panel), while the on average faster times for the other RoIs 
did not reach significance. Transit times for the specified RoIs were similar between the 
fitness groups in the older participants (Figure 4.7B right), whereas in the younger 






considered RoIs (cingulate gyrus (p = 0.01), frontal lobe (p = 0.01), motor lobe (p = 0.02), 
occipital lobe (p = 0.00) and parietal lobe (p = 0.02)) (Figure 4.7C right). This latter 




Figure 4.7. MRI resting CBF outcome measures of cerebral perfusion (left panel) and 
transit times (right panel) for all grey matter and specified regions of interest (RoIs). 
Metrics were separated into: A. Younger and older groups, B. Older fit and unfit groups, 
and C. Younger fit and unfit groups. Error bars denote standard deviations. Significance 
values: * p ≤ 0.05; ** p ≤ 0.01. 
t 




4.4.3. Correlations Between Different Approaches of Measuring Resting Cerebral 
Blood Flow (CBF) in Regions of Interest 
Correlations between different approaches of measuring resting CBF are summarised in 
Table 4.4.  
 
ASL cerebral perfusion and TCD: MRI CBF perfusion measures for all grey matter and 
RoIs showed no correlation with TCD resting measures calculated using MCAv and CVCi 
(Table 4.4). However, TCD CVRi measures negatively correlated with MRI CBF 
perfusion measures in the following RoIs: frontal lobe (p = 0.02), motor lobe (p = 0.04), 
occipital lobe (p = 0.02), and parietal lobe (p = 0.04), where higher cerebral perfusion was 
associated with decreased resistance.  
 
CBF transit times and TCD: MRI CBF transit time measures for all grey matter 
significantly correlated with all TCD resting measures (MCAv: p < 0.01; CVCi: p = 0.01, 
and CVRi: p = 0.01). In addition, resting MCAv significantly correlated with transit times 
in all RoIs (all p < 0.05, see Table 4.4 and Figure 4.8), indicating this relation was not 
region specific. Resting CVCi significantly correlated with transit times in the frontal (p = 
0.01) and motor (p = 0.02) lobes, and showed a trend towards significance for the 
cingulate gyrus (p = 0.06) and parietal lobe (p = 0.07). Finally, there was no correlation 






Figure 4.8. Correlation (Pearson’s r) between resting CBF measures for TCD MCA 
velocity (MCAv) and MRI transit times to the motor (A), frontal (B) and parietal (C) lobe. 
 
 
4.4.4. Sub-Set Analysis on Eight Participants Pair-Match for Age and Sex 
Due to the unexpected significantly higher CBF transit times observed in the younger fit 
group compared to their unfit counterparts (i.e., the unfit group had significantly faster 
blood flow), a separate analysis was performed on a sub-set of the participants who were 
pair-matched for age and sex (6 males and 2 females). After pair-matching the younger 
group for age and sex they still showed that transit times were faster in the unfit group 
compared to the fit group; specifically showing significance in the whole of the grey 
matter (p = 0.046), the cingulate gyrus (p = 0.050), and the occipital lobe (p = 0.048). 
These observations were therefore consistent with that observed for the whole younger 
group (Figure 4.7C). No between group differences were observed in TCD measures for 





4.5. Discussion  
The aims of this chapter were to examine how measures of resting CBF differed between 
healthy age groups and how they were affected by aerobic fitness. This was done by 
examining group differences in mean outcome measures in younger and older, fit and unfit 
individuals, and by correlating outcome measures with age and fitness. Further, this 
chapter investigated whether differences in neuroimaging modality (i.e., MRI and TCD) 
would influence the resting CBF outcome measure and its interpretation. In addition, 
associations between different measures of resting CBF were examined (i.e., MRI: 
cerebral perfusion and transit times in all grey matter and RoIs; and TCD: resting MCAv, 
CVCi and CVRi).   
 
Group differences in resting CBF measures 
Outcome measures from the MRI modality revealed that resting CBF perfusion was lower 
in the older group compared with the younger group in the whole grey-matter and all RoIs, 
though group differences were only significant in the occipital and parietal lobes. Transit 
times were longer in the older group compared with the younger group in the whole grey-
matter and all RoIs (significant for whole grey-matter, frontal lobe, motor lobe and parietal 
lobe, the cingulate gyrus and occipital lobe showed a trend towards significance). 
Outcome measures from the TCD modality revealed that resting MCAv and CVCi were 
significantly lower in the older group compared to the younger group. Fitness effects were 
observed in the younger group, though these were not in line with the existing literature. 
Specifically, the younger fit group showed significantly slower MCAv determined by 
TCD, and longer (i.e., slower) transit times determined by MRI. In contrast, findings for 




2010), where the fit group had higher resting CVCi and MCAv, although the latter 
measure did not reach statistical significance (0.099; see Figure 4.4).  
 
Correlations between resting CBF measures from different modalities 
The correlational analysis across the entire cohort revealed that as age increased both 
MCAv and CVCi metrics decreased. Specifically, MCAv decreased at a rate of 3.9 cm·s
-1
 




 every 10 years 
(Figure 4.6C and D). This is in line (though not as high) with findings from Ainslie and 
colleagues (2008), where they reported that MCAv decreased at a rate of 0.76 cm·s
-1 
every 
year (i.e., 7.6 cm·s
-1 
every 10 years). The difference in the magnitude of change may be 
related to the much larger sample size used in that large cohort study, which had 154 
trained and 153 untrained male only participants compared. In addition, both males and 
females were included in the current study, which may provide another explanation for 
lower rate of change across the age range that was compared here. 
 
Although age effects were not observed in all grey matter, significant group differences in 
CBF perfusion were observed between younger and older participants in RoIs including 
the occipital lobe (37% higher in the younger group) and the parietal lobe (24% higher in 
the younger group). Age differences were also observed in transit times and were clearest 
in the frontal and motor regions as well as the parietal lobe. This is likely due to these 
areas being associated with higher executive functions including attention, planned 
movements and spatial reasoning (Frank et al., 1998; Ridderinkhof et al., 2004). 
Performance in these domains is known to decline across the lifespan and to be impaired 
in clinical conditions such as dementia. This decline in cognitive performance co-occurs 




investigation into cognitive performance measures and effects of age and fitness). One 
point worth noting is that the findings of regional differences in these particular regions 
could also be explained by these areas having generally higher perfusion (Zhou et al., 
2015), which might mean we have more sensitivity to detect differences in these regions 
due to a higher signal-to-noise ratio.  
 
The results showing higher MCAv in the younger unfit compared to fit group, and 
supported by the differences in CBF transit times (though not perfusion measures), are not 
in line with existing literature (Ainslie et al., 2008; Barnes et al., 2013). One potential 
explanation for this finding is due to the unbalanced numbers of males and females in 
these groups. Specifically, there were more males than females in the fit group, whereas 
more females than males were in the unfit group. Given that previous studies have 
reported higher resting CBF measures in females compared with males (Marinoni et al., 
1998; Parkes et al., 2004), this may explain the inconsistent findings here, though this 
cannot be reliably tested due to the small sample sizes of these subgroups. Further, resting 
CBF is known to decline with age, and the average age of the young fit group was higher 
than the young unfit group. Although this difference was not significant, there was a trend 
towards significance. To try and interrogate these issues, further analysis was performed, 
specifically looking at the TCD resting MCAv, and MRI transit time data where 
participants were pair-matched for age and sex. Despite this procedure, the same pattern 
was observed where the younger unfit group had faster transit times than the younger fit 
group, though no differences were observed in the TCD data. This observation needs to be 
considered with caution given the very low numbers in each group and further 
investigation is required to test for reproducibility of these observations in a larger cohort 




Significant correlations were observed between resting CBF measures calculated using 
MRI and TCD approaches when measures used the speed of blood flow as an index of 
resting CBF (i.e., velocity (cm·s
-1
) with TCD vs. transit times (s) with MRI). Indeed, the 
two imaging approaches were able to differentiate the younger from the older and the fit 
from the unfit groups similarly, including the unexpected finding of increased resting CBF 
(MCAv and transit times for TCD and MRI, respectively) in the younger unfit group 
compared to the fit group (see Figure 4.4). The age-related findings complement those 
currently in the literature, where resting CBF naturally declines across the lifespan (e.g., 
Bailey et al., 2013; Ainslie et al., 2008; and Brown, 2010). However, there were no 
associations between MRI measures of cerebral perfusion and TCD measures of CVCi or 
MCAv. Further, though MRI ASL measured cerebral perfusion declined across the 
lifespan, the correlation with age was not significant, and no differences between fitness 
groups were observed for either the younger or the older group (in contrast to MCAv and 
transit time measures). These findings show that the modality used to determine the resting 
CBF measure can affect interpretation of the measure and its association with age or 
fitness. However, there were some associations between approaches and some consistent 
patterns between age and fitness groups (e.g., the interpretations from MRI grey matter 
transit times and TCD MCAv were in agreement). Given that MRI transit time and TCD 
MCAv are physiologically similar metrics of flow (both measure the speed of blood flow 
through the vasculature), whereas perfusion is measuring the rate at which blood is 
delivered to the capillary bed (i.e., tissue), it makes sense that these measures may not 





4.5.1. Study Limitations  
As mentioned previously, this study recruited more males than females, particularly in the 
fit groups and this may have affected the results. The scientific literature reports mixed 
findings on the effects of sex on resting CBF; specifically, studies using the TCD modality 
have shown both lower resting CBF in females compared to males (Marinoni et al., 1998) 
or vice versa (Purkayastha and Sorond, 2012), and studies using MRI measures have 
shown higher resting CBF in males compared to females (Kassner et al., 2010) or vice 
versa (Parkes et al., 2004). One confounding factor was that the fit younger group was on 
average older than the unfit group (28 vs. 22 years), meaning that the fitness effects within 
this group may be less likely to be detected due to the natural decline in resting CBF that 
occurs during ageing (Ainslie et al., 2008; Bailey et al., 2013). Future research in this area 
would benefit from better pair-matching of participants for both sex and age in order to 
differentiate the fitness effect on resting CBF.  
 
To try and address this issue a subgroup of the cohort were pair-matched for age and sex 
and their data compared. However, this did not alter the pattern of results, only removed 
the significance. Higher MCAv and transit times were still observed in the younger unfit 
group compared to their fit and age-matched counterparts. Therefore, individual variability 
may be causing these unexpected findings that would be less likely to be an influence in a 
study with a larger sample size. Examples of individual variability factors include: level of 
cognitive activity participants engage in (i.e., education, speaking multiple languages, 
playing a musical instrument, amongst many others) and activities that combine several 
functional skills including physical, cognitive and social/team working (e.g., dancing). 
These factors may further drive improvements in the cerebrovascular measures 




4.5.2. Summary and Conclusion 
In line with existing research, these data show that younger individuals have elevated 
resting CBF compared to older individuals. However, in this study, the younger fit group 
had lower resting CBF compared to their unfit counterparts. This result is surprising given 
that fitness is typically associated with elevated CBF (i.e., elevated MCAv and lower 
transit times) and although may be explained by a small sample size, warrants further 
investigation into both intra- and inter-individual variability. Further, MRI CBF measures 
can give more information about regional differences, where prefrontal areas of the brain 
are likely to be more sensitive to changes resulting from ageing and/ or diseases such as 
dementia (Gunning-Dixon et al., 2009; Alexopoulos et al., 2012). 
 
In conclusion, TCD and MRI imaging modalities provide complementary resting CBF 
measures when assessing similar metrics of flow (e.g., TCD velocity and MRI transit 
times), where similar differences across the whole cohort and within subgroups were 
observed across modalities. This indicates that findings between studies using different 
modalities to assess resting CBF can be compared when healthy participants are being 
investigated and the metrics of CBF measured are compatible (e.g., flow velocity vs. blood 
transit time). However, measures of MRI cerebral perfusion and associations with transit 
times and velocity (MCAv, CVCi and CVRi) were less clear, likely due to the difference 
in metric being used (rate of blood flow through the vessel/ vasculature vs. tissue perfusion 
in the capillary bed); thus, further research is needed investigating differences within and 
between modalities and associations with different populations (i.e., younger, older, 
disease, etc). Further, although beyond the scope of this study, it is important to consider 
the significance of the chemoreflex in the control of CBF (see Ogoh et al., 2013) and its 




investigated here. The findings in this study cannot be generalised to other imaging 
modalities for resting CBF or to disease populations. Therefore, further investigation is 
warranted to determine whether TCD and MRI resting CBF measures complement other 
resting CBF measures obtained using different imaging modalities (e.g., NIRS), and also 
to determine whether TCD and MRI resting CBF measures remain complementary in 





5. CEREBROVASCULAR REACTIVITY TO CARBON DIOXIDE 
USING TRANSCRANIAL DOPPLER AND MAGNETIC 
RESONANCE IMAGING 
5.1. Abstract 
Background: Cerebrovascular reactivity (CVR) to carbon dioxide (CO2) has emerged as a 
key marker of brain health.  However, recent findings report conflicting interpretations of 
CVR in healthy ageing, fitness and neurodegenerative conditions (e.g., dementia and 
stroke). This may be related to methodological differences and different typical 
disciplinary analysis approaches (i.e., imaging modality, analysis approach and/or CO2 
stimulus concentration). The purpose of this study was to examine whether these 
methodological and analysis differences alter the CVR outcome measure across a cohort. 
Within the same cohort, the following were examined: (1) imaging modality (magnetic 
resonance imaging (MRI) versus transcranial Doppler (TCD)); 2) typical analysis 
approach (linear regression (MRI) versus 30-s mean steady state (TCD)), and 3) CO2 
stimulus concentrations (5% vs. 7% CO2), for determination of CVR.  
Methods: Thirty-five healthy volunteers participated (20 young: 24 ± 7 years; 15 old: 66 ± 
7 years). Participants completed two experimental sessions (TCD/MRI) on separate days 
(randomised and counter-balanced). For both sessions, CVR data were obtained using two 
concentrations of CO2 via the same Douglas bag open circuit (4-min cycles of: room air, 
5% CO2 (in air), room air, 7% CO2 (in air)). CVR outcome measures were calculated for 
both MRI and TCD data using typical analysis approaches for each modality (e.g., Driver 
et al., 2010 and Vernieri et al., 2009 respectively), and then analysis approaches were 
applied to the other imaging modality for comparison. Differences in CVR outcome 




Results: There were no correlations (Pearson’s r) between TCD and MRI modalities for 
CVR measures calculated using typical analysis approaches from either stimulus 
concentrations (5% CO2: r = 0.033, p = 0.866; 7% CO2: r = 0.303, p = 0.117). Within each 
modality, there were strong correlations between CVR measures calculated via either 
analysis approach (r > 0.737, p < 0.001). Regardless of the modality used to obtain CVR 
data (TCD or MRI), CVR measures calculated using the TCD analysis approach (30-s 
steady state) were higher than CVR measures calculated using the MRI analysis approach 
(linear regression). Stimulus concentration altered CVR measures for the TCD (p > 0.001) 
but not the MRI modality. 
Conclusions: The imaging modality used to calculate CVR, as well as the CO2 
concentration for TCD measures, had significant effects on reported CVR outcome 
measures. Therefore, caution is needed when comparing studies that use different 
methodological approaches. Observed discrepancies between CVR measures across 
imaging modalities require further investigation to elucidate their cause. To improve the 
utility of CVR as an outcome measure, methodological guidelines are required that address 




Cerebrovascular reactivity (CVR) is a vascular response to alterations in arterial carbon 
dioxide (PETCO2) content and is a common test to assess brain health, described in more 
detail in Chapter 2, Section 2.3.2.3. Traditionally, higher CVR is associated with higher 
aerobic fitness (Bailey et al., 2013; Barnes et al., 2013), while a lower CVR is associated 
with natural ageing and brain-related conditions including dementia (Wolters et al., 2017; 




recent findings challenge some of these observations. For example, blunted CVR was 
reported in a group of Masters athletes relative to sedentary age-matched controls (Thomas 
et al., 2013). Further, in another study of older adults, higher cardiorespiratory fitness was 
associated with lower CVR (DuBose et al., 2016). 
 
Thomas and colleagues suggested that this blunted responsiveness was due to repeated 
exposure to elevated CO2 during exercise; however, another explanation for this 
contradictory finding, and findings from DuBose and colleagues, may be due to the 
methodology used to measure CVR, which was different to the method used by Bailey and 
colleagues and different again to that used by Barnes and colleagues (i.e., CO2 stimulus 
concentration and duration, steady-state time point; discussed in Chapter 2 and 
investigated in Chapter 3). In addition, another key difference of the Thomas et al., (2013) 
and DuBose et al., (2016) studies relates to the imaging technique used to determine CVR. 
These researchers used magnetic resonance imaging (MRI) to assess CVR, while the other 
studies discussed used transcranial Doppler (TCD) ultrasound (Markus and Cullinane, 
2001; Bailey et al., 2013; Barnes et al., 2013; Meel-van den Abeelen et al., 2014; Wolters 
et al., 2017). This highlights an important question within the research field of brain health 
assessment; namely, does the method by which CVR is assessed affect this outcome 
measure? 
 
Therefore, inconsistent findings in the literature regarding the directionality of the 
association between CVR and fitness, and indeed whether there is an association at all, 
may be related to different neuroimaging acquisition and analysis methods used to 
determine CVR. Firstly, studies use different imaging modalities to collect data (i.e., TCD 




the CVR measure (30/60 s data extraction in TCD, and linear regression in MRI). Finally, 
studies within both neuroimaging disciplines use different stimulus concentrations of 
carbon dioxide (4%, 5% or 7% CO2), and different stimulus durations during the 
experimental procedure that may also alter the reported CVR outcome measure (as 
explored in Chapter 3). 
 
5.2.1. Measuring Cerebrovascular Responsiveness 
TCD and MRI are examples of two neuroimaging modalities that can be used to measure 
and record brain blood flow responses to hypercapnia during a gas challenge involving the 
administration of elevated levels of CO2, and thus, give a measure of CVR. However, the 
way these techniques measure brain blood flow is quite different, despite both being 
referred to as CVR. Further, hypoxia has also been used to induce this response and other 
research groups have focused on the significance of the chemoreflex for the control of 
cerebral blood flow (Ogoh et al., 2013). TCD measures the echoes of ultrasound waves 
moving transcranially and typically involves placing two probes on either side of the head 
to allow bilateral recording of middle cerebral artery blood flow velocity (MCAv). A key 
assumption of this measure is that MCAv represents cerebral blood flow (CBF). In 
contrast to this approach, one typical approach within the MRI field uses the blood-oxygen 
level dependent (BOLD) signal to measure the haemodynamic response to a CO2 stimulus. 
The BOLD signal is reduced in the presence of increased deoxyhaemoglobin because of 
the difference in the magnetic susceptibility of deoxy and oxyhaemoglobin. The BOLD 
signal is influenced by a complex balance of physiological factors combined to calculate 
an arbitrary CVR outcome measure (specifically, blood flow, blood volume and tissue 
oxygenation). It therefore provides an indirect indication of changes in blood flow, and the 




such as CO2, assuming no change in neuronal activity (Febo 2011; Buxton 2013). 
However, studies have shown that CO2 is in fact not neuronally neutral and that not only 
does CO2 change CBF, it alters other neural frequencies (Hall et al., 2011). 
 
While research disciplines have recently begun to collaborate and merge together (e.g., see 
Chapter 2, section 2.5 for detail), traditionally different disciplines or research fields (e.g., 
neuroscience and physiology) use different modalities (i.e., Doppler ultrasound, near-
infrared spectroscopy (NIRS), MRI) and analysis approaches to measure brain blood flow. 
One similarity across modalities is that the vascular response may be measured either at 
rest or during functioning, such as physical activity, a cognitive task, or through 
manipulation of inhaled gases to obtain CVR. However, the analysis approaches used to 
derive a specific brain vascular outcome measure also differ between modalities. For 
example, the typical TCD approach of calculating CVR involves extracting either 30 or 60 
s of data from the end of the gas stimulus duration and then plotting the change in MCA 
velocity relative to 30 s of a resting period, against the change in PETCO2 taken from these 
same time points. Further, TCD approaches also use a resting index of cerebrovascular 
conductance (CVCi) to calculate CVCi-derived CVR, where the MCAv measure is 
divided by a measure of mean arterial blood pressure (MAP), thereby avoiding potential 
influences on changes in arterial blood pressure on cerebral blood velocity during the 
hypercapnic challenge (e.g., Low et al., 2008). By comparison to TCD, the typical MRI 
approach of calculating CVR involves a linear regression of the BOLD signal change 
against the PETCO2 changes over the entire gas challenge protocol, including the baseline 
period of data collection (Driver et al., 2010), which can be performed for each voxel of 
the brain or an average signal over the whole brain. An alternative MRI method to 




capillaries, often termed perfusion. However, few studies have used ASL to assess CVR 
and instead use BOLD (Ekstrom et al., 2010; Bhogal et al., 2014, 2015, 2016; Duffin et 
al., 2017) due to the inherently low SNR of ASL data (Buxton 2013).  
 
This leads us to consider whether the choice of neuroimaging modality or analysis 
approach used will alter the CVR measure. Further, no research has been done to compare 
whether these approaches differentiate between age and fitness groups similarly.  
 
5.2.2. Study Aims and Hypotheses 
The overall aims of this study were to: (1) investigate differences between age (younger 
versus older) and fitness (fit versus unfit) groups on the CVR outcome measure, and (2) 
compare the most robust and clinically transferrable CVR test (identified in previous 
studies) using TCD and MRI. Based on common CVR protocols previously used, and the 
findings from Chapter 3 (indicating that CVR measures calculated from 3-minutes into the 
stimulus duration would show the least variability, whilst allowing individuals enough 
time to reach steady-state), a 4-minute (to allow for error), two-stepped 5 and 7% CO2 gas 
challenge protocol was employed for both MRI and TCD acquisition approaches. The 5% 
and 7% CO2 stimuli were both used to investigate whether the different stimulus 
concentrations used in previous work discussed above, alter the CVR measure. 
 
There were two main research questions addressed in this chapter: 
 
1. Ageing and fitness effects on the CVR outcome measures: Do different 
methodological approaches show similar patterns in populations where differences 




2. Imaging modality and analysis approaches used to obtain the CVR outcome 
measure: Do CVR outcome measures obtained from data collected using different 
brain imaging modalities (TCD vs. MRI) directly correlate with one another? 
Further, do typical analysis approaches normally used in different disciplines give 
similar CVR measures? (i.e., TCD approach: 30/60 seconds of extracted data vs. 
MRI approach: linear regressions). 
 
It was hypothesised that: (1) MRI and TCD assessment of CVR will provide a similar 
pattern across the entire cohort as well as separation between younger/older and fit/unfit 
participants, and (2) the assessment of the CVR measure will be different between the 
typical analysis approach used, though group differences (younger/ older and fit/unfit) will 
remain the same.  
 
5.3. Materials and Methods 
The imaging modalities used for this chapter are the same as those described in Chapter 4 
(i.e., TCD and MRI). However, the data acquisition and analysis methods employed 
specifically for obtaining the outcome measures of CVR are described in more detail in 
this chapter (see below). CVR measures were calculated using data obtained from TCD 
and MRI BOLD signal acquisition methods and their accompanying typical analysis 
approaches. Further, both TCD and MRI analysis approaches were used for data obtained 
using both modalities (i.e., typical TCD analysis approaches were used with MRI data and 






Thirty-five healthy participants (20 younger and 15 older) completed the CVR CO2 gas 
challenge and fitness test. One participant chose not to go onto complete the MRI visit. 
One participant chose not to complete the 7% CO2 gas challenge during the TCD visit and 
3 participants chose not to complete the 7% CO2 gas challenge during the MRI visit or 
ended the 7% CO2 gas challenge early. CVR datasets for two participants from the MRI 
visit could not be used due to technical issues and missing data. This resulted in 28 
participants (16 younger and 12 older) with complete datasets for TCD and MRI CVR 
measures from both the 5% and 7% CO2 stimulus durations. All participants completed the 
same experimental visits described in Chapter 4 (see Section 4.3.2), with the gas challenge 
to obtain CVR measures included during both the TCD and MRI visits (Figure 4.1 and 
4.2). 
 
5.3.2. Pilot Testing 
The final protocol was developed after several pilot scans to test the sequences and refine 
the protocol as necessary, as well as to develop an easy to use method for delivering gases 
into the scanner room, which ultimately could be implemented by other researchers in the 
field. Initially the practical set-up and optimisation of the MRI scanning protocols was 
performed to achieve the desired measures. The set-up of the breathing equipment was 
tested on eight pilot participants with both TCD and MRI modalities to check that: 1) 
reliable data could be collected; 2) the equipment was all MRI compatible; 3) the 
equipment could fit into the MRI head coil with a variety of head sizes, and 4) measures of 
end-tidal CO2 could be synchronised to MRI acquired data via post-processing analysis. 
The final experimental set up developed through piloting the equipment both inside and 




using the equipment outside of the MRI scanner at the School of Sport, Exercise and 
Rehabilitation Sciences and from using a similar methodological approach to that 
previously employed by others (Tancredi et al., 2014, 2015; Moreton et al., 2016).  
 
Some practical issues were encountered that affected the quality of the data, which 
required solutions to be developed in order to be overcome and be consistently applied 
thereafter. The size of the mouth piece bore affected the participant’s breathing ability and 
the data, where a larger mouth piece improved data quality and participant comfort (large 
Hans Rudolph T shaped valve and silicone rubber mouthpiece; Figure 5.1). Tape was used 
across the participant’s nose to prevent the nose peg from slipping. A researcher was 
present in the MRI scanning room to visually and verbally check the set-up before the 
CVR acquisition commenced. On occasion, leaking of breath around the mouthpiece was 
observed in the end-tidal traces, so clear instructions were given to participants explaining 
the procedures prior to scanning (i.e., requesting they kept a tight seal around the mouth 
piece throughout) and participants practiced putting in place and removing the mouthpiece 
before going into the MRI scanner. The finalised breathing equipment set-up is shown in 
Figure 5.1, and was used for both TCD and MRI data acquisitions. All the equipment was 
MRI safety checked by the Birmingham University Imaging Centre safety officer. 
 
5.3.3. Familiarisation of Cerebrovascular Reactivity Gas Challenges 
Participants completed a full familiarisation session of the gas challenge protocol (Chapter 
4, Figure 4.1) whilst MCAv measures were recorded using TCD. Participants were asked 
to lie in supine position, relax and breathe as naturally as possible. A 20-minute resting 
period was followed by a 4-minute resting data collection period. They then breathed 4 




7% CO2 stimulus, followed by 4 minutes of room air. After satisfactory completion of 
familiarisation trials (i.e., no adverse reactions to breathing the CO2 stimulus were 
experienced by the participant and adequate Doppler signals were identified), participants 
were invited back for the two full testing sessions, one where MCAv was measured using 
TCD and one where BOLD and ASL were measured using MRI to give different indirect 
measures of brain blood flow. The order of these two testing session visits was randomised 
between participants to avoid order effects.  
 
5.3.4. Gas Challenge set up for Cerebrovascular Reactivity Outcome Measures  
To ensure mouth breathing only, participants wore a nose peg whilst breathing through a 
mouthpiece connected to the gas delivery apparatus shown in Figure 5.1. A large 3-way 
valve (2700 series: NRBV; Hans Ruldolph Inc., Kansos City, MO, USA) was connected to 
the mouthpiece, an inhalation tube that was connected to one of two open-circuit Douglas 
bags (containing 5% CO2 or 7% CO2 gas in dry air) or left open to room air, and an 
exhalation tube that lead to room air. Within this circuit for the TCD session only, was a 
heated pneumotachograph (3813 Series, Hans Rudolph Inc., Kansas, USA); however, due 
to the non-MRI compatibility of any available spirometer, ventilation volume and rate was 
not recorded during the MRI session. Switching the Douglas bag valves from ambient 
room air to the 5 and 7% CO2 mixture was done by a researcher sitting beside the 
participant for both TCD and MRI sessions.  
 
During both visits, fractional changes in inspired and expired oxygen (O2) and carbon 
dioxide (CO2) were measured via a sample line inserted into the mouth piece, as shown in 
Figure 5.1. The sample line connected to a fast responding gas analyser (ML206, 






and CO2 data were acquired continuously at a sample rate of 1kHz via an analogue-to-
digital converter (PowerLab 16/35, ADInstruments) interfaced with a computer, displayed 
in real time and stored for offline analysis using commercially available software 
(LabChart v7.3.5, ADInstruments). Beat-by-beat blood pressure (BP) was measured using 
photoplethysmography via a finger cuff placed on the middle finger of the left hand 
(Portapres, Finapres, Medical System BV, the Netherlands) during the TCD visit. A 3-lead 
electrocardiogram (ECG) was used to continuously measure heart rhythm and electrical 
activity.  During the MRI visit, cardiac and respiratory cycles were simultaneously 
recorded using the vector cardiogram (VCG; Philips Medical Systems, The Netherlands) 
and respiratory belt, respectively. 
 
Calibration of the breathing equipment through PowerLab was performed before each 
testing session for airflow and gas concentration. A 3-L calibration syringe was used for 
volume measurement and certified reference gases used for gas concentration (5.00% CO2, 






Figure 5.1. Breathing equipment set-up used for gas challenge protocol. Participants wore 
a nose peg and breathed through the mouth piece. The mouthpiece connected to a 3-way 
valve with inhalation and exhalation tubes. The inhalation tube connected to room air or 
one of two open-circuit Douglas bags (containing 5% CO2 or 7% CO2 gas in dry air).  
 
5.3.5. Data Acquisition 
MRI data: All MRI data were acquired on a 3-T Philips Achieva MRI scanner (Philips 
Medical Systems, Best, Netherlands) using the same hardware and software as described 
in Chapter 4 (see Chapter 4, Figure 4.2 for protocol). To allow measurement of CVR using 
MRI, a flow sensitive alternating inversion recovery (FAIR) double acquisition 
background suppression (DABS) sequence (Mullinger et al., 2013, 2017) was used for 




in the familiarisation and TCD visits (Figure 4.1) was used with the BOLD and ASL 
signals recorded simultaneously (total scan duration of 18 min).  
 
Importantly, in the DABS sequence, ASL data are collected with a short echo time (TE) 
following two background suppression pulses, ensuring that the signal from the static 
tissue in the label and control ASL images is close to suppressed in order to reduce 
physiological noise and any BOLD contamination in the CBF response. To maximize 
BOLD contrast, the BOLD data are acquired at the end of each TR period to allow partial 
recovery of the static signal, with an echo time approximately matched to the T2* of grey 
matter. Imaging parameters used in this study were: TR = 5.2 s (label-control pair), with 
background suppression pulses at TBGS1/TBGS2: 339 ms/899 ms, label delay = 1400 ms, 
TE = 9 ms (ASL)/40 ms (BOLD), voxel size: 3.25 × 3.25 × 5 mm, 12 slices of ASL and 
BOLD data, FOV: 212 × 212 mm, SENSE factor: 2.3, volumes: 205 (label-control pairs).  
 
As mentioned in Chapter 4, Section 4.3.3, a whole head T1-weighted anatomical image 
(magnetisation prepared rapid gradient echo; MPRAGE) with 1 mm
3
 resolution was also 
acquired to allow normalisation of the individual subject to the standard brain and 
definition, and segmentation of the grey and white matter so that CVR measures in these 
tissues could be assessed separately. 
 
TCD session: Bilateral blood flow velocity in the right and left middle cerebral artery 
(MCAv) was measured using TCD (Doppler Box, DWL, Compumedics Ltd, Germany), 
with a 2-MHz probe placed over each temporal window on the right and left side of the 
head. Probes were prepared with ultrasound gel and held in place with a headset. Search and 





5.3.6. Data Analysis 
For both TCD and MRI visits, collected gas fractions were converted to partial pressure 
measures of end tidal CO2 and O2 using the measured barometric pressure (Fortin 
Barometer, Russell Scientific Instruments Ltd, Norfolk, UK) of that day ((percentage 
CO2/100)*(760-barometric pressure)). 
 
5.3.6.1. Calculating CVR from MRI data 
Pre-processing 
The DABS data were separated into the BOLD and ASL data for subsequent analysis. The 
BOLD data were physiologically corrected for cardiac and respiratory effects using 
RETROICOR (Glover et al., 2000). All data were then motion corrected using Oxford 
University Functional Magnetic Resonance Imaging of the Brain (FMRIB) Linear 
Regression Tool (FLIRT) (Jenkinson et al., 2002) in the FMRIB Software Library (FSL, 
https://fsl.fmrib.ox.ac.uk/fsl/fslwiki). Using in-house Matlab programmes, separately the 
ASL data (perfusion (CBF)-weighted images acquired at TE = 9 ms) and BOLD data 
(BOLD-weighted images acquired at TE = 40 ms) were then linearly interpolated (Interp 
function, Matlab, Mathworks USA) to an effective TR of 2.6 s. Label-control pairs of ASL 
data were subtracted (using simple subtraction) to create perfusion weighted (CBF) 
images. BOLD-weighted image pairs were averaged to produce mean BOLD-weighted 
data. Further pre-processing was carried out in FSL. BOLD data were normalised to the 
standard Montreal Neurological Institute (MNI) template using the anatomical-to-standard 
space transform derived in the resting CBF data analysis (Chapter 4, Section 4.3.4). After 
inspection of CBF data it was decided that further analysis could not be performed due to 




gas challenges. Therefore, the post-processing stages outlined below were only carried out 
on the BOLD data to give an MRI measure of CVR. 
 
Post-processing 
The CVR outcome measure was calculated using several different methodological 
approaches that are commonly used and are described in more detail below. This was done 
to determine whether they gave similar results and showed similar differences between 
groups. Approaches included calculating a linear regression and a general linear model 
(GLM) analysis across the entire gas challenge and across the 5% CO2 and 7% CO2 gas 
challenges separately.  
 
Linear regression: Firstly, the mean BOLD signal for each volume over the individual 
subject grey matter tissue mask (i.e., excluding veins) was calculated. The mask to exclude 
veins was created by plotting a histogram of the percentage BOLD signal change to the 
entire gas challenge across the grey matter and where this was greater than 15% was 
regarded as a vein so excluded. To account for the delay in the PETCO2 readings relative to 
the BOLD readings (due to the sample line length, enabling readings to be taken from the 
facemask on the participant to the MRI control room), the mean % BOLD signal intensity 
was temporally aligned with the PETCO2 (mm Hg) trace using an iterative process to 
maximise the correlation of the BOLD and PETCO2 trace, with an example shown in 
Figure 5.2C. The BOLD signal was converted to a percentage change relative to baseline 
and plotted against the corresponding PETCO2 values to give a plot such as that shown in 
Figure 5.2D. The data were then modelled using a linear regression, with Equation 5.1 
used to obtain the line of best fit over the whole data acquisition (including periods of 




y = mx + c 
Equation 5.1 
where m is the gradient and c is the intercept of the line with the y axis at x=0 and y and x 
are variables (in this case y is the BOLD data and x is the PETCO2 trace). The gradient (m) 
of the line of best fit was the first BOLD CVR outcome measure. 
 
 
Figure 5.2. Obtaining the CVR measure using a linear regression analysis approach. The 
BOLD (or MCAv) data (A) and the PETCO2 data (B) were temporally aligned (C). 
Percentage change in the BOLD signal relative to baseline was then plotted against the 







GLM analysis: The GLM uses a mass univariate approach by applying the same statistical 
analysis on every single voxel. For these data, this process involved looking at the 
relationship between the dependent variable: Y (the BOLD signal) and the eight dependent 
variables (i.e., regressors): X1, X2… X8 (PETCO2, linear drift and six movement parameters) 
(see Equation 5.2).  
 
Y = Constant + X1 ß1 + X2 ß2 + X3 ß3 + X4 ß4 + X5 ß5 + X6 ß6 + X7 ß7 + X8 ß8 +  
        Equation 5.2 
where in this case: X1 is the PETCO2 regressor, X2 the linear drift regressor, X3-X8 the 
motion regressors, the constant is the mean BOLD signal over time and ε the noise term. Y 
is the measured BOLD signal time-course in a given voxel.  
 
The beta weights are regression coefficients that are used when both the variables are 
standardised. For the purpose of calculating CVR, it is clear from the similarity of 
Equations 5.1 and 5.2 that the beta weight ß1 (related to the PETCO2 regressor) at each 
voxel provided a metric of CVR in units of % BOLD signal change/ mm Hg PETCO2 
change at each voxel (e.g., Thomas et al., 2013). These BOLD-derived CVR measures 
using the GLM take account of any BOLD signal changes linked to motion or drift due to 
the nuisance regressors modelled (Equation 5.2), and therefore should provide a more 
accurate estimate of CVR than the linear regression method. The GLM-derived CVR 
measures were masked to only include grey matter tissue (excluding veins, see linear 
regression analysis for details). The mean CVR over all grey matter was then calculated 
and, in addition, CVR measures in different RoIs were also assessed. The RoI masks 
described in Chapter 4, Section 4.3.4 were used (akin to Thomas et al., 2013). Both the 




derived measures of CVR. Finally, to further understand regional variation, mean CVR 
maps from the GLM analysis were created over all participants and the younger and older 
groups separately by averaging the participants individual mean GLM-derived CVR for 
each RoI (see Appendix A5.1). 
 
5.3.6.2. Calculating CVR using TCD 
CVR was calculated using Equations 5.3 and 5.4 and the same methods described in 
Chapter 3. Given that the findings of Chapter 3 indicated that 3 minutes into the gas 
challenge produced the least variability in relative CVR, this 3-minute time-point was used 
for analysis in this Chapter. Further relative CVR is used as the main TCD analysis 
approach (see Chapter 3; Results, and Discussion, Sections 3.5 and 3.5). TCD analysis 
approaches included extracting 60 seconds of stable resting data, and 30 seconds of data 
from both the 5% CO2 and 7% CO2 stimulus durations, preceding 3 minutes of the 
stimulus duration (i.e., starting from 2.5 minutes into the stimulus duration).  
 
Absolute CVR: 
hypercapnic (5% or 7% CO2) MCAv – resting MCAv 
hypercapnic (5% or 7% CO2) PETCO2 – resting PETCO2 
Equation 5.3 
Relative CVR: 
100 ((hypercapnic (5% or 7% CO2) MCAv – resting MCAv) / resting MCAv) 






TCD CVR measures using cerebrovascular conductance (CVCi-derived CVR) were also 
calculated using mean arterial blood pressure (MAP) (Equation 5.5), where CVCi replaces 
MCAv in Equation 5.3 and 5.4 (Brown et al., 2010 and Barnes et al., 2013). 
CVCi = MCAv 
  MAP 
Equation 5.5 
5.3.6.3. Calculating CVR using different gas concentrations and analysis approaches 
Above, the CVR measures calculated for both MRI and TCD data are described using 
typical analysis approaches (e.g., Thomas et al., 2013, Driver et al., 2010 and Vernieri et 
al., 2009). Whilst the MRI-derived CVR calculations described above were over the entire 
data, using 5% and 7% CO2 challenges, previous work has indicated that there may be a 
non-linearity in responses between gas challenges both in MRI response (Bhogal et al., 
2014) and TCD responses (Battisti-Charbonney et al., 2011). Therefore to allow for this 
possibility, additional analyses of the MRI BOLD data were performed.  
 
Calculating CVR using different gas concentrations: MRI analysis approaches included 
calculating a linear regression using BOLD signal intensity and PETCO2 data from: i) the 
entire gas challenge (as described above); ii) the first baseline period and the 5% CO2 
stimulus duration, and iii) the second baseline period and the 7% CO2 stimulus duration. 
The GLM approach was also adapted to use the same periods and interrogate 5% and 7% 
CO2 responses separately for the whole of grey matter and the ROIs described above.  This 
then would serve to match the TCD measures on the 5% and 7% CO2 data, which were 
done separately using the typical CVR analysis described above (see Section 5.3.6.2). 





Calculating CVR using different analysis approaches: To allow comparison between CVR 
measures from different imaging modalities it was important to match analyses as closely 
as possible. Therefore, BOLD data (in this case the mean over all grey matter tissue) were 
analysed using the TCD approach (outlined in Section 5.3.6.2) by extracting 30 seconds of 
data from 3 minutes into the stimulus duration to calculate the mean BOLD response in 
this time window, and 60 seconds of BOLD data from the resting baseline. The average 
BOLD signal then replaced the MCAv in Equation 5.4 to calculate CVR.  An important 
note is that the TCD MCAv and PETCO2 data were not temporally aligned as they were for 
the MRI BOLD and PETCO2 data when using the linear regression approach described 
above (Section 5.3.6.1). This was because this is not typical for TCD methodological 
approaches and the aim was to keep the approaches used in this study as close to typical 
approaches as possible. Therefore, in addition, the TCD modality data were used to form a 
linear regression analysis, akin to that described in Section 5.3.6.1, linear regression 
subsection. Linear regressions were performed for: i) the entire gas challenge, ii) the first 
baseline and the 5% CO2 stimulus duration, and iii) the second baseline and the 7% CO2 
stimulus duration – matching the BOLD MRI linear regression method.  
 
Regional comparisons: Although MRI RoI approaches cannot be directly compared to 
TCD approaches, an analysis investigating CVR measures calculated between modalities 
from anatomically similar locations was also performed (i.e., TCD MCAv measures were 







A: Typical MRI approaches for calculating CVR: 
 
Linear regressions and General Linear Model  
CVR measures calculated from: 
1. Entire gas challenge (18 minutes) 
2. Baseline and 5% CO2 (8 minutes) 
3. Baseline and 7% CO2 (8 minutes) 
 
Calculations were made, first for all grey matter, followed by several regions of interest 
 
B: Typical TCD approaches for calculating CVR: 
60 s of resting data and 30 s of data extracted preceding 3 minutes of the stimulus 
duration from: 
1. 5% CO2 stimulus  
2. 7% CO2 stimulus 
 
Calculations were performed using: MCAv and CVCi (MCAv/MAP). 
 




5.3.7. Statistical Analysis 
Group means were compared between younger and older groups, younger fit and unfit 
groups, and older fit and unfit groups using ANOVAs. Differences between analysis 
approaches were compared where possible using ANOVAs and t-tests. Stimulus 




approaches were measured using different units, correlational analyses were performed to 
investigate correlations between approaches. 
 
Change in PETCO2 values from baseline to both stimulus concentrations were compared 
between TCD and MRI visits using paired t-tests to ensure they were not significantly 
different. Further, maximum PETCO2 values were checked to see if they went over 55 mm 
Hg, as this would introduce a further potential confound on the CVR outcome measure 
where linearity of changes between CBF and PETCO2 would no longer be expected 




The following results only includes participants who completed both the 5% CO2 and 7% 
CO2 stimulus concentrations during both TCD and MRI modality visits (n = 28; 16 
younger and 12 older). Mean participant characteristics are shown in Table 5.1, including: 
age, fitness (V̇O2 max), resting heart rate and MAP measures. ANOVAs were performed 
to test for differences between age and fitness groups. Tests of homogeneity of variances 
showed no significant effects apart from V̇O2 max measures between the older fit and 
unfit group, where the fit group had a significantly higher variance (SD = 14.06 versus 









Table 5.1. Characteristics of participants who completed the CVR challenge for both 5% 































          


























































11:5 7:5  7:1 4:4  6:1 1:4  
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 









for the younger and older groups respectively. 
Significant age/fitness effects (different from younger group/ different from fit group):  
* p ≤ 0.05; ** p ≤ 0.01. 
t 
Shows a trend towards significance: 0.05 < p ≤ 0.1. 
Abbreviations: V̇O2 max, maximum oxygen consumption; MAP, mean arterial blood 
pressure. 
 
PETCO2 values were assessed using paired t-tests to ensure there were no significant 
differences between visits for change in PETCO2 values between the two visits. There were 
no significant differences in PETCO2 change from baseline to the 5% (p = 0.153) or the 7% 
CO2 stimulus (p = 0.280) between the TCD and MRI visits (see Appendix A5.2 for 
values). To determine whether there were significant differences between groups in 
movement during the MRI protocol that may have influenced the CVR outcome measure, 






) from the 
movement parameters. No significant differences were observed between younger and 
older groups in mean movement (p = 0.254), standard deviation of movement (p = 0.413) 
or maximum movement (p = 0.252), neither were differences in movement observed 
between fitness groups (younger fit and unfit groups: p = 0.298, p = 0.344 and p = 0.947, 
respectively; older fit and unfit groups: p = 0.579, p = 0.928 and p = 0.848, respectively) 




5.4.1. Aim 1: Effects of Ageing and Fitness on the Cerebrovascular Responsiveness 
Outcome Measure 
The following section looks at differences in CVR outcome measures in different age and 
fitness groups. This section will also look at CVR outcome measures obtained from 
specific regions of interest from the MRI modality. The between group (i.e., age and 
fitness) effects on all CVR outcome measures are summarised in Table 5.2, and Table 5.3 
shows correlations between all CVR measures, as well as between CVR measures and age 
and fitness subgroups. Figure 5.4 shows differences between younger and older groups, 
whilst Figures 5.5 and 5.6 show differences between fit and unfit groups in the younger 
and older cohorts respectively. 
 
Age: No significant differences were observed between age groups on any of the CVR 
measures derived from the BOLD data, though they did all show the same pattern where 
CVR was higher in the younger group than the older group (Figure 5.4A). In contrast, 
CVR measures derived from the TCD-MCAv data showed the opposite pattern where 
CVR was lower in the younger group than the older group (Figure 5.4B), though this was 
only significant for absolute measures from the 5% CO2 stimulus concentration (p = 
0.008). No age group differences were observed in TCD-CVCi CVR measures (Figure 
5.4C). As the BOLD data with TCD relative CVR analysis approach showed the same 
pattern as the BOLD data with linear regression approach, this indicates that differences in 
the CVR measure are more related to acquisition method (i.e., imaging modality) than the 
analysis approach. However, the CVR measure was sensitive to the analysis approach as 





Fitness: Figure 5.5 shows some effects of fitness in the younger group though only when 
CVR was calculated from the BOLD data using 7% CO2 stimulus and a linear regression 
analysis approach (p = 0.028), or using 7% CO2 stimulus and the TCD relative analysis 
approach (p = 0.013). No other significant fitness group differences were observed, though 
all CVR measures were lower in the younger fit group than the unfit group (Figure 5.6A 
and 5.6B). Figure 5.6 shows no significant effects of fitness on CVR in the older group 
regardless of imaging modality, analysis approach or stimulus concentration. 
 
Regions of interest: The CVR outcome measures calculated from separate RoIs within the 
MRI modality showed no significant age or fitness effects (all p > 0.10).  However, in the 
older group CVR significantly decreased as age increased, for CVR measures calculated 
using the 5% CO2 stimulus (all p < 0.05) from all RoIs: frontal lobe, motor lobe and 
parietal lobe. There were no correlations between the same measures and age from the 7% 




Table 5.2. Means and standard deviations for CVR measures obtained from MRI BOLD data and TCD MCAv data using typical analysis 
approaches from a 5% CO2 and 7% CO2 stimulus duration. Analysis approaches include, for MRI: linear regressions and general linear model 
(GLM) for all grey matter (GM); and for TCD: averaged right and left relative and absolute CVR calculated using MCAv and CVCi from 30-
seconds of data. CVR measures are shown for all participants followed by groups: younger/ older; younger fit/ unfit; and older fit/ unfit. 
    All participants By age groups  By age and fitness groups 
Modality Analysis approach (units) Stimulus (28) 
n = 33 
Younger (16) 
n= 19 
Older (12)  
n= 16 
Younger fit  
n= 9 
Younger unfit  
n = 10 
Older fit  
n = 9 
Older unfit  
n = 7 
 age  42.8 ± 22.1 25.1 ± 7.4 66.4 ± 7.5** 27.6 ± 8.1 22.6 ± 6.0 63.6 ± 7.7 70.4 ± 5.8 
 V̇O2 max  40.6 ± 14.8 45.8 ± 11.0 34.2 ± 16.8* 54.5 ± 5.0 35.9 ± 6.2 44.7 ± 14.1 19.4 ± 3.7 
TCD LR MCAv 5% 5% CO2 2.20 ± 0.72 2.22 ± 0.51 2.17 ± 0.96 2.13 ± 0.32 2.32 ± 0.79 2.36 ± 0.83 1.92 ± 1.16* 
 LR MCAv 7% 7% CO2 2.11 ± 1.00 1.93 ± 0.87 2.35 ± 1.15 1.76 ± 0.79 2.10 ± 1.00 2.67 ± 1.00 1.90 ± 1.31* 
 LR CVCi 5% 5% CO2 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.03 ± 0.02 0.02 ± 0.01 
 LR CVCi 7% 7% CO2 0.02 ± 0.01 0.02 ± 0.01 0.01 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.00 0.02 ± 0.01 
 MCAv relative 5% 5% CO2 3.79 ± 0.85 3.44 ± 0.77 4.26 ± 0.73** 3.52 ± 0.81 3.36 ± 0.76 4.27 ± 0.61 4.26 ± 0.95 
 MCAv relative 7% 7% CO2 4.74 ± 1.09 4.55 ± 0.83 5.00 ± 1.36 4.85 ± 0.84 4.24 ± 0.76 5.14 ± 0.75 4.81 ± 2.04 
 MCAv absolute 5% 5% CO2 2.39 ± 0.78 2.31 ± 0.75 2.49 ± 0.84 2.15 ± 0.56 2.48 ± 090 2.73 ± 0.66 2.15 ± 1.01 
 MCAv absolute 7% 7% CO2 2.83 ± 0.90 2.86 ± 0.68 2.79 ± 1.17 2.72 ± 0.41 3.0 ± 0.89 3.05 ± 0.95 2.43 ± 1.46 
 CVCi relative 5% 5% CO2 2.58 ± 0.99 1.96 ± 1.51 2.56 ± 0.85 2.57 ± 1.25 2.65 ± 1.08 2.69 ± 0.65 2.38 ± 1.13 
 CVCi relative 7% 7% CO2 3.25 ± 0.88 2.98 ± 1.22 3.30 ± 0.87 3.50 ± 0.87 2.80 ± 0.86 3.46 ± 0.93 3.08 ± 0.83 
 CVCi absolute 5% 5% CO2 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 
 CVCi absolute 7% 7% CO2 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.03 ± 0.01 0.02 ± 0.01 
MRI LR BOLD 5% 5% CO2 0.25 ± 0.10 0.28 ± 0.11 0.22 ± 0.09 0.24 ± 0.70 0.32 ± 0.13 0.21 ± 0.10 0.22 ± 0.07 
 LR BOLD 7% 7% CO2 0.29 ± 0.80 0.31 ± 0.08 0.25 ± 0.07
t
 0.27 ± 0.08 0.35 ± 0.05* 0.24 ± 0.08 0.27 ± 0.06 
 GLM GM 5% 5% CO2 0.30 ± 0.10 0.31 ± 0.12 0.27 ± 0.10 0.29 ± 0.13 0.33 ± 0.12 0.29 ± 0.07 0.30 ± 0.09 
 GLM GM 7% 7% CO2 0.28 ± 0.09 0.29 ± 0.09 0.27 ± 0.10 0.26 ± 0.07 0.32 ± 0.10 0.28 ± 0.11 0.25 ± 0.10 
 30-s 5% 5% CO2 0.27 ± 0.12 0.30 ± 0.12 0.23 ± 0.11 0.28 ± 0.09 0.31 ± 0.15 0.23 ± 0.13 0.23 ± 0.09 
 30-s 7% 7% CO2 0.31 ± 0.09 0.33 ± 0.10 0.27 ± 0.08
 t
 0.28 ± 0.09 0.31 ± 0.15* 0.23 ± 0.09 0.29 ± 0.05 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (50-80 years). 
* Significant age/fitness effects (different from younger group/ different from fit group): * p ≤ 0.05; ** p ≤ 0.01. t Shows a trend towards significance: 0.05 < p ≤ 0.1. 
Abbreviations: MRI, magnetic resonance imaging; LR, linear regression; TCD, transcranial Doppler, GM, grey matter; MCAv, middle cerebral artery blood velocity; 




Table 5.3. Correlations (Pearson’s r) with CVR outcome measures and age, followed by fitness for the younger group and older group 
separately. 
  All participants (n=28) Younger (n=16) Old (n=12) 
  Age Fitness: V̇O2 max Fitness: V̇O2 max 
Modality Analysis approach r  r r 
 V̇O2 max -0.453*   
TCD LR MCAv 5% -0.080 -0.197  0.276 
 LR MCAv 7%  0.098 -0.285  0.413 
 LR CVCi 5% -0.123 -0.039  0.700* 
 LR CVCi 7% -0.329 -0.280  0.525
t
 
 MCAv relative 5%  0.503**  0.072 -0.140 
 MCAv relative 7%  0.187  0.192  0.088 
 MCAv absolute 5%  0.043 -0.217  0.285 
 MCAv absolute 7% -0.133 -0.268  0.329 
 CVCi relative 5% -0.066 -0.082  0.229 
 CVCi relative 7%  0.064  0.130  0.552 
 CVCi absolute 5% -0.070  0.148  0.117 
 CVCi absolute 7% -0.136  0.169  0.434 
MRI LR BOLD 5% -0.406* -0.534*  0.386 
 LR BOLD 7% -0.408* -0.454
t
  0.038 
 GLM GM 5% -0.149 -0.083  0.193 
 GLM GM 7% -0.278 -0.271  0.276 
 30-s 5% -0.383* -0.305  0.397 
 30-s 7% -0.418* -0.582* -0.133 
Values represent Pearson’s r correlations. Significance (2-tailed) Significant age/fitness effects:  
* p ≤ 0.05; ** p ≤ 0.01. 
t 







Figure 5.4. Graphs showing CVR outcome measures for younger and older groups. Measures were calculated using different neuroimaging 
modalities (A. MRI vs. B and C TCD data). Graphs show different analysis approaches and different stimulus concentration (5 versus 7% 







Figure 5.5. Graphs showing CVR outcome measures for younger fit and unfit groups. Measures were calculated using different neuroimaging 
modalities (A. MRI vs. B and C TCD data). Graphs show different analysis approaches and different stimulus concentration (5 vs. 7% CO2). 







Figure 5.6. Graphs showing CVR outcome measures for older fit and older unfit groups. Measures were calculated using different 
neuroimaging modalities (A. MRI vs. B and C TCD data). Graphs show different analysis approaches and different stimulus concentration (5 






5.4.2. Aim 2: Effects of Imaging Modality and Analysis Approaches on the 
Cerebrovascular Responsiveness Outcome Measure 
Given that the differences in CVR observed between groups were inconsistent depending 
on the imaging modality used (e.g., MRI approaches showed higher CVR in the younger 
group whereas TCD approaches showed higher CVR in the older group), it is important to 
see if differences are observed across the whole group due to the imaging modality, 
stimulus concentration and analysis approach. Therefore, this section looked at differences 
between the imaging modality and analysis approach for all the participants as one group. 
 
Effect of imaging modality with typical analysis approach 
As expected MRI BOLD-derived CVR measures calculated using the linear regression 
significantly correlated with MRI BOLD-derived CVR measures calculated using a 
general linear model (GLM) as shown in Figure 5.7.  
 
Figure 5.7. Correlation between MRI linear regression CVR and MRI GLM CVR analyses 






Effects of imaging modality and analysis approach: 
For all participants, MRI GLM-derived CVR showed no correlation with TCD CVR 
measures calculated from the 5% CO2 stimulus or 7% CO2 stimulus using respective 
typical analysis approaches (relative TCD: 30-s steady state versus MRI: GLM, see Figure 
5.8A). However, MRI GLM CVR measures did correlate with absolute TCD CVR 




Figure 5.8. Correlation (Pearson’s r) of the CVR outcome measure between different 
modalities (MRI versus TCD using their typical analysis approaches: MRI GLM (BOLD) 
using the entire gas challenge and TCD using a 30-s steady state for the 5 and 7% CO2 gas 
challenges separately. A: shows relative TCD CVR values, and B: shows absolute TCD 
CVR values. Solid lines show lines of best fit.   
 
CVR measures obtained from the same modality but calculated using different analysis 
approaches correlated significantly in most cases (p < 0.05, Figure 5.9), except for the 
MRI data obtained during the 5% CO2 stimulus concentration (Figure 5.9). Specifically, 
MRI-derived CVR measures calculated using the MRI GLM approach did not correlate 
with CVR measures calculated using the TCD 30-s steady-state approach (r = 0.168; p = 
0.393) (Figure 5.9B). However, with the 7% CO2 challenges these CVR measures 








Figure 5.9. Correlations of the CVR outcome measure obtained from MRI and TCD 
modalities analysed using different analysis approaches. A and B show MRI BOLD data: 
A. MRI linear regression and TCD 30-s steady-state data analysis approaches; B. MRI 
GLM and TCD 30-s steady-state data analysis approaches. C and D show TCD MCAv 
data: C. MRI linear regression and TCD 30-s steady-state data (relative) analysis 
approaches. D. MRI linear regression and TCD 30-s steady-state data (absolute) analysis 
approaches. Lines of best fit are shown along with R values and associated p values 
(Pearson’s r).* p ≤ 0.05; ** p ≤ 0.01.
t 
Shows a trend towards significance: 0.05 < p ≤ 0.1. 
 
 
A repeated-measures ANOVA revealed significant effects of analysis approach on MRI 
CVR measures (linear regression vs. GLM vs. 30-s steady state) (p = 0.010) and TCD 
CVR measures (linear regression vs. 30-s relative steady state vs. 30-s absolute steady 






Figure 5.10. Graphs showing effects of stimulus concentration (5 vs 7% 
CO2) on CVR measures using different modalities and different analysis 
approaches over all participants. A. BOLD data; B. TCD (MCAv) data 
and C. TCD (CVCi) data. Analysis approaches: TCD approaches: 30-
seconds relative and absolute; MRI approaches: linear regression and 
general linear model (GLM). Complete lines show main effects of 
analysis approach shown by repeated-measures ANOVA; adjustment for 
multiple comparisons done via Bonferroni. Broken line shows stimulus 







Effects of stimulus concentration:  
CVR measures correlated significantly between stimulus concentrations in most cases 
when using measures (BOLD and MCAv) with typical analysis approaches from the 
corresponding modality (all p < 0.05; Table 5.4), except the relative CVCi-CVR measure 
(r = 0.214). However, they did not correlate when a TCD approach (30-s steady state) was 
used to calculate CVR from MRI BOLD data (r = 0.305). Although there were significant 
correlations between CVR measures from different stimulus concentrations, the magnitude 
of the CVR outcome value was significantly different for the TCD modality whereas the 
stimulus concentration had less effect on the CVR measure for the MRI modality (Table 
5.4, Figure 5.4).  
 
 
Table 5.4. Correlations and paired sample t test between 5% and 7% CO2 CVR measures 
from MRI and TCD data modalities calculated using typical analysis approaches. 
 




     
TCD 
data 
MRI: linear regression (MCAv) 28 0.579**  0.596 
 MRI: linear regression (CVCi) 28 0.596**  0.955 
 TCD: 30-s steady state (MCAv relative) 28 0.502* -5.08** 
 TCD: 30-s steady state (MCAv absolute) 28 0.828** -4.573** 
 TCD: 30-s steady state (CVCi relative) 28 0.214 -2.88* 
 TCD: 30-s steady state (CVCi absolute) 28 0.546** -2.33* 
MRI 
data 
MRI: linear regression 28 0.442* -1.84
t
 
 MRI: GLM 28 0.517**  1.15 
 TCD: 30-s steady state 28 0.305 -1.64 
Abbreviations: CVCi, cerebrovascular conductance; GLM, general linear model; MCAv, 
middle cerebral artery blood velocity; TCD, transcranial Doppler. 
* p ≤ 0.05; ** p ≤ 0.01.
t 








When comparing CVR outcome measures obtained from the 5% and 7% CO2 stimulus 
concentrations, paired t-tests showed no difference for measures calculated from the MRI 
data modality (all p > 0.05). However, when looking at data from the TCD modality, all 
measures calculated using typical TCD analysis approaches showed significant differences 
between stimulus concentrations (p < 0.05) (Figure 5.10, Table 5.4).  
 
Correlations between all data acquisition and analysis approaches on the CVR measures in 
the same participants are shown in Table 5.5. Generally, CVR measures were more likely 
to correlate if the same imaging modality had been used to acquire the data, regardless of 
the analysis approach used (Figure 10; Table 5.5, white blocks). Where CVR measures 
were correlated between different imaging modalities they were less likely to correlate 
(Table 5.5, orange block). As shown in Table 5.4 and Table 5.5, most CVR measures 
calculated using a 5% or 7% CO2 stimulus concentration correlated if the same imaging 
modality and analysis approach was used (Table 5.5, blue values). As shown in Figure 5.9, 
there were no correlations between CVRs calculated using TCD or MRI modalities with 








































Values represent Pearson’s r correlations. Significance (2-tailed): * p ≤ 0.05; ** p ≤ 0.01. t Shows a trend towards significance: 0.05 < p ≤ 0.1. Correlations in the orange block 
show CVR measures from TCD versus MRI data modality. Red numbers show correlations between TCD and MRI measures using typical analysis approaches. Blue numbers show 
correlations between 5 and 7% CO2 from the same modality and approach. Abbreviations: LR; linear regression (pre-processing), MCAv; middle cerebral artery blood velocity, 
CVCi, cerebrovascular conductance; BOLD, blood-oxygen-level dependent signal, GLM, general linear model (post-processing), GM, grey matter  
  TCD data (MCAv)          MRI data (BOLD)    































































































































































































age _                   
V̇O2 max -0.45*                   
LR MCAv 5% -0.08 _                  
LR MCAv 7%  0.10 0.58** _                 
LR CVCi 5% -0.12 0.56**  0.30 _                
LR CVCi 7% -0.33 0.71** 0.53**  0.59** _               
MCAv relative 5%  0.50** 0.40*  0.19  0.32 0.16  _              




  0.50** _             




  0.65**  0.43* _            




  0.35  0.68**  0.83** _           




  0.58**  0.36  0.63**  0.46* _          
CVCi relative 7% 0.06 0.26  0.25  0.21 0.19 -0.02  0.37 -0.01  0.20  0.21 _         
CVCi absolute 5% -0.07 0.27  0.35  0.38* 0.24  0.31  0.16  0.23  0.11  0.74** -0.02 _        




  0.01  0.45*  0.22  0.45*  0.37  0.48* 0.55** _       
LR BOLD 5% -0.41* 0.20 -0.25  0.30 0.29  0.01 -0.12  0.32  0.28  0.02 -0.17 -0.32 -0.24 _      
LR BOLD 7% -0.41* 0.21  0.18 -0.34 0.25  0.15 -0.07  0.10  0.18 -0.07 -0.18  0.03 -0.19 0.44* _     
GLM GM 5% -0.15 0.01  0.32 -0.01 -0.03  0.03  0.05 -0.09  0.01  0.17 -0.18  0.06 -0.14 0.22 0.47* _    
GLM GM 7% -0.28 0.27  0.22  0.16 0.29  0.16  0.30  0.28  0.41*  0.16 -0.09  0.02 -0.03 0.40* 0.56** 0.52** _   
30-secs 5% -0.38* 0.16 -0.25  0.34 0.24  0.09 -0.20  0.30  0.16  0.32 -0.30 -0.17 -0.15 0.89** 0.28 0.17 0.30 _  






The overall aim of this chapter was to determine whether differences in neuroimaging 
modality (i.e., MRI/ TCD) would influence the CVR outcome measure and its 
interpretation. To do this, associations between different measures of CVR within and 
between imaging modalities and different analysis approaches were examined (i.e., MRI: 
linear regressions and GLM for all GM and RoIs; and TCD: 30-s of steady-state data 
extracted for relative and absolute CVR measures and CVCi derived CVR) for groups of 
individuals where differences in CVR were expected. Specifically, group differences in 
CVR outcome measures for younger versus older and fit versus unfit individuals were 
compared and outcome measures were correlated with age and fitness. Collectively, these 
findings demonstrated that the imaging modality used (TCD versus MRI) as well as the 
stimulus concentration (5% versus 7% CO2) will significantly affect the calculated CVR 
outcome measure. The implications of these findings is that studies using different imaging 
modalities or different stimulus concentrations to determine the CVR measure cannot be 
easily compared to one another.  
 
These findings showed directional discrepancies between age groups when using different 
neuroimaging modalities (Figure 5.4). MRI-derived CVR measures were elevated in the 
younger group compared to the older group, in line with other research studies (Bailey et 
al., 2013; Guiney et al., 2015). However, TCD CVR measures were lower in the younger 
group compared to the older group. It may be that large-scale studies (for example, Bailey 
and colleagues study included 81 participants) are more likely to report higher mean CVR 
measures at the population level, while studies such as the present with smaller samples 
sizes are more susceptible to individual variability. Therefore, study sample size is another 





Participants with higher aerobic fitness showed a blunted response in CVR when measured 
with MRI (similar to Thomas et al., 2013). However, this was in the younger group and 
not the older group as found from Thomas and colleagues study looking at Masters 
Athletes (Thomas et al., 2013). The differences between fitness (V̇O2 max) between fit 
and unfit groups in the current study were not as large as reported in other studies. For 
example, participants in Bailey and colleagues (2013) study had a mean V̇O2 max score of 




 for the younger ‘trained’ and ‘sedentary’ groups, respectively 














 in the present study). Although the older group were more similarly defined, there 
were fewer of them (12 vs. 42 older participants in total). An important difference in this 
study is that ‘fit’ and ‘sedentary’ individuals were defined by reported lifetime physical 
activity levels (trained >150 minutes recreational aerobic activity per week versus 
sedentary, no activity) and V̇O2 max was calculated after group assignment. Further, sex 
differences may explain the unexpected CVR results given that females typically have 
higher resting CBF (see Chapter 4), and the present study recruited more males than 
females, and more of the fit group were male and the unfit group were female. However, 
this area of research has also reported conflicting findings where either males or females 
have been reported to have greater CVR depending on the modality used. For example, in 
an MRI study using BOLD, a 22% greater response to CO2 was reported in males 
compared to females (Kassner et al., 2010).  
 
No significant correlations between CVR outcome measures obtained using TCD and MRI 
modalities with their typical analysis approaches for all of the stimulus concentrations 





the 7% CO2 (r = 0.303) than the 5% CO2 (r = 0.033) stimulus. This higher correlation may 
be explained by an increased signal-to-noise ratio within the TCD modality when the 7% 
CO2 concentration is used, and may also be because the typical MRI analysis approach 
used the entire gas challenge whereas the typical TCD approach calculates CVR from one 
gas concentration.  
 
An important point to consider is that discrepancies between modalities may be explained 
by the technology targeting different areas of the vascular bed; i.e., TCD is imaging a 
precise location within the centre of the blood vessel (in this case the MCA) whereas MRI 
BOLD is imaging changes (global or regional) further down the vascular tree within 
micro-vessels. Larger vessels such as the MCA may also be more affected by changes in 
blood pressure compared to the cerebral capillaries. Given the known pressure effect of 
CO2 on MCAv (Battisti‐Charbonney et al., 2011), the differences seen between 5 and 7% 
with TCD but not MRI are likely explained by the targeted vasculature used to determine 
CVR.  Further, in this study, the CVR measures correlated better with the 7% CO2 
challenges. This could be because MRI signal changes are longer and will also drive GLM 
BOLD fits. 
 
Comparing typical analysis approaches within the same modality showed that typical 
conventional approaches were closely matched to the alternative modality (i.e., using 30-s 
steady state extracted data from the BOLD data and calculating CVR using a linear 
regression with the TCD data). Although significant differences were observed between 
calculated CVR when comparing analysis approaches and stimulus concentrations within 
the same modality (Figure 5.4), the measures did significantly correlate in most cases for a 





modality where TCD analysis approaches were used, indicating that most of the variability 
is removed when using this approach.  
 
It was also considered whether more variability in the MRI modality data could be 
explained by movement parameters. Analysis of motion parameter measures between age 
and fitness groups was performed to determine whether they were significantly different, 
and could have influenced the CVR measure calculated by MRI GLM. On visual 
observation, participants displayed more movement during the 7% than the 5% CO2 
stimulus concentration. However, no statistically significant differences in movement 
parameters between different age or fitness groups were observed, indicating that the 
increased variability in the MRI CVR measures is caused by other factors. Although 
movement was not recorded with TCD, due to the way TCD probes are secured to the head 
it could be argued that the TCD modality is less affected by movement artefacts. Certainly 
a more multifactorial approach in determining CVR that considers other physiological 
changes that occur in response to a stimulus may be beneficial and lead to less conflicting 
findings. 
 
Another explanation for conflicting findings in the literature and confusion around the 
CVR measure, as well as different methodological approaches, may be explained by a 
publication bias where studies that find no association between fitness (as determined by 
V̇O2 max) and CVR fail to be reported. Reasons for this could be that the lack of findings 
is explained by limitations within the study such as small sample sizes, rather than 
addressing the issue of the different methodological approaches being used leading to 





methodological approaches is required to examine variability observed in the CVR 
outcome measure.  
 
5.5.1. Limitations 
In this study the sample sizes became quite small after the age groups had further been 
divided into sub-groups of fit and unfit (8 younger fit and 8 unfit; 7 older fit and 5 unfit) 
compared with previously published studies (Ainslie et al., 2008; Bailey et al., 2013). The 
reason for this is that this study required a large amount of data to be collected on each 
participant due to the modality comparison limiting the total number of participants that 
could be recruited and data acquired from in the time frame available. Another 
consideration is the use of maximal oxygen consumption as a measure of fitness and how 
motivation may influence this measure. Particularly in individuals who exercise less, they 
may be less motivated or less physiologically aware of their bodies, so despite receiving 
the same verbal encouragement, may be less likely to reach their V̇O2 max. One way to 
address this issue is to use other methods of assessing fitness such as questionnaires (see 
Chapter 6, Section 6.2.2, where the New Zealand physical activity readiness questionnaire 
(NZPARQ) is discussed in more detail). However, the issue with these was that the age 
groups differed in the method of interpreting the questionnaire (i.e., 7-day activity 
frequency, self-rated activity rating, or activity category), such that fitness effects were not 
consistent across different methods of calculating fitness. Another approach may be to 
assess participant motivation at performing well in the fitness test with a questionnaire, 
similar to the Situational Motivational Scale (SIMS) (Guay et al., 2000), though this would 






5.5.2. Perspectives and Significance 
In addition to setting out gold-standard guidelines to determine CVR, a clearer 
understanding around what the different methodological approaches are revealing about 
cerebrovascular health is required, and more descriptive terminology needed to describe 
what, where and how CVR is being measured. The currently used term ‘CVR’ for 
‘cerebrovascular reactivity’ (also described as ‘CBF-CO2 responsiveness’) to describe this 
outcome measure fails to recognise its complexity and what it means in the context of 
health and disease. It may be that certain blood vessels (i.e., macro versus micro) and 
locations within the vascular tree will be more relevant for certain disease pathologies and 
stages of disease progression. This will therefore determine the most appropriate modality 
to use (i.e., MRI BOLD or TCD MCAv) on an individual basis.  
 
5.5.3. Conclusion and Recommendations 
The findings in this chapter support recent literature reporting conflicting interpretations of 
CVR in healthy ageing, fitness and neurodegenerative conditions, making the fidelity of 
this biomarker problematic. This study demonstrated that discrepancies arise from the 
range of image acquisition and analysis approaches used to determine CVR, making 
direct comparison questionable. A validated ‘gold standard’ test across imaging modalities 
is needed. Internationally, few research groups can directly compare CVR across 
imaging modalities, due to limited access and/or expertise. Our findings showed no 
significant correlation in the standard CVR measures across modalities (TCD MCAv-
derived measures and MRI BOLD-derived measures), raising the question of why this 
arises given the two techniques are theorised to provide similar measures of brain vascular 
function. We hypothesize this is due to over-simplistic standard literature methods 





techniques (e.g., GLM using all data collected in MRI-BOLD analysis versus using a 
small subset of the data collected (30-60s once a steady state is reached compared with a 
short baseline measure) and calculating a fractional change in these data in TCD analysis). 
This hypothesis needs to be tested with advanced imaging and analysis techniques on 
larger cohorts with intermediatory measures taken such as CBF measures using MRI phase 
contrast (PC) angiography analysis (Stoquart-ElSankari et al., 2009; Verbree et al., 2014) 
and Duplex Doppler ultrasound (Willie et al., 2014), where vessel diameter and movement 






6. COGNITIVE PERFORMANCE AND QUALITY OF LIFE 
6.1. Abstract  
Background: The incidence of dementia and age-related neurodegenerative disease is 
increasing in line with an ageing and increasingly sedentary population. Recent studies 
have shown that physical activity benefits the brain and can protect against factors 
associated with neurodegeneration. Dementia and natural ageing are associated with 
impaired performance on cognitive tasks that rely on the prefrontal cortex (e.g., attention 
switching task (AST) and mental arithmetic). Further, neurodegenerative conditions 
drastically impair quality of life (QoL) and well-being. This study investigated the effects 
of age and aerobic fitness on brain health outcome measures including tasks assessing 
cognitive performance and questionnaires assessing quality of life (QoL).  
Methods: During separate visits, thirty-six healthy volunteers (nineteen younger: 25±7 
yrs, seventeen older: 67±7 yrs) completed an aerobic fitness test, cognitive tasks (three pen 
and paper tasks, five tablet-based tasks using Cambridge Cognition CANTAB software, 
and a mental arithmetic task), two quality of life questionnaires and the PASAT mental 
arithmetic task. ANOVAs and correlations were used to examine the effects of age and 
fitness. The cognitive tasks included: attention switching, paired associated learning, 
working memory, mental arithmetic, digit-decoding and verbal fluency. 
Results: Cognitive performance was lower in the older group compared to the younger 
group in attention switching (by 18%), learning (by 65%) and spatial working memory (by 
56%), whereas QoL was higher. In the older group, attention switching, and mental 
arithmetic were significantly higher in the fit group versus the unfit group (p<0.05). 
Aerobic fitness significantly correlated with overall QoL and psychological subscale 





Conclusions: Age-related decline in attention switching was offset by physical fitness. 
Higher physical fitness also improved mental arithmetic in older participants. Further, 
physical fitness may significantly improve well-being and quality of life across ages. 
Taken together, findings lend further support to the evidence that physical activity may be 
protective against neurodegenerative disease. 
 
 
6.2. Introduction  
The incidence of dementia and age-related neurocognitive disorders is increasing in line 
with an ageing and increasingly sedentary population (Deary et al., 2009). Therefore, 
effective prevention and treatment strategies are desperately needed, as well as reliable 
tools to measure brain health. Brain health outcome measures include several different 
disciplinary approaches that are associated with neurocognitive disorders. These include, 
though are not limited to: measures of cerebrovascular health (e.g., resting cerebral blood 
flow (CBF), and functional cerebrovascular reactivity (CVR) to carbon dioxide); reviewed 
in Chapter 2 and investigated in Chapters 3-5), measures of cognitive function determined 
by performance in tasks that target specific domains (e.g., attention, mental arithmetic, 
memory, learning, verbal fluency and decoding), and measures of quality of life and well-
being, often determined via questionnaire responses (including overall health scores as 
well scores in sub-domains focusing on psychological, physical, emotional, social and 
environmental aspects of a person’s well-being). However, studies seldom combine these 
measures to assess brain health to determine possible associations between cognitive 






Cognition encompasses a range of higher executive brain functions that, when working 
optimally, are considered to enable humans to perform at their best in professional and 
personal endeavours. Examples of these higher cognitive abilities include: the ability to 
switch attention between tasks; retain information in short-term memory; make effective 
use of strategy, and fast and effective learning. Performance in these tasks is known to 
naturally decline during healthy ageing and impairment is associated with neurological and 
psychiatric conditions including dementia, stroke and depression (see Voss et al., 2011).  
Thus, tasks like these can be used as important outcome measures to reveal possible 
therapeutic effects of targeted interventions and have also been used to pre-screen 
individuals for early Alzheimer’s disease in clinical trials (Barnett et al., 2016; Nathan et 
al., 2017).  
 
Aerobic fitness has been associated with improved cognition in several cross-sectional and 
intervention studies in humans and animals (Kramer et al., 1999; Vaughan et al., 2014; 
Barcelos et al., 2015). Further, interventions involving physical and cognitive activity 
(e.g., motor tasks requiring sustained attention and concentration) have been investigated 
in humans and revealed improvements in cognition (Vaughan et al., 2014; Barcelos et al., 
2015).  In Vaughan and colleague’s randomised controlled trial they investigated the 
effects of a 16-week multimodal exercise programme that included cardiovascular, 
strength conditioning and motor fitness training. This study was performed in older 
women and they found improvements in cognition, including: working memory; 
inhibition; shifting; verbal fluency, and reaction times. This was in addition to 
improvements in physical function measured by a six-minute walk test and timed up and 
go. Similarly, Barcelos and colleagues (2015) examined a combination of stressors by 





varying loads (virtual bike tour and video gaming). They found that everyday function 
improved in both conditions, though those in the high cognitive demand group performed 
better than those in the low cognitive demand condition; providing support to further 
‘stressing’ the system by using multiple approaches and the additive benefits that can 
occur in a dose-dependent manner. Such findings are consistent with observations from 
cross-sectional studies (Eskes et al., 2010), where the diversity of cognitively stimulating 
activities was an independent predictor of cognitive function in older (female) adults, and 
that there was an additive effect on neuropsychological performance with the combination 
of fitness, cerebrovascular reserve and cognitive stimulation. Research should further 
explore the underlying mechanisms driving these adaptations with additional cognitive 
loading, as well as focusing on specific brain areas affected through neurodegenerative 
disease.  
 
The beneficial role of exercise for brain health in clinical populations and older adults has 
been demonstrated in numerous studies. For example, physically active dementia patients 
may deteriorate at a slower rate than their sedentary counterparts (Buchner et al., 2007; 
Zschucke et al., 2013). Grey matter hippocampal volume and performance on memory 
tasks has also been positively correlated with physical exercise in healthy adult human 
populations and those at risk for dementia (Erickson et al., 2011; Killgore et al., 2013). 
While such findings indicate that exercise improves markers of brain health (e.g., brain 
volume and memory performance), many tend to use self-report questionnaires to assess 
levels of exercise. These may be less reliable than quantitative measures such as a maximal 






Quality of life (QoL) and well-being outcome measures also reveal important information 
about the subjective experience of individuals in the face of debilitating conditions. The 
measurement of health-related quality of life for people with dementia (DEMQOL) is a 
quality of life questionnaire carefully adapted specifically for dementia patients (Smith et 
al., 2007). The questionnaire considers language and mental capacity barriers elicited by 
the disease, and has a reported reliability coefficient of 0.82 (Whitaker et al., 2014). A 
randomised controlled trial using this measure has shown improvements in well-being in 
dementia patients in care homes following non-pharmacological interventions that 
included exercise (Ballard et al., 2016). In populations like these, performance in cognitive 
tasks may no longer be considered a primary outcome measure since cognitive impairment 
is so severe and rapidly deteriorating. Alternatively, the subjective well-being of these 
patients is arguably far more important, where tests of cognition are likely to miss 
important factors (Banerjee et al., 2006).  
 
Similar questionnaires have also been used in the general population, including the World 
Health Organisation Quality of Life (WHOQOL) questionnaire (WHOQOL group, 1998) 
and RAND-36 (Hays et al., 1993), which have been shown to have excellent psychometric 
properties of reliability and perform well in tests of validity (Skevington et al., 2004; 
Vlander Zee et al., 1996). The literature reports mixed findings on the effects of healthy 
ageing on such QoL measures, where some studies report QoL decreases with ageing 
(Demura et al., 2003) and this is further exacerbated by sex where depression increases 
more in older-old (>74 years) females compared to males. In contrast, other studies have 
reported that older respondents display lower levels of negative affect than their young-old 
counterparts (Mroczek et al., 1998), indicating there is an improvement in well-being 





clinical deterioration that will be associated with reduced QoL revealed by the DEMQOL, 
though has been shown to be offset by physical activity (Ballard et al., 2016). Further, in 
healthy populations, physical activity levels have been associated with improved well-
being in younger (Hinkley et al., 2014) and older (meta-analysis of 36 studies) healthy 
individuals (Netz et al., 2005). 
 
In summary, a wealth of evidence has emerged in support of the effects of physical activity 
and improved cardiorespiratory fitness on brain health outcome measures relating to 
cognition and QoL. Interventions involving physical activity have been shown to improve 
such measures in healthy and clinical populations (Gillison et al., 2009), though the 
underlying mechanisms are poorly understood (Lucas et al., 2015). Further, little research 
has been done investigating a combination of brain health outcome measures including 
cognitive function and QoL in the same individuals; or considered how they may differ 
between significantly different age groups (some of the findings in the studies discussed 
compare ‘young-old’ with ‘old-old’ rather than two samples with a larger age-gap) with 
significantly different levels of fitness determined using both quantitative and qualitative 
measures (i.e., with V̇O2 max test and a physical activity questionnaire). 
 
6.2.1. Study Aims and Hypotheses 
Therefore, the overall aims of this cross-sectional study were to examine whether 
differences in brain health measures, including several measures of cognitive function and 
QoL, will be observed in healthy younger and older individuals with varying levels of 
physical fitness (determined by V̇O2 max and the New Zealand physical activity readiness 
questionnaire (NZPARQ)). These outcome measures included: cognitive function 





provide evidence that physical activity can be a first-call consideration that is beneficial 
and neuroprotective to individuals across the lifespan, and may help protect against 
neurodegenerative conditions.  
 
It was hypothesised that the brain health outcome measures would differ between younger 
and older groups, such that measures of cognitive performance would decline with age in 
line with existing research, and measures of QoL would be different between age groups. 
However, the directionality of QoL measures hypothesis was 2-tailed due to the 
discrepancies in the existing scientific evidence. In addition, it was hypothesised that 
differences between fitness groups would be observed in our brain health outcome 
measures, such that both cognitive and QoL outcome measures would improve with 
increased aerobic fitness (as determined by V̇O2 max and/ or NZPARQ).  
 
 
6.3. Materials and Methods 
Thirty-six healthy volunteers in two age groups participated, 19 younger participants (age, 
25 ± 7 years) and 17 older participants (age, 67 ± 7 years). The age groups were further 
divided into fit and unfit groups, determined by performance on a maximal aerobic (i.e., 


















). Ethical approval was obtained for all experimental protocols and procedures by 
the University of Birmingham Ethics Committee and the study conformed to the 
Declaration of Helsinki (ethics code: ERN_14-1423). Participant visits took place at the 





Prior to participation, a detailed verbal and written explanation of the study was provided, 
and written informed consent to participation was obtained.  
 
In summary (described in more detail below), during separate visits, participants 
completed: 1) an electrocardiogram (ECG) and general health screening; 2) aerobic fitness 
assessment (including self-reported frequencies and a maximal oxygen uptake assessment 
(V̇O2 max)); 3) familiarisation in cerebrovascular measures; 4) collection of 
cerebrovascular measures (data presented in Chapters 4 and 5); 5) cognitive outcome 
measures (including 3 pen and paper tasks and  5 tablet-based tasks), 6) a mental 
arithmetic task, and 7) two QoL questionnaires. Prior to all testing visits, participants were 
asked to abstain from heavy physical exercise and alcohol for 24 hours. For all visits, 
participants were asked to avoid vigorous exercise and alcohol 24 hours prior to study 
participation, caffeine for 12 hours and heavy meals for 4 hours prior. 
 
6.2.1. Electrocardiogram (ECG) and General Health Screening 
All participants underwent a pre-exercise evaluation prior to the exercise testing and 
completed a general health questionnaire. Participants over fifty years of age also 
completed a resting 12-lead electrocardiogram (ECG) assessment and a resting blood 
pressure measurement, which was reviewed by a cardiologist. Participants who revealed a 
contraindication to non-medically supervised exercise testing in the general health 
questionnaire (e.g., family history of heart attack), had high resting blood pressure 
(systolic >160, diastolic >90), or showed ECG abnormalities (e.g., S-T suppression, 
multiple ectopic beats in a row (i.e., >3)) were excluded from the aerobic fitness testing 





6.2.2. Aerobic Fitness Assessment 
Measures of aerobic fitness included maximal oxygen consumption (V̇O2 max) and 
measures scored from the New Zealand Physical Activity and Readiness Questionnaire 
(NZPARQ). This particular questionnaire was chosen as previous research identified 
associations between the NZPARQ and CBF-CO2 responsiveness measures (Guiney et al., 
2014). After screening and inclusion into the study all participants completed a maximal 
aerobic fitness test to determine V̇O2 max (procedure described in Chapter 4, section 
4.3.3).  
 
Three measures of activity were scored from the NZPARQ completed by participants, 
these were: 1) last 7-days frequency of activity (0-7 days); 2) self-rated activity category 
(1-5; 1 being the least active to 5 being the most active), and 3) activity category (1-3; 
assessed by adding together participant responses to frequency of mild, moderate and 
intense activity; category 1 being the least active and category 3 being the most active). 
 
6.2.3. Cognitive Performance Outcome Measures  
Firstly, participants completed three pen and paper tasks administered by the PhD 
candidate. These included the Hopkins verbal learning task (HVLT; Brandt 1991), the 
verbal fluency task and a digit decoding task. These tests were selected due to previously 
established associations between performance scores and age-related conditions including 
dementia (Hogervorst 2014).  The HVLT was scored by counting the total number of 
recalled items across the three trials with a total possible score of 36. Verbal fluency was 





seconds. Digit-coding was scored by counting how many numbers participants could 
successfully draw the corresponding code for in 90 seconds.  
 
Secondly, participants completed a mental arithmetic task under stressful conditions using 
the paced auditory serial addition task (PASAT), where the total number of correct 
responses was calculated. Stress was induced by a combination of factors that were 
initiated in the same way across participants. These included: the paced serial addition 
increasing in speed during the duration of the task; the sound of a buzzer indicating an 
incorrect answer or too much hesitation; the PhD candidate explaining that they were 
competing against other participants in the study and their results would be displayed in 
tables; participants being required to watch themselves on a TV screen throughout whilst 
being recorded, and the PhD candidate explaining to them that their body language would 
be assessed by two independent body language experts. Throughout the task heart rate, 
blood pressure and ECG were continuously measured. A 4-minute resting baseline 
preceded the 4-minute mental arithmetic task, which was then followed by a 4-minute 
recovery period. 
 
Finally, participants completed five tablet-based cognitive tasks on the CANTAB® 
Cognitive assessment software (Cambridge Cognition, UK). Tasks were administered in 
the same order across participants in a quiet laboratory room where they were not 
disturbed. Completion of the tasks took approximately 30-40 minutes. The tests included: 
reaction time (RTI); attention switching task (AST), paired associates learning (PAL), 






Figure 6.1. Examples of each of the CANTAB tasks. A. Reaction time (RTI); B. Attention 
switching task (AST); C. Spatial working memory task (SWM), and D. Paired associates 
learning (PAL) task. 
 
 
The RTI, AST, SWM and PAL have been associated with ageing and neurodegenerative 
disease in several studies (Barnett 2016; Nathan 2017) and form part of the CANTAB 
Connect cognitive assessment for Alzheimer’s clinical trials. The main outcome measures 
for the CANTAB tasks involved assessing the number of correct and incorrect responses 
and reaction latencies (in ms) in several conditions.  
 
During the RTI, participants were required to respond as quickly as possible by moving the 
finger from a starting position, to a circle that would appear at the top of the screen, and 





responses and reaction times (i.e., latency) during several conditions including: mean 
simple reaction time (time taken from the onset of the circle to the participant pressing on 
the circle) and mean simple movement time (time taken from when the participant’s finger 
left the starting position to touching the circle) for trials where the stimulus would appear 
in one location only and in trials where the stimulus could appear in one of five locations 
(five-choice reaction/movement time).  
 
The AST involved responding as quickly as possible to stimuli on the screen whilst 
ignoring conflicting information. Conditions included: congruent, incongruent, non-
attention switching, attention switching, and responding to either the side or direction of 
stimuli whilst ignoring irrelevant stimulus information (i.e., a distractor). As with the RTI, 
outcome measures included number of correct responses and reaction times/latency. The 
main outcome measures from the AST included in the analysis for this study were: total 
correct (TC); total incorrect (TI); mean reaction latency during congruent trials (RLC); 
mean reaction latency during incongruent trails (RLI); congruent errors (CE); incongruent 
errors (IE); congruency cost (CC); omission errors (OE); commission errors (CE); mean 
reaction latency (RL); mean reaction latency from non-switching trials (RLN), and mean 
reaction latency from switching trials (RLS).  
 
Outcome measures relating to attention switching between side and direction included: 
total side errors (SE); mean side reaction latency (SRL); total direction errors (DE), and 
mean direction reaction latency (DRL). The CANTAB software also calculated 
congruency cost and switching cost using algorithms. The congruency cost algorithm 
calculated the difference between the mean reaction time of a response (from stimulus 





incongruent. This was calculated by subtracting the mean congruent latency from the mean 
incongruent latency. Values close to zero indicate less variation in reaction times across 
congruent and incongruent trials. A positive value indicates that the participant is faster on 
congruent trials and a negative score indicates that the participant is faster on incongruent 
trials. The switching cost algorithm calculated the difference between the mean reaction 
time (from stimulus appearance to button press) during assessed blocks where the rule is 
switching, versus assessed blocks in which the rule remains constant. This was calculated 
by subtracting the mean latency of response during non-switching block from the mean 
latency of response during switching blocks. Values close to zero indicated less variation 
in latencies across non-switch and switch trials. A positive score indicated that the 
participant responded more quickly in non-switching blocks. 
 
The SWM task began with a number of coloured squares that represented boxes. The 
participant needed to find a yellow token in each of a number of boxes and use them to fill 
up the empty column on the right-hand side of the screen by selecting the boxes and using 
a process of elimination. The number of boxes increased to make the task more difficult 
until the participant failed a level. The colour and position of the boxes used were changed 
from trial to trial to discourage the use of stereotyped search strategies. The main outcome 
measures for the SWM were working memory defined by the number of errors, and higher 
executive function defined by use of strategy. Use of strategy refers to where participants 
used distinct boxes to begin a new search, rather than returning to a previously opened box 
where they had already seen the contents.  
 
The PAL task involved boxes that were displayed on the screen and opened by the 





were then displayed in the middle of the screen, one at a time and the participant had to 
select the box in which the pattern was originally located. If the participant made an error, 
the boxes were all opened in sequence to remind the participant of the locations of the 
patterns. The outcome measures for the PAL task were the total adjusted errors calculated 
by the number of times the participant chose the incorrect box for a stimulus on assessment 
problems, but with an adjustment for the estimated number of errors they would have 
made on any problems, attempts and recalls they did not reach due to failing the test. Other 
measures included in this analysis were: the first attempt memory score; the total number 
of patterns reached, and the total number of errors before adjustment. 
 
6.2.4. Quality of Life Outcome Measures 
Quality of life was assessed using two questionnaires; the World Health Organisation 
Quality of Life (WHOQOL) questionnaire and the Research and Development 36-item 
short form survey instrument (RAND36). Participants completed the questionnaires in the 
same order in a quiet room with no interruptions. Prior to completing the questionnaires, 
the PhD candidate explained that all answers were anonymous, confidential, and that they 
did not have to answer anything they were not comfortable with. All participants 
completed both questionnaires in their entirety. Outcome measures included overall health 
scores and sub-scores focusing on specific domains (e.g., physical, psychological, social, 
etc.) for each of the questionnaires. 
 
6.2.5. Statistical Analysis 
T-tests were used to compare participant characteristics between groups. All mean 





fit/ unfit groups, and older fit and unfit groups and compared using one-way between 
subjects ANOVAs. Outcome measures were also correlated (Pearson’s r) against age and 
across the whole group, while fitness was correlated against the outcome measures 
separately for the younger group and the older group. All data were analysed using SPSS 
statistical software (SPSS version 17.0, SPSS Inc., Chicago, IL). Statistical significance 
was established at a level of 0.05, and data are expressed as means (± standard deviation). 




Thirty-five participants completed the QoL questionnaire. Thirty-three participants 
completed the cognitive tasks, though three had to be repeated on a separate session due to 
software errors. Two participants did not complete the cognitive tasks due to availability. 
Thirty-one participants completed the mental arithmetic task (see Table 6.1 for participant 
characteristics).  
 
6.4.1. Participant Characteristics and Fitness Assessment 
Participant characteristics are summarised in Table 6.1. By design, there was a significant 
difference in age between the younger and older group, while fitness (determined by V̇O2 
max) and resting blood pressure were higher and lower, respectively, in the younger 
compared to the older group. There was also a strong negative correlation between V̇O2 
max and age (Figure 6.2), indicating that V̇O2 max declined with age. There were no 






In the younger participants, V̇O2 max was higher, resting heart rate lower, and NZPARQ 
self-rated activity rating and activity category higher in the younger fit group compared to 
the unfit group. There were no differences between age, BMI, blood pressure or NZPARQ 
7-day activity frequency between the fit and unfit younger groups. In the older 
participants, V̇O2 max was higher, resting heart rate lower, and NZPARQ 7-day activity 
frequency higher in the older fit group compared to the unfit group. There were no 
differences between age, BMI, blood pressure, NZPARQ self-rated activity rating or 
activity category between fit and unfit older groups.  
 
Figure 6.2. Correlation between age and physical fitness (V̇O2 max). Data illustrate that 





Table 6.1. Characteristics of study participants. 
 
 All participants By age groups  By age and fitness groups 
 n = 35 Younger n= 19 Older n= 16 Younger fit n= 9 Younger unfit n = 10 Older fit n = 9 Older unfit n = 7 
Age 43.9 ± 22.4 24.6 ± 7.0 66.9 ± 6.7** 27.7 ± 7.6 21.9 ± 5.3 64.2 ± 6.8 70.3 ± 5.1 
Sex ratio (male: female) 22:13 12:7 10:6 8:1 4:6 8:1 2:5 
Body mass index (kg·m2) 23.6 ± 2.7 22.7 ± 2.3 24.8 ± 2.8 23.4 ± 2.3 22.0 ± 2.2 23.7 ± 1.3 25.7 ± 3.5 
V̇O2 max relative (mL·kg-1·min-
1) 
38.7 ±14.3 44.5 ± 9.8 32.1 ± 15.9* 53.8 ± 5.5 37.0 ± 4.5†† 42.3 ± 13.4 19.0 ± 6.3†† 
Resting systolic BP (mm Hg)  120 ± 16 111 ± 12 130 ± 14** 115.0 ± 8.8 107.0 ± 13.9  128.6 ± 10.3 132.8 ± 17.9 
Resting diastolic BP (mm Hg) 71 ± 9 67 ± 9 76 ± 7* 69 ± 10 66 ± 7 78 ± 4 73 ± 8 
Resting heart rate (b·min-1) 59 ± 10 64 ± 10 56 ± 6 55 ± 8 68 ± 9
† 52 ± 6 61 ± 3 † 
PARQ_7 days activity freq. 5.0 ± 2.0 5.1 ± 2.0 4.9 ± 2.0 6 ± 2 4.2 ± 2.1 6.0 ± 1.4 3.4 ± 1.8†  
PARQ_Self activity rating (1-5) 4.6 ± 0.9 4.5 ± 1.0 4.8 ± 0.6 5.0 ± 0.0 1.2 ± 0.4† 5.0 ± 0.0 4.4 ± 0.9 
PARQ_Activity category (1-3) 2.5 ± 0.7 2.7 ± 0.7 2.5 ± 0.7 3.0 ± 0.0 2.3 ± 0.9† 2.6 ± 0.5 1.8 ± 0.8 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (60-80 years). Fitness groups were defined as: younger fit 

















). Abbreviations: V̇O2 max, maximal oxygen consumption; NZPARQ, New Zealand Physical Activity Readiness Questionnaire. 
* Significant AGE effect (different from younger group): * p ≤ 0.01; ** p ≤ 0.001. 





6.4.2. Cognition Outcome Measures  
6.4.2.1. Hopkins Verbal Learning Task, Verbal Fluency, Digit-Coding and Mental 
Arithmetic  
No significant age or fitness effects were observed using the HVLT (p = 0.878 and p = 
0.785, respectively), verbal fluency (p = 0.766 and p = 0.801, respectively) or digit-coding 
tasks (p = 0.702 and p = 0.316, respectively). In the mental arithmetic task, ANOVA post-
hoc analysis revealed a main effect of fitness on the number of correct responses in the 











Figure 6.3. Number of correct responses in a mental arithmetic task for younger (18-40) 










younger and older, respectively) groups. † Significant FITNESS effect (different from fit 
group): † p ≤ 0.01; †† p ≤ 0.001. 
 
6.4.2.2. Reaction Time (RTI) 
The following results were found from the CANTAB reaction time task (see Tables 6.2 
and 6.3). Simple reaction time (mean duration between the onset of the stimulus and the 





location only) was not different between age (p = 0.364) or fitness (younger group: p = 
0.455 and older group: p = 0.519) groups. However, there was a significant effect of age (p 
< 0.01) but not fitness (younger group: p = 0.819 and older group: p = 0.522) on the 
simple movement time (mean time taken to touch the stimulus after the button has been 
released). Similarly, there was a significant effect of age (p < 0.001) but not fitness 
(younger group: p = 0.841 and older group: p = 0.694) on the five-choice movement time 
(when the stimulus could appear in one of five locations), while five-choice reaction time 
was not different between age and fitness groups (age: p = 0.387; fitness: younger, p = 
0.157 and older, p = 0.811). In addition, correlational analysis demonstrated strong 
associations between age and RTI performance (see Table 6.3), where age was 
significantly positively associated with reaction time for both the simple movement (r = 
0.454) and 5-choice movement (r = 0.577) RTs. No associations were observed for simple 
RT (r = 0.188) or 5-choice RT (r = 0.201). No fitness effects were observed for any of the 
RTI measures.    
 
6.4.2.3. Attention Switching Task (AST)  
AST outcome measures are summarised in Tables 6.4 and 6.5. Consistent with the RTI 
findings noted above, reaction times for the non-switching and switching trials, and 
congruent and incongruent trials of the AST were all slower in the older group (all p < 
0.05, see Figure 6.4, Panel A). Overall, the number and type (e.g., side, congruency) of 
errors were higher in the younger group compared to the older group, although statistical 
significance was only reached for the difference in error rate for the non-switching block 
trials (p = 0.027, Table 6.3). The exception to this age-effect pattern was the larger number 
of omission errors in the older group (p = 0.018 vs. younger). Switching cost and 





showing less variation in responses between congruent and incongruent trials, and 
switching and non-switching trials. In addition, correlational analysis demonstrated 
moderate-to-strong associations between age and AST performance (see Table 6.5), where 
age was negatively associated with number of errors obtained (r: -0.235 to -0.443), and 
positively associated with longer reaction times (r: 0.314 to 0.601). 
 
In the older group, the higher fitness group had faster reaction times for all AST outcome 
measures; although the threshold for significance was not reached on 3 of the 9 measures 
(see Table 6.4 and Figure 6.4, Panel B). In contrast, fitness status did not affect AST 
reaction time performance in the younger group. In addition, fitness status did not alter the 
number of correct or incorrect responses, nor the congruency/switching costs in either age 






Figure 6.4. Attention switching task (AST) outcome measures showing mean (±SD) 
reaction time (ms) during non-switching and switching trials, and congruent and 
incongruent trials. A. shows younger and older groups. B. shows older fit and unfit groups. 
Significant age/fitness effects: * p ≤ 0.05; ** p ≤ 0.01. 
t 
Shows a trend towards 





Table 6.2. Mean ± standard deviation in performance scores on reaction time cognitive task (RTI) outcome measures. Scores are shown for 
all participants followed by groups: younger/ older groups; younger fit/ unfit, and older fit/ unfit.  
 All participants By age groups  By age and fitness groups 
  





Younger fit  
n= 9 
Younger unfit  
n = 10 
Older fit  
n = 9 
Older unfit  
n = 7 
Simple RT (ms) 353.9 ± 39.7 348.0 ± 40.5 360.8 ± 39.0 367.8 ± 45.4 336.8 ± 18.2 375.8 ± 36.8 343.8 ± 36.6 
Simple Movement RT (ms) 197.1 ± 59.7 172.1 ± 41.3 227.0 ± 65.7* 162.4 ± 37.1 189.9 ± 47.9 221.2 ± 62.2 233.9 ± 73.9 
5 choice RT (ms) 401.8 ± 42.6 395.9 ± 46.7 408.9 ± 36.2 415.5 ± 55.6 382.5 ± 19.3 406.7 ± 42.5 411.4 ± 30.7 
5 choice Movement RT (ms) 218.0 ± 65.6 183.5 ± 33.8 259.4 ± 71.4** 191.2 ± 29.8 188.0 ± 33.0 252.3 ± 67.6 267.6 ± 80.0 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (50-80 years). Higher values are slower reaction times (ms). 
* Significant age/fitness effects (different from younger group/ different from fit group): * p ≤ 0.05; ** p ≤ 0.01. 
t Shows a trend towards significance: 0.05 < p ≤ 0.1. 
 
Table 6.3. Correlations (Pearson’s r) with reaction time cognitive task (RTI) outcome measures and age, followed by fitness (V̇O2 max) for 
the younger group, followed by fitness for the older group. 
 All participants 
(n=33) 
Younger (n=19) Older (n=16) 
 Age Fitness: V̇O2 max Fitness: V̇O2 max 
Measure r  r r 
Simple RT 0.188 -0.217 -0.197 
Simple Movement RT 0.454**  0.067  0.196 
5-choice RT 0.201 -0.216  0.110 
5-choice Movement RT 0.577** -0.291  0.087 
Values represent Pearson’s r correlations. * Significant age/fitness effects:  










Table 6.4. Mean ± standard deviation in performance scores on the attention switching cognitive task (AST) outcome measures. Scores are 
shown for all participants followed by groups: younger/ older groups; younger fit/ unfit; and older fit/ older unfit.  
 All participants By age groups  By age and fitness groups 
 n = 33 Younger n= 19 Older n= 16 Younger fit n= 9 Younger unfit n = 
10 
Older fit n = 9 Older unfit n = 7 
Total correct  152.9 ± 7.3 151.8 ± 7.9 154.3 ± 6.5 151.8 ± 8.3 151.8 ± 7.9 154.0 ± 7.9 154.6 ± 5.3 
Total incorrect  6.2 ± 6.9 7.9 ± 7.6 4.2 ± 5.4 7.8 ± 7.7 8.1 ± 8.0 5.0 ± 6.9 3.3 ± 3.0 
Switching block errors 4.4 ± 5.5 5.2 ± 5.6 3.3 ± 5.4 5.1 ± 5.3 5.3 ± 6.3 4.4 ± 7.2 2.1 ± 2.2 
Non-switching block errors 1.9 ± 2.4 2.7 ± 2.9 0.9 ± 1.1* 2.7 ± 2.9 2.8 ± 3.1 0.6 ± 0.9 1.1 ± 1.2 
Side block errors  0.5 ± 1.3 0.8 ± 1.6 0.1 ± 0.3
t
 0.9 ± 2.0 0.8 ± 1.3 0.1 ± 0.4 0.0 ± 0.0 
Direction block errors 1.4 ± 1.9 1.9 ± 2.3 0.8 ± 1.1 1.8 ± 2.5 2.0 ± 2.3 0.5 ± 0.9 1.1 ± 1.2 
Congruent errors  0.9 ± 1.6 1.4 ± 2.1 0.4 ± 0.5
t
 1.4 ± 1.7 1.3 ± 2.6 0.5 ± 0.5 0.3 ± 0.5 
Incongruent errors 5.3 ± 5.9 6.6 ± 6.3 3.8 ± 5.2 6.3 ± 6.5 6.8 ± 6.4 4.5 ± 6.7 3.0 ± 3.1 
Side errors  2.5 ± 3.4 3.3 ± 4.3 1.4 ± 1.7 3.1 ± 4.4 3.6 ± 4.3 1.3 ± 1.7 1.6 ± 1.9 
Direction errors  3.8 ± 4.2 4.6 ± 4.3 2.8 ± 4.1 4.7 ± 4.3 4.6 ± 4.5 3.8 ± 5.4 1.7 ± 1.6 
Omission errors  0.8 ± 1.5 0.3 ± 0.6 1.5 ± 1.9* 0.4 ± 0.7 0.1 ± 0.3 0.9 ± 1.2 2.1 ± 2.5 
Commission errors  0.0 ± 0.2 0.0 ± 0.0 0.1 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.4 0.0 ± 0.0 
Mean reaction time (RT)(ms)  704.7 ± 136.6 644.2 ± 116.1 777.3 ± 126.1** 650.0 ± 147.6 638.3 ± 82.5 715.0 ± 63.0 848.6 ± 146.2* 
Switching RT (ms)  842.1 ± 181.5 758.2 ±161.3 942.7 ± 154.3** 760.7 ± 212.0 755.7 ± 101.5 862.2 ± 88.2 1034.7 ± 167.3* 
Non-switching RT (ms)   569.1 ± 104.7 530.5 ± 79.5 615.4 ± 114.7* 539.8 ± 89.3 521.2 ± 72.2 569.5 ± 56.0 667.8 ± 144.9
t
 
Side blocks RT (ms)  513.1 ± 137.3 477.5 ± 134.4 555.8 ± 132.5
t
 493.7 ± 165.8 461.4 ± 101.4 500.3 ± 44.2 619.2 ± 173.0
t
 
Direction block RT (ms)  625.3 ± 102.0 583.8 ± 79.5 675.1 ± 105.9* 586.6 ± 96.9 581.0 ± 63.3 638.8 ± 74.7 716.6 ± 126.1 
Congruent reaction RT (ms) 666.9 ± 130.8 615.1 ± 113.3 729.2 ± 126.0* 623.5 ± 142.1 606.7 ± 83.3 663.7 ± 44.7 803.9 ± 150.0
*
 
Incongruent RT (ms) 742.7 ± 147.0 673.3 ± 122.7 826.1 ± 132.2** 676.5 ± 154.9 670.1 ± 89.4 766.7 ± 90.4 894.0 ± 145.4
t
 
Side RT (ms) 657.5 ± 154.9 592.9 ± 146.2 735.0 ± 130.7* 606.4 ± 182.0 579.4 ± 109.2 677.6 ± 74.8 800.6 ± 154.7
t
 
Direction RT (ms) 751.8 ± 125.7 695.3 ± 96.4 819.6 ± 125.7** 693.5 ± 125.2 697.2 ± 63.9 752.3 ± 56.3 896.4 ± 142.4* 
Congruency cost  75.8 ± 51.9 58.2 ± 43.4 96.9 ± 54.7* 52.9 ± 35.7 63.4 ± 51.6 102.9 ± 66.7 90.1 ± 41.2 
Switching cost 273.0 ± 110.3 227.7 ± 102.8 327.3 ± 95.7* 220.9 ± 135.5 234.5.1 ± 63.2 292.7 ± 75.6 367.0 ± 106.1 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (50-80 years). Higher AST RT outcome measures indicate 






Table 6.5. Correlations between attention switching task (AST) outcome measures and age, followed by fitness (V̇O2 max) for the younger 
group and fitness for the older group. 
 All 
participants(n=33) 
Younger (n=19) Older (n=16) 
 Age: years Fitness: V̇O2 max Fitness: V̇O2 max 
Measure r  r r 
Total correct   0.236  0.147  0.048 
Total incorrect  -0.346* -0.134 -0.041 
Switching block errors -0.235 -0.117 -0.101 
Non-switching block errors -0.443** -0.123  0.307 
Side block errors  -0.340 -0.088 -0.111 
Direction block errors -0.337
t
 -0.092  0.333 
Congruent errors  -0.365* -0.110  0.357 
Incongruent errors -0.301
t
 -0.127 -0.077 
Side errors  -0.340
 t
 -0.070 -0.027 
Direction errors  -0.284 -0.173 -0.043 
Omission errors   0.420* -0.228 -0.007 
Commission errors   0.219 all 0 -0.341 
Mean reaction time 
(RT)(ms)  
 0.565** -0.305 -0.208 
Switching RT (ms)   0.585** -0.330 -0.205 
Non-switching RT (ms)    0.476** -0.228 -0.175 
Side blocks RT (ms)   0.314
 t
 -0.225 -0.158 
Direction block RT (ms)   0.552** -0.058 -0.178 
Congruent reaction RT 
(ms) 
 0.507** -0.235 -0.163 
Incongruent RT (ms)  0.601** -0.357 -0.237 
Side RT (ms)  0.517** -0.285 -0.248 
Direction RT (ms)  0.591** -0.297 -0.151 
Congruency cost   0.425* -0.343 -0.191 
Switching cost  0.511** -0.331 -0.089 
Values represent Pearson’s r correlations. * Significant age/fitness effects: * p ≤ 0.05; ** p ≤ 0.01.t Shows a trend towards significance: 0.05 < p ≤ 0.1. For all 





6.4.2.4. Spatial Working Memory (SWM) 
SWM outcome measures are summarised in Tables 6.6 and 6.7. There were marked age 
effects on measures of working memory (number of errors; p < 0.01) and higher executive 
function (use of strategy; p < 0.01), as illustrated by ~3-fold difference in performance 
scores between the younger and older groups where the younger group performed better 
on both of these measures (see Table 6.6). In addition, correlational analysis demonstrated 
moderate-to-strong associations between age and SWM performance (see Table 6.7).  
 
Fitness effects were less clear, with no significant differences between fitness groups for 
either the younger or older group (p > 0.05); although fit participants in both age groups 
had on average better performance for error rate and the use of strategy (see Figure 6.5). In 
support of this fitness effect, correlational analysis showed some associations between 
fitness and performance on some of the SWM outcome measures, although none reached 






Figure 6.5. Spatial working memory task (SWM) outcome measures of number of errors in 
the total number of trials and trials with 4, 6 and 8 tokens. Use of strategy score is also 
shown (high scores indicate poor use of the best strategy). (A) shows younger/ older 





Table 6.6. Mean ± standard deviation in performance scores on spatial working memory (SWM) cognitive task outcome measures. Scores are 
shown for all participants followed by groups: younger/ older groups; younger fit/ unfit; and older fit/ unfit. Higher values indicate poorer 
performance (i.e., more errors or failure to use strategy and memory recall). 
 All participants By age groups  By age and fitness groups 
 n = 33 Younger  Older  Younger fit  Younger unfit  Older fit  Older unfit  
  n= 19 n= 16 n= 9 n = 10 n = 9 n = 7 
Between errors (all trials) 9.9 ± 9.2 5.6 ± 6.1 15.1 ± 9.7** 4.3 ± 7.0 6.9 ± 5.1 15.4 ± 9.9 14.9 ± 10.3 
Between errors (4 boxes) 0.7 ± 1.3 0.4 ± 0.7 1.1 ± 1.7 0.3 ± 0.7 0.6 ± 0.7 1.1 ± 1.6 1.0 ± 1.8 
Between errors (6 boxes) 2.8 ± 3.0 1.4 ± 2.4 4.5 ± 2.9** 1.6 ± 3.1 1.3 ± 1.5 4.8 ± 3.0 4.3 ± 2.9 
Between errors (8 boxes) 6.7 ± 6.2 3.7 ± 5.0 10.6 ± 5.5** 2.4 ± 4.9 5.0 ± 5.1 9.5± 6.1 12.0 ± 4.9 
Within errors (all trials) 0.3 ± 0.6 0.2 ± 0.5 0.4 ± 0.6 0.0 ± 0.0 0.4 ± 0.7
t
 0.4 ± 0.5 0.3 ± 0.8 
Within errors (4 boxes) 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0  0.0 ± 0.0 0.0 ± 0.0 
Within errors (6 boxes) 0.1 ± 0.3 0.1 ± 0.3 0.7 ± 0.3 0.0 ± 0.0 0.2 ± 0.4 0.1 ± 0.4 0.0 ± 0.0 
Within errors (8 boxes) 0.2 ± 0.5 0.1 ± 0.3 0.3 ± 0.6 0.0 ± 0.0 0.2 ± 0.4 0.3 ± 0.5 0.3 ± 0.8 
Total errors (all trials) 10.4 ± 9.2 5.8 ± 6.3 16.4 ± 9.2** 4.3 ± 7.0 7.2 ± 5.5 15.6 ± 10.1 17.3 ± 8.7  
Total errors (4 boxes) 0.7 ± 1.3 0.4 ± 0.7 1.1 ± 1.7 0.3 ± 0.7 0.6 ± 0.7 1.1 ± 1.6 1.0 ± 1.8 
Total errors (6 boxes) 2.9 ± 3.0 1.6 ± 2.5 4.5 ± 2.9** 1.6 ± 3.1 1.6 ± 1.7 4.7 ± 3.0 4.3 ± 2.9 
Total errors (8 boxes) 6.8 ± 6.3 3.8 ± 5.1 10.7 ± 5.6** 2.4 ± 4.9 5.1 ± 5.2 9.8 ± 6.3 12.0 ± 4.9 
Use of strategy 6.8 ± 3.2 5.4 ± 2.5 8.6 ± 3.1** 4.7 ± 2.4 6.1 ± 2.6 8.4 ± 3.8 8.8 ± 2.2 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (60-80 years). For all SWM outcome measures, higher scores 
mean poorer performance.* Significant age/fitness effects (different from younger group/ different from fit group): * p ≤ 0.05; ** p ≤ 0.01.t Shows a trend towards 






Table 6.7. Correlations between spatial working memory (SWM) outcome measures and 
age, followed by fitness (V̇O2 max) for the younger group and fitness for the older group. 
 All 
participants(n=33) 
Younger (n=19) Older (n=16) 
 Age: years Fitness: V̇O2 max Fitness: V̇O2 max 
Measure r  r r 
Between errors (all trials) 0.456**  -0.332
t
 -0.267 
Between errors (4 boxes) 0.227 -0.508* -0.189 
Between errors (6 boxes) 0.472** -0.452* -0.394
t
 
Between errors (8 boxes) 0.519** -0.100 -0.169 
Within errors (all trials) 0.097 -0.129 -0.150 
Within errors (4 boxes) Technical fault 0.309 Technical fault 
Within errors (6 boxes) -0.114 0.328 -0.200 
Within errors (8 boxes) 0.184  0.182 -0.069 
Total errors (all trials) 0.532** -0.289 -0.274 
Total errors (4 boxes) 0.227 -0.508* -0.189 





Total errors (8 boxes) 0.517** -0.078 -0.184 
Use of strategy 0.504** -0.147 -0.262 
Values represent Pearson’s r correlations.  
* Significantly age/fitness effects: * p ≤ 0.05; ** p ≤ 0.01. 
t Shows a trend towards significance: 0.05 < p ≤ 0.1 
For all SWM outcome measures, higher scores mean poorer performance. 
 
 
6.4.2.5. Paired Associates Learning (PAL) 
Between groups analysis of outcome measures from the PAL are summarised in Table 6.8 
and correlations are summarised in Table 6.9. Significant ageing effects were observed 
where the younger group achieved a significantly higher first memory score (p < 0.01) and 
made fewer errors compared to the older group (p < 0.05). No significant fitness effects 
were observed in either of the age groups. However, the younger group did show a trend 
towards more errors in the fit group compared to the unfit group.  
 
There were marked age effects on the measure of first memory score (p < 0.01), and the 
younger group made 63% fewer errors than the older group (p < 0.01). In addition, 





performance (see Table 6.9), where a greater age was associated with lower performance 
on the first attempt memory score and a higher number of errors.  
 
Fitness effects were less clear, with no significant differences between fitness groups for 
either the younger or older group (p > 0.05); although the younger fit group showed a 
trend towards significance where the unfit group made fewer errors (see Table 6.8). In 
contrast, the older fit group made fewer errors than the unfit group and performed better, 







Table 6.8. Mean ± standard deviation in performance scores on paired associates learning (PAL) cognitive task outcome measures. Scores are 
shown for all participants followed by groups: younger/ older groups; younger fit/ unfit; and older fit/ unfit. Higher values indicate poorer 
performance (i.e., more errors).  
 All participants By age groups  By age and fitness groups 
  





Younger fit  
n= 9 
Younger unfit  
n = 10 
Older fit  
n = 9 
Older unfit  
n = 7 
1
st
 attempt memory score 14.3 ± 3.4 15.8 ± 2.3 12.6 ± 3.7** 15.4 ± 2.5 16.2 ± 2.2 12.0 ± 4.0 13.3 ± 3.5 
Total patterns reached 7.9 ± 0.5 7.7 ± 0.7 8.0 ± 0.0 8.0 ± 0.0 8.0 ± 0.0 7.8 ± 0.7 7.7 ± 0.8 
Total errors 9.3 ± 6.6 6.9 ± 5.1 11.9 ± 7.3* 9.1 ± 5.7 5.0 ± 3.7
t
 13.1 ± 8.4 10.4 ± 6.0 
Total errors adjusted 11.0 ± 9.6 6.9 ± 5.1 15.6 ± 11.4* 9.1 ± 5.7 5.0 ± 3.7
t
 16.6 ± 11.3 14.4 ± 12.4 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (50-80 years). Higher scores mean better performance for 1
st
 
attempt memory score and total patterns reached. Higher scores mean poorer performance for total errors and total errors adjusted. 
* Significantly age/fitness effects (different from younger group/ different from fit group): * p ≤ 0.05; ** p ≤ 0.01. 
t Shows a trend towards significance: 0.05 < p ≤ 0.1. 
 
Table 6.9. Correlations (Pearson’s r) with paired associates learning (PAL) outcome measures and age, followed by fitness (V̇O2 max) for the 
younger group, followed by fitness for the older group. 
 All participants 
(n=33) 
Younger (n=19) Older (n=16) 
 Age Fitness: V̇O2 max Fitness: V̇O2 max 
Measure r  r r 
1
st
 attempt memory 
score 
-0.498**  0.100  0.158 
Total patterns reached -0.311
t
   0.219 
Total errors  0.445* 0.001 -0.221 
Total errors adjusted  0.530** 0.001 -0.323 
Values represent Pearson’s r correlations.  
* Significantly age/fitness effects: * p ≤ 0.05; ** p ≤ 0.01. 





6.4.3. Quality of Life Outcome Measures 
Quality of life measures are summarised in Tables 6.10 and 6.11. Data from the 
WHOQOL questionnaire revealed significant age effects in measures of overall health (p = 
0.016) and the social subscale (p = 0.025). From the RAND36, significant age effects were 
observed for: general health (p = 0.010), limitations due to emotional well-being subscale 
(p = 0.013), energy and fatigue (p = 0.020), emotional well-being (p = 0.004) and social 
functioning (p = 0.032). Older participants scored higher (more desirable scores) on all 
measures compared to their younger counterparts (Table 6.10). 
 
In the younger group, significant fitness effects were found in the RAND36 limitations 
due to emotional well-being subscale (p = 0.004) and a trend was observed in the 
WHOQOL psychological health subscale (p = 0.077). In the older group, significant 
fitness effects were observed for the RAND36 physical limitations subscale (p = 0.007) 
and a trend was observed for the WHOQOL social health subscale (p = 0.078; Table 6.10). 
A number of significant correlations between QoL outcome measures and fitness were 







Table 6.10. Mean ± standard deviation in quality of life outcome measures from two quality of life (QoL) questionnaires (WHOQOL and 
RAND-36). Scores are shown for all participants followed by groups: younger/ older groups; younger fit/ unfit; and older fit/ unfit. 
 
  All participants By age groups By age and fitness groups 
 Measure  





Younger fit  
n= 9 
Younger unfit  
n = 10 
Older fit  
n = 9 
Older unfit  
n = 7 
WHOQOL Overall health score 8.5 ± 1.0 8.1 ± 1.1 8.9 ± 0.8* 8.4 ± 0.9 7.9 ± 1.2 9.0 ± 0.8 8.9 ± 0.9 
 Subscale: Physical health 28.5 ± 2.6 27.9 ± 3.2 29.1 ± 1.6 28.1 ± 2.6 27.8 ± 3.7 29.1 ±1.1 29.0 ± 2.2 
 Subscale: Psychological 
health 
24.8 ± 2.9 24.1 ± 2.7 25.5 ± 2.9 25.4 ± 2.0 23.1 ± 2.9
t
 26.3 ± 1.9 24.3 ± 3.8 
 Subscale: Social health 11.4 ± 1.9 10.7 ± 2.1 12.2 ± 1.5* 11.5 ± 1.3 10.1 ± 2.5 12.7 ± 1.1 11.4 ± 1.7
t
 
 Subscale: Environmental 
health 
32.1 ± 4.0 31.0 ± 4.8 33.2 ± 2.7 32.6 ± 4.7 29.7 ± 4.6 32.8 ± 2.7 33.7 ± 2.8 
RAND-36 Overall general health 
score 
75.6 ± 14.9 69.4 ± 15.4 82.1 ± 11.5* 75.6 ± 3.3 64.5 ± 17.9 85.0 ± 10.3 77.9 ± 12.5 
 Subscale: Physical function 93.3 ± 16.8 92.8 ± 22.3 93.8 ± 8.2 99.4 ± 1.8 87.5 ± 29.5 98.0 ± 3.5 87.9 ± 9.5** 
 Subscale: Limit. physical 93.6 ± 18.8 88.9 ± 24.6 98.5 ± 6.1 93.8 ± 11.6 85.0 ± 31.6 100.0 ± 0.0 96.4 ± 9.4 
 Subscale: Limit. emotional 83.8 ± 33.7 70.4 ± 42.6 98.0 ± 8.1* 100.0 ± 0.0 46.7 ± 45.0** 100.0 ±0.0 95.2 ± 12.6 
 Subscale: Energy/ fatigue 68.4 ± 15.9 62.4 ± 15.5 74.7 ± 14.2* 67.5 ± 17.0 58.3 ± 13.9 78.0 ± 10.6 70.0 ± 18.0 
 Subscale: Emotional 
wellbeing 
77.7 ± 15.6 70.7 ± 17.5 85.2 ± 8.6** 68.5 ± 18.8 71.7 ± 17.3 86.0 ± 8.1 84.0 ± 9.8 
 Subscale: Social 
functioning 
90.7 ± 17.2 84.7 ± 21.7 97.1 ± 7.0* 89.1 ± 22.6 81.2 ± 21.4 98.8 ± 4.0 94.6 ± 9.8 
 Subscale: Pain 88.2 ± 10.5 88.9 ± 8.8 87.5 ± 12.2 86.9 ± 9.5 90.5 ± 8.2 89.0 ± 13.7 85.4 ± 10.5 
Values represent mean ± standard deviation. Age groups were defined as younger (18-40 years) and older (50-80 years). Higher scores indicate better QoL. 
* Significantly age/fitness effects (different from younger group/ different from fit group): * p ≤ 0.05; ** p ≤ 0.01. 







Table 6.11. Correlations between quality of life (QoL) outcome measures and age, followed by fitness (V̇O2 max) for the younger group, 
followed by fitness for the older group. 




 Fitness (V̇O2 max) 
Older (n=17) 
Fitness (V̇O2 max) 
  Age (years) Fitness (V̇O2 max) Fitness (V̇O2 max) 
Questionnaire Measure Pearson’s r    
WHOQOL Overall health score  0.455**   0.410
*
 -0.234 
 Subscale: Physical health  0.251  0.319
t
 -0.013 
 Subscale: Psychological health  0.236  0.527*  0.494* 
 Subscale: Social health  0.375*  0.525*  0.368
t
 
 Subscale: Environmental 
health 
 0.313  0.353 -0.366
t 
RAND36 Overall general health score  0.424*  0.482*  0.331
t
 
 Subscale: Physical function  0.040  0.090  0.638** 
 Subscale: Limitations-physical  0.266  0.112  0.181 
 Subscale: Limit. emotional  0.468**  0.580**  0.170 
 Subscale: Energy/ fatigue  0.404*  0.311
t
  0.063 
 Subscale: Emotional wellbeing  0.458** -0.098  0.028 
 Subscale: Social functioning  0.397*  0.303  0.161 
 Subscale: Pain -0.009 -0.019  0.022 
Values represent Pearson’s r correlations. Age groups were defined as: younger (18-40 years) and older (50-80 years). 


















Abbreviations: WHOQOL: World Health Organisation Quality of Life questionnaire; RAND36: Research and 
Development 36-item short form survey instrument.  
* Significant correlation with age/fitness: * p ≤ 0.05; ** p ≤ 0.01. 








Figure 6.6. Correlations between fitness (V̇O2 max) and quality of life (A. WHOQOL: 







6.5. Discussion  
The aims of this study were to compare outcome measures of cognitive function and QoL 
between younger and older groups with varying levels of aerobic fitness. Significant 
ageing and fitness effects were observed in several of the investigated outcome measures. 
Overall, our findings demonstrate that higher aerobic fitness is associated with a range of 
brain health outcome measures, including performance in attention switching and mental 
arithmetic, and quality of life. Therefore, physical activity may protect against the natural 
decline associated with healthy ageing, in addition to declines associated with sedentary 
behaviour. Further, aerobic fitness may protect against neurodegenerative conditions by 
modifying factors associated with disease pathology (i.e., cognitive function and QoL). 
However, these findings should be taken with caution given that the study design is cross-
sectional.  
 
Maximal oxygen consumption was significantly higher in fit compared to unfit groups for 
both the young participants and the older participants. The NZPARQ 7-day activity 
frequency was better at distinguishing between fit and unfit groups for the older 
participants, whereas the self-rated activity category and researcher calculated activity 
category were better at differentiating the younger fit and unfit groups. These differences 
in self-reported activity ratings between age groups should be considered in research 
where fitness is determined by using similar methods. Certainly, issues around the use of 
self-reported activity ratings have been discussed extensively in the literature (see Hays et 
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As expected and consistent with the literature (Deary et al., 2009; Shiroma and Lee, 2010), 
significant age effects were observed for outcome measures of cognitive function, where 
performance in cognitive tasks decreased with age. The older group reported higher scores 
in outcome measures of QoL, in line with existing research associating older age with less 
anxiety, lower stress and a decreased risk of depression (Mroczek et al., 1998).  
 
The results from the AST cognitive task showed that the younger participants were less 
affected by the task that required attention switching and that their response times were 
less likely to slow down due to trying to ignore conflicting irrelevant stimuli. While fitness 
showed no effect on the younger cohort, in the older cohort the fit group responded more 
quickly to the task, indicating that fitness improves performance in ignoring irrelevant 
stimuli (that declines with healthy ageing). The findings from the QoL questionnaires 
showed significant positive associations between fitness and QoL in both age groups. 
Benefits were seen particularly in subscales relating to psychological health, providing 
further evidence that physical activity is good for our emotional health, as well as our 
cognitive health (e.g., ability to attend relevant stimuli and ignore distractors) and physical 
health. 
 
In line with existing literature, clear ageing effects were observed in the memory and 
learning tasks (SWM and PAL), where the older group showed a significant increase in 
reaction time, scored higher in the strategy score (indicating less use of higher executive 
function) and made more errors than the younger group. This decline in performance has 
also been shown to increase in mild cognitive impairment and dementia (Saunders & 
Summers 2011). Although no significant fitness effects were observed, the results did 





times and poor use of strategy) in the unfit group compared to the fit group, in both the 
younger and older cohorts. 
 
The tablet-based cognitive measures were better at differentiating between age and fitness 
groups, likely due to the greater sensitivity and ability to detect subtle differences, as well 
as a larger array of outcome measures to assess (i.e., number of correct responses as well 
as time to respond in several different conditions). Further development of cognitive 
measures with increased sensitivity and sophistication will greatly improve our 
understanding of brain function in health and disease, particularly if measures are designed 
that are more translatable to everyday life, can be individually tailored, and designed to 
target the specific symptoms of disease pathology through associated brain regions. 
 
6.5.1. Study Limitations and Methodology Considerations 
This study recruited a relatively small sample size and our participants were not perfectly 
pair-matched for age and sex. Age effects were clearer than fitness effects due to the larger 
sample size and many significant effects of age on cognition were observed. In contrast, 
the fitness effects tended to reach borderline significance (due to the smaller sample size 
after the age groups were further divided in sub-groups ‘fit’ and ‘unfit’). Based on these 
findings, it is recommended that a sample size of 40 participants in each subgroup be 
recruited in similar studies investigating ageing and fitness using similar cognitive 
measures. Further, all participants were healthy volunteers so findings cannot be 
generalised to clinical populations. However, our findings do support existing research 
where interventions involving physical activity have been used in clinical populations, and 
found improvements in brain health outcome measures of cognition similar to those used 





occasion, so any practice or learning effects that may be a confounding factor in 
intervention studies (Cacciamani et al., 2017) have been avoided in this study. Despite this, 
it is also important to consider that participants may have previously been exposed to 
similar tasks prior to taking part in this study, though it is unlikely that this would have 
affected the results.  
 
Caution should also be taken in generalising results from cognitive tasks to everyday life 
and consider transferability of specific cognitive function to other tasks and situations. 
Similar cognitive tasks to those used as outcome measures in this study are often used in 
brain training tools (e.g., Luminosity, Lumo Labs Inc., https://www.lumosity.com). 
Certainly, there is heated debate around whether ‘brain-training’ (using tasks similar to 
those used in this study as outcome measures) improves cognitive function (Simons et al., 
2016). Further, cognitive training and investigation has been extended to the affective 
domain by adding emotional material to traditionally dry cognitive tasks (Schweizer et al., 
2011). Interestingly in our study, better performance was observed in cognition in 
association with objective measures of aerobic fitness, without any repeated exposure to 
these tasks (i.e., learning effects), providing further evidence that physical activity is 
beneficial for cognitive health.  
 
It is always necessary to consider issues around cause and effect in cross-sectional studies 
that rely on associations between measures. It cannot be concluded that increased physical 
activity will lead to increased objective fitness measures that will lead to benefits in every 
other aspect of physical and psychological health. Although the findings from this study do 
indicate that individuals are more likely to experience benefits across a range of health 





physical activity and fitness and then using outcome measures assessing cognition would 




6.5.2. Conclusion and Recommendations 
 
These data support existing literature showing that physical activity can benefit the brain 
and improve cognitive health. More research is needed that investigates the underlying 
mechanisms that drive these improvements as well as links between different types of 
brain health measures (i.e., cerebrovascular measures). Longitudinal studies that 
incorporate more holistic approaches would allow the investigation of mechanisms and 
demonstrate the cause and effect nature of physical activity interventions. In line with 
better understanding of how to adequately measure brain health we will be better equipped 








This thesis aimed to investigate brain health measures of cerebrovascular health, cognitive 
performance and quality of life, whilst also examining methodological differences in the 
obtainment of some of these measures (i.e., resting cerebral blood flow (CBF) and 
cerebrovascular reactivity (CVR) measures derived using transcranial Doppler (TCD) 
ultrasound and magnetic resonance imaging (MRI)). Further, the effects of ageing and 
fitness on these outcome measures were investigated. 
 
One key finding from this thesis was that different methodological approaches used to 
calculate CVR, including stimulus duration, stimulus concentration, imaging modality and 
analysis approach will alter this widely used outcome measure. These alterations can be 
explained by physiological differences underpinning the process by which these measures 
are derived. With regard to stimulus duration and concentration, these factors affect the 
balance between the contribution of the ventilatory and vascular response to carbon 
dioxide (CO2) during data collection processes for CVR, which is further influenced by the 
choice of steady-state location.  
 
In terms of imaging modalities, TCD and MRI are measuring distinctly different 
physiological phenomena to determine resting CBF and CVR values that likely explains 
some of the discrepancies shown in the results of Chapters 4 and 5, including different 
effects of ageing and fitness on the CVR measure. Specifically, MRI arterial spin labelling 
(ASL) calculates regional perfusion and transit times in the tissue for resting CBF 
measures, and regional changes in blood-oxygen-level dependent (BOLD) signal intensity 
(driven by a delicate balance of CBF velocity, volume and tissue oxygenation) for CVR 





middle cerebral artery blood velocity (MCAv), essentially a conduit vessel that supplies a 
large proportion of cerebral tissue. These differences may explain the contradictory ageing 
and fitness effects observed with CVR measures, though resting CBF measures appear to 
be complementary between imaging modalities. These findings may help explain why 
there is conflicting information in the literature about ageing and fitness effects on CVR. 
Further research is warranted to investigate the discrepancies between modalities, 
specifically looking at how vessel diameter and structure change may influence these 
measures and observed differences between groups. 
 
Measures of resting CBF and cognition (including reaction time, attention switching and 
spatial working memory) were observed to decline across the lifespan; though attention 
switching and mental arithmetic improved with cardiorespiratory fitness. Further, quality 
of life measures significantly correlated with fitness in both younger and older groups. 
Taken together, these findings show that physical activity has many benefits for the brain, 
as has been shown previously in the literature, and discussed throughout this thesis. Future 
research is required to investigate how various measures of brain health are associated with 
one another in carefully matched groups (for age, sex and fitness). 
 
This research highlights existing pitfalls within the scientific literature around inconsistent 
methodological approaches used to determine measures, indicating that guidelines are 
needed and perhaps a gold-standard approach to be developed (or specific gold-standard 
approaches depending on the vessel of interest, clinical condition and/or population being 
investigated). This would make it easier for findings between research centres to be 
directly compared, assuming the studies were using the same methods in similar 





measures may be useful in recognising brain vulnerability to neurodegeneration and 
cognitive decline, which can be detected earlier than currently used approaches, and if 
measured in the same individual over time, may eventually coincide with later biomarkers 
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